data_2n01_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n01 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 . . . . . 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.625 ' CD2' ' HB ' ' B' ' 183' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.559 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.559 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 228' ' ' THR . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . 0.456 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.474 ' CB ' HD21 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 . . . . . 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.516 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.636 0.255 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.401 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.45 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.414 ' CG2' HD12 ' B' ' 229' ' ' LEU . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . 0.408 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 14.2 m120 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.45 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.516 ' HB3' HD23 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.449 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 . . . . . 0 CA--C 1.502 -0.866 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.448 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.48 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.48 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.458 HD23 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.41 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.474 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.474 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.41 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CB ' HD23 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 . . . . . 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 . . . . . 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HD3' ' HH ' ' B' ' 169' ' ' TYR . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.43 ' HH ' ' HD3' ' A' ' 35' ' ' LYS . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.538 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.418 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.488 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 19.9 m170 -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB3' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.535 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . 0.419 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.411 HG21 HG12 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.429 HG23 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.544 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . 0.544 HD21 ' HB2' ' B' ' 242' ' ' HIS . 2.1 t30 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 120.822 0.344 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.445 HG23 HG21 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.412 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.445 HG21 HG23 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.523 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.467 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.433 ' HG3' ' CD2' ' B' ' 214' ' ' HIS . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' B' ' 213' ' ' GLU . 32.9 m170 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.467 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 . . . . . 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' B' ' 163' ' ' TYR . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.474 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.476 HD23 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.401 HG21 HG22 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 251' ' ' ARG . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.478 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.401 HG22 HG21 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.428 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.476 ' CB ' HD23 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . 0.42 HD21 ' N ' ' B' ' 245' ' ' ASN . 0.7 OUTLIER -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.519 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 185' ' ' ASP . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 . . . . . 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.599 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.545 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.444 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.403 HG21 HG22 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.403 HG22 HG21 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.458 HD13 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.485 ' CG2' HD12 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.523 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.523 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.421 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.444 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.599 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 . . . . . 0 N--CA 1.43 -1.452 0 CA-C-O 120.813 0.339 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.429 ' HD2' ' OD1' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 228' ' ' THR . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.429 ' OD1' ' HD2' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.498 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.486 HD12 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . 0.413 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.634 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.504 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . 0.504 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 26.7 m170 -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.583 HD12 ' CG2' ' B' ' 207' ' ' VAL . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.393 0.139 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.42 HG23 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.473 ' HB ' ' OD1' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.426 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . 0.42 HG12 HG23 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.424 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.403 HG22 HG22 ' B' ' 192' ' ' ILE . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.403 HG22 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . 0.446 ' CD2' ' H ' ' B' ' 214' ' ' HIS . 3.1 p80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.431 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . 0.473 ' OD1' ' HB ' ' B' ' 173' ' ' THR . 2.8 t30 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.424 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.495 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.469 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.426 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.426 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.553 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.488 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' B' ' 185' ' ' ASP . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 . . . . . 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.429 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.403 HD23 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.41 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.527 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.527 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.429 ' CG2' HD11 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.426 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.407 ' HA ' ' CD1' ' B' ' 208' ' ' PHE . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.429 HD11 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.403 ' CB ' HD23 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.429 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.204 0.526 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.594 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.572 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.572 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.45 ' SD ' HG13 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.518 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.45 HG13 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.417 ' HB3' HD23 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 . . . . . 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 120.787 0.327 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.553 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.456 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.409 HG22 HG21 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.456 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . 0.458 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.409 HG21 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.447 HD12 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' B' ' 204' ' ' PHE . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' B' ' 202' ' ' GLY . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.52 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD12 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . 0.436 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p . . . . . 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 164' ' ' TYR . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . 0.417 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.439 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.459 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . 0.419 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.51 ' CB ' HD21 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.461 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 . . . . . 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 110.811 -0.07 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.422 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.485 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.419 HG21 HG21 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.465 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.453 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.526 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.4 ' H ' HD21 ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . 0.511 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.528 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . 0.528 HD21 ' HB2' ' B' ' 242' ' ' HIS . 2.8 t30 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 . . . . . 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 . . . . . 0 C--O 1.211 -0.97 0 CA-C-O 120.765 0.317 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.448 HD23 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.412 HG21 HG22 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.412 HG22 HG21 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.4 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.506 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.421 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.4 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.409 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.448 ' CB ' HD23 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? . . . . . 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.547 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.434 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.41 HG22 HG22 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . 0.414 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.41 HG22 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.422 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.548 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.442 HD21 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.434 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 . . . . . 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.433 -1.311 0 CA-C-O 122.055 0.931 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.452 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.413 HD23 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.491 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . 0.548 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.413 ' CB ' HD23 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.531 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.539 0.209 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . 0.414 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' B' ' 228' ' ' THR . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.413 HD13 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.413 ' HG ' HD13 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' B' ' 190' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.442 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' THR . . . . . 0.54 ' OG1' HG21 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.54 HG21 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 190' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 191' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.437 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD12 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' B' ' 190' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.436 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.94 95.51 15.28 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.37 31.65 0.52 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 123.172 2.581 . . . . 0.0 112.971 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.97 154.96 23.46 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -59.56 126.54 20.94 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 122.002 1.801 . . . . 0.0 109.781 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.72 -55.47 9.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 109.566 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CD2' ' HA3' ' B' ' 248' ' ' GLY . 27.7 p90 -118.13 148.38 42.39 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.649 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.46 -160.35 31.71 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.31 -62.34 4.33 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -143.99 97.37 3.04 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p -131.19 16.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -44.96 139.91 2.89 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.022 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.406 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 22.3 t-160 -59.28 90.89 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.405 1.098 . . . . 0.0 113.102 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -141.79 74.21 1.44 Allowed 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 167.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.76 -21.68 24.99 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.687 -168.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -167.66 -39.54 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.77 169.05 13.96 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.86 -32.33 84.63 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.403 2.069 . . . . 0.0 111.755 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -153.88 -58.6 0.12 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.969 0 C-N-CA 127.152 2.181 . . . . 0.0 105.638 176.735 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.506 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -74.25 104.11 4.9 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 73.19 -55.58 0.68 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.115 1.366 . . . . 0.0 111.821 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -175.18 3.4 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.955 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -115.57 112.47 22.22 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.177 0.591 . . . . 0.0 109.579 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.34 99.67 12.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -97.65 116.06 29.13 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.828 0.823 . . . . 0.0 112.378 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.48 134.4 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.344 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 91.4 mt 58.89 -167.33 0.15 Allowed 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.677 1.191 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.22 158.07 17.4 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.38 131.25 37.95 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -112.12 138.13 49.21 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -153.53 100.48 2.42 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.671 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 -80.44 105.72 11.91 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.625 ' CD2' ' HB ' ' B' ' 183' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.559 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.559 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.625 ' HB ' ' CD2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 228' ' ' THR . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . 0.456 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.474 ' CB ' HD21 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 30' ' ' PHE . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -100.63 123.55 45.0 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 165.51 7.78 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.643 0.589 . . . . 0.0 112.066 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -103.41 113.28 26.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.417 -179.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.621 0.248 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.85 90.86 50.28 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.39 161.49 8.22 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.77 1.646 . . . . 0.0 111.378 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.02 105.68 54.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.596 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.32 98.42 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.908 2.406 . . . . 0.0 110.469 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.45 ' H ' HG23 ' B' ' 246' ' ' VAL . 5.4 t70 -106.69 3.87 27.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.011 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -74.05 140.82 45.63 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.939 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.04 -153.0 23.06 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 108.146 -1.981 . . . . 0.0 108.146 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.59 -81.53 1.74 Allowed Glycine 0 C--N 1.288 -2.09 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.515 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -122.52 95.27 4.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.516 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.28 36.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' CB ' ' HA ' ' B' ' 166' ' ' ASP . 28.3 p-10 -64.29 108.27 1.55 Allowed 'General case' 0 C--O 1.25 1.105 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.384 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' B' ' 182' ' ' ARG . 20.0 t-160 69.8 -95.4 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.957 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.762 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -152.77 9.41 0.46 Allowed 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -112.91 -161.14 0.74 Allowed 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.43 16.85 1.86 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.815 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.0 137.84 92.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.54 17.53 1.7 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.728 2.285 . . . . 0.0 115.153 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.258 9.6 t 40.24 74.39 0.1 Allowed 'General case' 0 C--O 1.253 1.273 0 C-N-CA 124.519 1.127 . . . . 0.0 113.211 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HA ' ' HZ3' ' B' ' 255' ' ' LYS . 5.5 tp10 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.656 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.1 m -92.08 -27.55 17.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.61 -45.64 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 91.1 mtp 60.52 -93.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 113.056 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -143.68 169.12 18.34 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 122.911 0.484 . . . . 0.0 110.23 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.06 126.83 46.32 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.397 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -77.87 120.63 23.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.7 mt -81.47 135.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 72.4 mt 60.18 75.66 0.4 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.034 0.921 . . . . 0.0 109.924 -172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -51.28 112.3 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.364 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.0 t70 172.26 -159.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -83.33 -172.68 4.28 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -120.74 40.45 3.52 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.818 0.818 . . . . 0.0 109.849 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 -69.95 121.0 16.53 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.692 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.46 ' HA ' ' CB ' ' A' ' 38' ' ' ASN . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.401 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.504 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.45 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.414 ' CG2' HD12 ' B' ' 229' ' ' LEU . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . 0.408 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . 0.408 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 14.2 m120 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.45 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.516 ' HB3' HD23 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.45 HG23 ' H ' ' A' ' 29' ' ' ASP . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.449 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -79.31 152.41 30.51 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -91.27 152.33 20.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 166.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -87.31 98.32 11.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.054 -1.459 . . . . 0.0 110.445 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . 0.526 ' HZ3' ' HA ' ' A' ' 46' ' ' GLU . 50.6 pttt . . . . . 0 C--O 1.259 1.572 0 C-N-CA 127.056 2.142 . . . . 0.0 115.406 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -150.58 100.42 3.13 Favored Pre-proline 0 N--CA 1.434 -1.231 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 123.33 8.68 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.729 1.62 . . . . 0.0 111.239 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 135.77 25.8 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.697 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.36 165.65 8.87 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.375 2.05 . . . . 0.0 112.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -107.3 133.91 51.15 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.996 -173.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -83.22 153.26 24.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.599 ' O ' ' HB1' ' B' ' 170' ' ' ALA . . . -108.51 144.36 16.28 Favored Glycine 0 CA--C 1.461 -3.339 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.242 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.58 51.68 2.26 Favored Glycine 0 C--O 1.219 -0.841 0 CA-C-N 117.175 0.487 . . . . 0.0 113.011 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -101.42 27.72 6.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p -104.14 21.9 2.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -71.24 109.91 5.57 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -108.23 8.04 27.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.285 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -89.95 84.0 6.17 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.974 0.892 . . . . 0.0 108.949 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -152.62 -69.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -155.05 145.22 21.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.09 115.78 64.56 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.46 -54.57 3.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.65 2.233 . . . . 0.0 110.755 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -92.14 80.14 5.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.89 0.852 . . . . 0.0 109.868 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.426 -1.652 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.437 -178.448 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 35.6 t -142.6 170.59 15.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -120.6 6.32 10.55 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 -173.96 3.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.774 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 77.19 98.57 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.53 1.132 . . . . 0.0 110.182 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 68.3 -175.75 0.2 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.028 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -100.19 125.05 46.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.495 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.4 140.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.452 HD22 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -61.14 118.75 7.22 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.13 -165.31 1.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.211 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -68.41 140.86 55.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -76.55 87.91 3.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.957 1.36 . . . . 0.0 111.334 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -136.75 88.31 2.36 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.205 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -124.67 135.01 52.69 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 31' ' ' GLY . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.48 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.48 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.458 HD23 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.41 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.474 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.474 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.41 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CB ' HD23 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -77.31 159.22 29.72 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -126.19 171.48 10.86 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.79 105.13 7.67 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--N 1.323 -0.578 0 C-N-CA 126.579 1.951 . . . . 0.0 109.191 -176.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -151.26 83.38 5.53 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.26 117.59 2.5 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.532 2.155 . . . . 0.0 110.846 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.98 95.73 48.81 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.203 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.84 -42.59 24.11 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.014 -1.572 . . . . 0.0 108.014 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.9 t70 68.24 -60.53 0.41 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.698 1.999 . . . . 0.0 110.071 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 38.7 p90 -101.2 172.68 6.85 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.458 1.103 . . . . 0.0 108.852 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.55 -155.25 21.46 Favored Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.028 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.41 -72.3 2.37 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 -110.95 91.47 3.67 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HD3' ' HH ' ' B' ' 169' ' ' TYR . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.22 90.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.05 154.93 50.22 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.501 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 73.65 -86.68 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.483 1.113 . . . . 0.0 112.644 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.37 168.52 19.58 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.508 0.671 . . . . 0.0 112.222 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 42' ' ' GLU . 6.5 p-10 -107.97 -99.0 0.37 Allowed 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.626 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 15.9 mm-40 -95.31 -33.99 12.33 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 65.2 98.46 0.04 OUTLIER Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.997 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.33 100.26 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.718 1.612 . . . . 0.0 108.851 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.7 p -77.69 136.58 38.21 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-O 121.75 0.786 . . . . 0.0 112.669 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.411 -2.398 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.6 t -92.5 95.24 9.51 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -84.32 -40.16 18.28 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.51 104.88 16.73 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -75.07 87.08 2.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.93 96.54 10.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.07 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -118.05 135.19 54.34 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.0 mt -74.62 115.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.448 HD21 ' H ' ' B' ' 158' ' ' LEU . 1.9 pt? -98.32 -16.49 19.33 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.965 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 58.7 pttt 32.03 75.34 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.955 2.034 . . . . 0.0 112.754 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.67 15.78 19.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.966 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -73.27 96.82 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.163 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -110.07 -138.92 0.38 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 -65.29 124.47 22.3 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.43 ' HH ' ' HD3' ' A' ' 35' ' ' LYS . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.538 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.418 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 41' ' ' ASP . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.488 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.411 HG12 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 19.9 m170 -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB3' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.535 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . 0.419 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.411 HG21 HG12 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.429 HG23 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.544 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . 0.544 HD21 ' HB2' ' B' ' 242' ' ' HIS . 2.1 t30 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.569 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 -76.98 156.63 31.78 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -68.59 176.26 3.03 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.382 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -69.91 103.79 2.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.288 -2.102 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.373 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -140.76 99.61 6.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 111.469 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -96.85 172.97 0.8 Allowed 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.362 2.042 . . . . 0.0 110.514 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.53 139.42 86.54 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' B' ' 172' ' ' ARG . 4.2 Cg_endo -49.13 -34.78 31.4 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.983 2.455 . . . . 0.0 113.812 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 66.3 166.07 0.2 Allowed 'General case' 0 C--O 1.248 1.023 0 O-C-N 124.088 0.868 . . . . 0.0 110.536 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -92.42 131.17 37.8 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.033 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.44 -152.36 24.07 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.27 -69.89 3.25 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -130.4 95.41 3.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 122.869 0.468 . . . . 0.0 110.143 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.73 9.75 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 12.6 p-10 -81.19 111.35 17.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.455 0.645 . . . . 0.0 111.399 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -108.57 110.24 21.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.1 t80 72.47 121.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.825 1.328 . . . . 0.0 111.252 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -120.15 -153.15 0.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.64 138.85 31.11 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.74 103.91 7.59 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.75 107.44 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.37 2.047 . . . . 0.0 110.773 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 p -93.31 89.4 6.36 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.861 0.839 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -178.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 21.7 p -98.72 -83.29 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -114.05 -1.25 13.8 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 78.8 mtp -155.33 154.22 31.71 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -113.12 112.94 24.68 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.19 136.02 33.17 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -93.69 73.8 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mt -92.84 113.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 92.7 mt -92.75 165.7 12.81 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -84.73 50.62 1.95 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.337 1.065 . . . . 0.0 111.781 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -122.3 117.12 25.34 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' B' ' 163' ' ' TYR . 14.0 ptp180 -81.41 -21.02 39.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.407 ' HA ' ' CZ ' ' B' ' 162' ' ' ARG . 1.2 tpm_? 71.6 11.21 6.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.957 1.303 . . . . 0.0 111.4 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.4 ' H ' ' HG3' ' B' ' 161' ' ' ARG . 72.9 m-85 -99.1 123.79 43.65 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.716 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 28' ' ' PRO . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.445 HG23 HG21 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.412 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.445 HG21 HG23 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.523 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.467 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.433 ' HG3' ' CD2' ' B' ' 214' ' ' HIS . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' B' ' 213' ' ' GLU . 32.9 m170 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.467 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 -98.68 145.49 26.83 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -66.77 173.27 3.62 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.547 0.689 . . . . 0.0 112.338 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' B' ' 254' ' ' GLN . 15.0 mm-40 -88.36 116.42 26.57 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.01 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 126.038 1.735 . . . . 0.0 109.933 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm 72.17 100.27 0.04 OUTLIER Pre-proline 0 C--N 1.345 0.412 0 C-N-CA 123.929 0.892 . . . . 0.0 109.821 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.04 0.48 8.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.237 2.625 . . . . 0.0 113.389 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.89 90.63 47.22 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.21 135.41 59.72 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.67 2.913 . . . . 0.0 113.393 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.33 156.82 19.53 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.995 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 38.1 p90 -66.05 162.03 20.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.892 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' B' ' 171' ' ' THR . . . -86.84 -166.31 42.34 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.21 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.34 8.35 26.66 Favored Glycine 0 N--CA 1.42 -2.38 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -87.75 70.43 9.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p -129.75 25.57 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 20.0 p-10 -68.23 94.08 0.5 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.703 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 70.25 -81.27 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 110.906 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -158.51 113.6 2.59 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 125.564 1.546 . . . . 0.0 109.301 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -94.82 -16.5 22.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 63.59 83.06 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.983 1.313 . . . . 0.0 113.13 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.18 97.05 5.28 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.423 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.29 101.51 0.99 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.396 2.064 . . . . 0.0 111.22 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -114.62 93.65 4.43 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.888 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.947 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 16.5 t 61.85 23.59 13.89 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.953 0.901 . . . . 0.0 112.658 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -109.22 120.76 43.48 Favored 'General case' 0 C--O 1.246 0.911 0 O-C-N 121.528 -0.732 . . . . 0.0 111.325 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 94.7 mmm 68.47 -80.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.072 1.749 . . . . 0.0 110.677 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.14 83.25 1.87 Allowed 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.61 155.02 32.55 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.979 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.94 -165.01 0.98 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 45.7 mt -94.16 128.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.477 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.1 pt? -80.77 116.82 20.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.411 0.624 . . . . 0.0 110.016 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 160' ' ' ASP . 29.0 mtpp -86.7 126.65 34.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' B' ' 159' ' ' LYS . 19.1 t70 74.02 94.97 0.07 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.645 1.212 . . . . 0.0 107.857 -166.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.59 172.53 2.05 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.972 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' B' ' 162' ' ' ARG . 0.6 OUTLIER -112.47 -154.11 0.54 Allowed 'General case' 0 N--CA 1.385 -3.708 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.454 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 -104.63 152.53 22.35 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.474 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.476 HD23 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.401 HG21 HG22 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.438 ' CG ' HH12 ' B' ' 251' ' ' ARG . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.478 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.401 HG22 HG21 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.428 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' THR . . . . . 0.478 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.476 ' CB ' HD23 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . 0.42 HD21 ' N ' ' B' ' 245' ' ' ASN . 0.7 OUTLIER -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.519 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . 0.438 HH12 ' CG ' ' B' ' 185' ' ' ASP . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 -90.72 108.67 19.97 Favored 'General case' 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -71.03 134.32 47.02 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.346 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.58 122.31 24.43 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.193 0 C-N-CA 127.065 2.146 . . . . 0.0 108.797 -173.571 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 120.685 0.279 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -127.43 92.35 43.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.43 146.9 19.77 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.397 2.065 . . . . 0.0 113.957 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 67.77 105.16 0.03 OUTLIER Pre-proline 0 C--O 1.252 1.214 0 C-N-CA 125.722 1.609 . . . . 0.0 112.798 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.57 63.31 5.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.069 2.512 . . . . 0.0 110.115 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -132.16 -176.96 4.24 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -89.8 172.17 9.09 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.762 0.71 . . . . 0.0 111.293 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 -158.38 27.42 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.72 -75.31 2.39 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER -123.06 92.98 3.82 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -177.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.599 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p -153.9 85.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -137.06 155.37 49.74 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.297 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.429 ' HB2' ' CG ' ' B' ' 182' ' ' ARG . 8.5 t60 -104.95 85.55 2.3 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.117 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.31 71.17 0.74 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.288 1.042 . . . . 0.0 108.789 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -157.23 112.06 2.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.648 -1.615 . . . . 0.0 107.714 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.29 25.75 1.34 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.66 134.12 26.96 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.69 126.5 22.62 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.5 2.133 . . . . 0.0 110.356 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -137.86 179.59 6.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.715 0.293 . . . . 0.0 110.309 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.4 p -82.3 -55.66 4.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.496 0.665 . . . . 0.0 109.747 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -92.4 -30.0 16.0 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.866 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 60.2 ttp -97.54 76.74 2.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.677 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -155.48 70.09 0.72 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.685 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 175.12 177.2 0.17 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.09 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.91 95.58 6.48 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.45 128.59 35.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.416 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -137.41 167.77 20.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.98 97.21 10.13 Favored 'General case' 0 N--CA 1.388 -3.568 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.44 103.78 13.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -77.72 128.44 34.06 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 13.5 ttm180 -166.66 94.96 0.52 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 -92.54 107.07 18.94 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.545 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.444 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.403 HG21 HG22 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.403 HG22 HG21 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.458 HD13 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.485 ' CG2' HD12 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.523 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.523 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.421 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.444 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.599 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -74.03 170.67 14.97 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -68.96 146.03 53.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.401 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . 0.418 ' OE1' ' HD3' ' B' ' 162' ' ' ARG . 47.9 mt-30 -83.68 108.93 17.06 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 tptp . . . . . 0 C--O 1.244 0.766 0 C-N-CA 124.982 1.313 . . . . 0.0 110.355 -176.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 25' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 24' ' ' THR . 25.6 mtpp -129.26 100.26 20.49 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.45 -14.52 10.41 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.518 2.145 . . . . 0.0 112.225 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.65 136.18 6.51 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.99 151.97 46.6 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.687 2.258 . . . . 0.0 111.535 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -104.8 130.98 52.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.781 0.801 . . . . 0.0 112.776 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -87.98 152.25 22.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.5 -150.62 22.67 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.48 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.81 -66.31 3.14 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -144.18 102.5 3.87 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.79 101.73 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -134.62 165.52 25.03 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.45 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.9 117.65 13.76 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -86.73 103.25 15.0 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.36 -19.42 42.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.16 109.67 6.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.51 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.71 88.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.83 -10.89 25.38 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.416 2.078 . . . . 0.0 112.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.4 m -149.43 99.59 2.92 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.167 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.244 0.792 0 C-N-CA 124.945 1.298 . . . . 0.0 112.492 175.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.744 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.0 m -63.64 154.54 32.56 Favored 'General case' 0 C--O 1.249 1.028 0 C-N-CA 123.475 0.71 . . . . 0.0 111.162 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -67.17 -35.42 79.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.352 0.596 . . . . 0.0 109.945 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 88.2 mtp -93.13 21.21 6.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.036 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 49.0 t30 79.47 137.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.333 1.453 . . . . 0.0 110.52 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.11 97.49 2.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.498 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.71 38.36 0.74 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.38 108.4 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.59 95.87 6.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.519 1.152 . . . . 0.0 113.537 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -138.29 147.89 44.09 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.051 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.78 103.64 5.11 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.806 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -151.98 2.4 0.37 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -138.99 92.84 2.63 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.813 0.34 . . . . 0.0 110.586 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 -76.76 112.53 13.44 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.401 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.429 ' HD2' ' OD1' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 228' ' ' THR . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.429 ' OD1' ' HD2' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.498 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.486 HD12 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.583 ' CG2' HD12 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.41 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . 0.413 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.634 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.504 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . 0.504 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 26.7 m170 -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.583 HD12 ' CG2' ' B' ' 207' ' ' VAL . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -76.4 160.04 29.92 Favored 'General case' 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 162.65 13.88 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.193 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -85.35 104.04 14.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.941 1.296 . . . . 0.0 111.856 178.219 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.756 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -151.34 100.49 2.99 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -86.49 154.46 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.298 1.999 . . . . 0.0 111.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 110.0 57.84 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.88 82.63 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.473 2.116 . . . . 0.0 110.859 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.94 -174.05 2.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 35.4 p90 -73.61 149.68 41.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 119.045 0.839 . . . . 0.0 112.563 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.74 -159.36 28.0 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.13 -61.82 4.43 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 -133.41 98.21 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.878 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.415 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.56 -35.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' B' ' 183' ' ' VAL . 65.0 t30 -134.47 176.48 8.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.205 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 76.66 4.17 3.48 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.636 1.574 . . . . 0.0 106.819 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -78.32 -24.1 46.77 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.723 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.56 89.01 2.87 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.58 118.74 16.89 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.233 -1.348 . . . . 0.0 110.296 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.39 110.36 50.27 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.205 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 117.29 4.21 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.467 2.112 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -128.78 15.8 6.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.329 -176.55 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.561 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 54.0 m -87.1 92.69 9.14 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.283 0.564 . . . . 0.0 112.032 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -95.19 -37.93 10.81 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 14.4 tpt -150.46 86.91 1.42 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -80.62 144.84 32.03 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.858 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.39 121.28 29.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -82.07 128.05 33.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.476 0.655 . . . . 0.0 109.956 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.99 137.5 28.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 63.0 mt -92.46 54.58 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.523 0.677 . . . . 0.0 109.784 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt 53.73 29.23 9.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.643 1.977 . . . . 0.0 113.039 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -83.67 108.39 16.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -139.73 83.92 1.95 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.531 0.682 . . . . 0.0 112.456 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -167.09 81.11 0.22 Allowed 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.723 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.61 120.87 22.36 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.42 HG23 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.473 ' HB ' ' OD1' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.426 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . 0.42 HG12 HG23 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.424 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.418 ' H ' ' HB2' ' A' ' 38' ' ' ASN . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.403 HG22 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . 0.446 ' CD2' ' H ' ' B' ' 214' ' ' HIS . 3.1 p80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.431 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . 0.473 ' OD1' ' HB ' ' B' ' 173' ' ' THR . 2.8 t30 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.424 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.414 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.415 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -86.36 175.72 8.27 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -125.25 142.22 51.63 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.552 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -112.55 112.23 23.62 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.258 1.508 0 O-C-N 125.149 1.53 . . . . 0.0 108.563 -173.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 175.14 130.42 0.14 Allowed Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 124.839 1.255 . . . . 0.0 107.639 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -86.68 -12.54 5.27 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.769 1.646 . . . . 0.0 112.27 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.29 126.33 7.53 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.77 89.45 1.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.808 1.672 . . . . 0.0 109.959 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.07 144.84 50.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.277 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.251 30.3 p90 41.39 -158.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.995 1.718 . . . . 0.0 114.854 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.77 -124.57 2.7 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.57 -4.71 0.1 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.161 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -86.85 79.67 8.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.488 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.25 81.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 25.2 t-20 -113.64 111.55 22.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.125 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.537 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 69.2 m80 74.7 -58.78 0.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.195 0.998 . . . . 0.0 111.699 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -173.71 156.93 3.0 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' CG ' ' HD3' ' A' ' 35' ' ' LYS . 32.2 t70 -109.79 94.06 4.83 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 121.617 0.722 . . . . 0.0 109.432 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -130.53 21.25 5.13 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.52 141.5 22.94 Favored Pre-proline 0 N--CA 1.435 -1.189 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.626 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.76 14.75 0.15 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 123.168 2.579 . . . . 0.0 114.265 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -74.17 109.51 7.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.582 0.753 . . . . 0.0 109.998 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.291 1.436 . . . . 0.0 111.596 -179.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m -80.43 -40.24 26.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.803 0.335 . . . . 0.0 111.005 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -118.23 168.74 10.31 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 38.0 tpp 70.04 -62.41 0.43 Allowed 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 126.862 2.065 . . . . 0.0 110.543 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -96.51 89.93 5.19 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.16 102.28 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.349 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.35 125.35 29.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' B' ' 158' ' ' LEU . 49.5 mm -59.72 137.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.665 0.603 . . . . 0.0 110.951 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 157' ' ' ILE . 49.8 mt 73.86 108.09 0.07 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.122 1.769 . . . . 0.0 112.923 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -74.95 127.22 32.72 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.611 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.61 114.65 3.69 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 123.717 0.636 . . . . 0.0 109.556 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -77.41 147.13 36.17 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.21 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -87.23 82.24 7.7 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.188 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 -77.64 111.22 13.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.495 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . 0.437 ' HA ' ' CE ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.469 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.426 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.426 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.553 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.488 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' B' ' 185' ' ' ASP . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -59.79 118.42 6.15 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -67.46 154.9 40.31 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.11 -1.404 . . . . 0.0 108.168 173.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -86.92 98.69 11.37 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -175.162 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -121.62 89.99 47.81 Favored Pre-proline 0 N--CA 1.448 -0.551 0 CA-C-N 118.728 0.694 . . . . 0.0 109.732 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.2 -14.23 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.534 2.156 . . . . 0.0 113.104 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.08 93.4 47.9 Favored Pre-proline 0 N--CA 1.426 -1.635 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.79 84.26 1.94 Allowed 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.854 1.703 . . . . 0.0 109.762 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -128.96 -173.95 3.12 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -80.58 176.05 10.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.157 0.503 . . . . 0.0 112.344 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.94 -166.03 30.32 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.316 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.4 -4.31 22.01 Favored Glycine 0 N--CA 1.409 -3.142 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -78.73 77.18 5.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.429 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.64 14.24 7.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.85 123.78 20.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.961 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.49 ' CG ' ' HG3' ' B' ' 182' ' ' ARG . 28.1 t-80 -87.07 127.95 35.11 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.51 81.07 8.89 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.304 0.573 . . . . 0.0 112.212 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -100.14 81.81 2.45 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -107.68 129.28 55.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.768 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.43 63.27 7.51 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.298 1.039 . . . . 0.0 110.583 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -95.69 17.53 0.75 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.838 2.359 . . . . 0.0 111.784 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.8 m 72.28 -25.96 0.18 Allowed 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.817 1.247 . . . . 0.0 112.982 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.153 179.124 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.622 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 14.8 m -57.51 -18.97 21.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.145 . . . . 0.0 112.359 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -73.38 -28.48 62.04 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.415 0.686 . . . . 0.0 110.724 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 63.1 mtt -120.01 15.15 12.44 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.603 0.716 . . . . 0.0 110.44 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -126.94 169.55 13.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.1 129.27 34.48 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . 0.469 ' HB2' ' HZ3' ' B' ' 156' ' ' LYS . 0.1 OUTLIER -88.12 -174.04 4.5 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 61.7 mt -69.6 131.4 34.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.12 167.67 18.52 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.583 0.706 . . . . 0.0 111.712 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -88.4 45.78 1.32 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.459 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.04 175.71 5.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.002 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -101.15 -133.38 0.28 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -143.12 158.32 43.72 Favored 'General case' 1 N--CA 1.37 -4.432 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 177.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -69.29 111.26 5.08 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.355 1.034 . . . . 0.0 109.244 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.403 HD23 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.49 ' HG3' ' CG ' ' A' ' 39' ' ' HIS . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.41 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.527 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.527 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.429 ' CG2' HD11 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.426 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.407 ' HA ' ' CD1' ' B' ' 208' ' ' PHE . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.429 HD11 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.403 ' CB ' HD23 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.429 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -67.26 119.73 12.62 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.464 ' HB3' ' HZ1' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -70.42 153.84 42.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.292 178.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.54 99.1 8.62 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.137 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 113.349 -1.75 . . . . 0.0 106.589 179.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -134.89 103.22 10.91 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -90.61 -176.17 0.98 Allowed 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.382 2.055 . . . . 0.0 112.67 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.07 151.9 84.1 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.058 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.12 -56.77 2.72 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.948 2.432 . . . . 0.0 112.672 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.79 171.12 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.679 1.191 . . . . 0.0 114.006 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -98.92 135.43 40.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.22 -157.03 27.02 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.05 -61.44 4.01 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -145.64 102.91 3.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.83 8.91 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.35 99.28 1.18 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.875 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.11 142.19 30.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.952 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.27 82.8 4.55 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -101.74 -73.68 0.64 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.784 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -100.25 -78.05 0.52 Allowed 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 45' ' ' THR . . . -156.44 101.76 2.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 O-C-N 122.361 -0.212 . . . . 0.0 110.598 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.74 25.77 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.986 2.457 . . . . 0.0 112.378 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 43' ' ' ALA . 5.0 t -119.1 -37.14 3.25 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -175.646 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.759 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -68.92 -35.95 77.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -104.05 117.1 33.48 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 97.0 mmm 69.84 93.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.495 1.122 . . . . 0.0 110.715 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -113.55 140.82 47.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.427 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.26 145.03 30.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.81 58.61 4.74 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.957 0.884 . . . . 0.0 111.789 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.0 111.43 19.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 81.9 mt 56.41 -167.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.934 1.396 . . . . 0.0 111.254 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.83 -168.49 2.1 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' B' ' 161' ' ' ARG . 7.9 t70 -73.32 -161.22 0.09 Allowed 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . 0.519 ' O ' ' HD2' ' B' ' 162' ' ' ARG . 14.1 ptt-85 -61.48 142.47 57.0 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.5 0.72 . . . . 0.0 112.739 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.519 ' HD2' ' O ' ' B' ' 161' ' ' ARG . 19.9 mmm180 -125.69 27.01 6.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.012 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.594 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 -66.05 128.45 36.12 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.229 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.594 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.572 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.572 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.45 ' SD ' HG13 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.518 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.45 HG13 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.417 ' HB3' HD23 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -85.83 109.32 18.6 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 162.76 11.25 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.96 143.22 26.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 125.442 1.497 . . . . 0.0 110.368 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.436 -1.168 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.62 93.46 3.28 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.64 -68.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.259 1.972 . . . . 0.0 111.944 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 133.23 4.15 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.79 100.16 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.815 1.677 . . . . 0.0 112.594 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' O ' HG12 ' B' ' 246' ' ' VAL . 11.3 m-20 -77.99 -34.31 50.94 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.338 1.066 . . . . 0.0 108.298 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.03 153.47 42.99 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.655 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.37 -171.78 27.93 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.23 4.06 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 -124.35 92.03 3.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 122.137 0.175 . . . . 0.0 110.769 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p -128.67 19.85 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 3.1 t-20 -62.4 102.26 0.3 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.678 ' NE2' ' HA ' ' A' ' 42' ' ' GLU . 18.9 t-160 -144.42 99.25 3.34 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 118.77 -1.172 . . . . 0.0 112.733 -166.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -138.99 -17.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.208 1.004 . . . . 0.0 109.132 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -87.51 -0.61 57.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.246 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.678 ' HA ' ' NE2' ' A' ' 39' ' ' HIS . 34.3 mm-40 55.58 86.19 0.06 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.045 1.338 . . . . 0.0 113.362 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.42 154.78 38.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.818 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -69.68 95.1 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.188 1.925 . . . . 0.0 112.443 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -85.9 -68.1 0.76 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.423 -1.795 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.003 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -117.04 156.54 27.35 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 76.56 -41.38 0.4 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.231 1.012 . . . . 0.0 111.173 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 44.0 tpp -140.78 136.59 32.62 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -84.61 170.73 13.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -130.91 153.45 49.15 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -77.43 134.1 38.48 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.3 130.54 33.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.0 -169.7 2.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.6 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -61.24 142.56 56.72 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.628 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -81.02 102.69 10.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.94 0.876 . . . . 0.0 110.17 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -110.6 145.94 36.99 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.66 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 19.1 mtm180 -87.1 -1.0 57.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -83.96 112.32 20.06 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.186 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.553 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.456 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.409 HG22 HG21 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.66 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.456 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.458 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.409 HG21 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.447 HD12 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' B' ' 204' ' ' PHE . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' B' ' 202' ' ' GLY . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.52 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.52 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD12 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . 0.456 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . 0.436 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 29' ' ' ASP . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 -76.09 109.46 9.77 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -73.98 147.92 42.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.828 175.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.5 100.58 13.31 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.428 -1.55 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.419 -177.174 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.897 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -154.6 98.8 2.46 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.2 -174.66 2.07 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.16 1.907 . . . . 0.0 111.136 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' O ' ' HD2' ' B' ' 172' ' ' ARG . . . -99.53 107.57 46.16 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.36 153.3 10.65 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.192 1.928 . . . . 0.0 110.692 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 63.63 -160.84 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.21 0.604 . . . . 0.0 110.456 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.07 143.5 30.54 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.62 -159.51 28.1 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.029 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.28 -61.4 4.24 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.471 ' O ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -136.07 95.99 3.31 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 -179.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.657 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p -122.04 71.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 16.8 p30 -142.94 141.97 31.57 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.224 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -118.36 105.45 11.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -87.29 76.71 9.11 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.8 0.81 . . . . 0.0 111.406 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -125.15 89.34 3.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 123.009 1.385 . . . . 0.0 110.146 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.23 -31.86 55.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.103 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.53 164.29 18.45 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.01 148.57 76.1 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 121.927 1.751 . . . . 0.0 110.737 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -73.53 93.4 2.0 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.322 0.582 . . . . 0.0 110.97 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.703 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.2 p -91.75 161.33 14.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 117.657 0.729 . . . . 0.0 109.52 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -89.91 -80.68 0.31 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -142.47 109.81 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.85 100.83 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 110.666 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -126.11 164.14 21.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.142 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -65.58 154.82 37.65 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 122.092 0.949 . . . . 0.0 111.273 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.68 133.79 34.36 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.554 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.497 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -90.8 131.53 36.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -128.3 -177.67 4.25 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.612 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' B' ' 161' ' ' ARG . 20.7 t70 67.65 -156.14 0.21 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . 0.488 ' H ' ' CG ' ' B' ' 160' ' ' ASP . 4.3 mtp180 -74.1 -37.24 64.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' B' ' 162' ' ' ARG . 0.1 OUTLIER 67.97 110.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 112.76 -2.018 . . . . 0.0 113.663 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -70.13 117.39 11.63 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 164' ' ' TYR . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.657 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . 0.417 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.439 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.459 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . 0.419 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.51 ' CB ' HD21 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.461 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -69.61 154.93 41.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' B' ' 254' ' ' GLN . 13.2 tmtt? -66.62 143.96 56.69 Favored 'General case' 0 N--CA 1.416 -2.153 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.915 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . 0.468 ' N ' ' HD3' ' B' ' 253' ' ' LYS . 78.8 mt-30 -80.93 100.47 8.91 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.582 1.182 . . . . 0.0 111.148 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? . . . . . 0 C--N 1.29 -2.006 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.228 -178.853 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.553 1.071 0 CA-C-O 121.277 0.561 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -133.75 109.46 12.04 Favored Pre-proline 0 N--CA 1.434 -1.242 0 O-C-N 121.227 -0.92 . . . . 0.0 110.061 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -95.79 34.76 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.813 2.342 . . . . 0.0 110.097 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.1 146.89 95.35 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.887 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.86 105.27 0.15 Allowed 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 122.274 1.983 . . . . 0.0 112.915 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.498 ' N ' HG12 ' B' ' 246' ' ' VAL . 4.4 m-20 -67.74 84.87 0.2 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -121.25 135.22 55.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.91 166.32 13.93 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.356 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 -71.15 2.95 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 -84.76 69.09 10.65 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.811 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.39 21.55 5.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 31.4 t-20 -67.58 100.56 0.89 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.952 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 70.52 -7.18 1.06 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.484 1.114 . . . . 0.0 112.911 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' B' ' 181' ' ' SER . 70.0 t80 68.77 93.01 0.08 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -168.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.87 -31.56 14.28 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.628 -168.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.74 106.96 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.149 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.56 117.4 57.08 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.285 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.03 -49.14 7.01 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.124 1.883 . . . . 0.0 110.648 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 1.2 p -119.06 94.44 4.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.329 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 45' ' ' THR . 14.6 mm-40 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.716 2.007 . . . . 0.0 107.759 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.965 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 26.1 t -88.26 82.9 6.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -94.16 104.82 16.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 56.6 ttp -108.63 118.9 37.97 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -76.84 97.3 4.51 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.531 0.681 . . . . 0.0 109.459 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.38 106.17 17.76 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.419 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -109.33 120.93 44.0 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.418 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.61 136.95 23.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.324 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.21 171.76 8.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.806 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -76.59 142.99 40.54 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.646 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -134.07 149.69 51.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -79.15 102.92 8.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -100.33 11.33 39.65 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.392 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 -69.14 116.98 10.21 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.437 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.422 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.485 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.419 HG21 HG21 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.465 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.453 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.526 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.4 ' H ' HD21 ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . 0.511 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.528 ' HB2' HD21 ' B' ' 245' ' ' ASN . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . 0.528 HD21 ' HB2' ' B' ' 242' ' ' HIS . 2.8 t30 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 29' ' ' ASP . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 -85.99 138.26 32.11 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 154.44 30.1 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.135 173.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.27 101.73 0.14 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 124.312 1.008 . . . . 0.0 112.387 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--N 1.289 -2.043 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.796 174.546 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -133.79 106.2 11.7 Favored Pre-proline 0 N--CA 1.428 -1.553 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.235 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -94.92 -172.01 0.24 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.152 1.902 . . . . 0.0 109.948 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.05 111.4 38.03 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -84.47 96.33 0.7 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.111 1.874 . . . . 0.0 110.194 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -102.64 174.2 6.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.436 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.595 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 31.0 p90 -117.69 167.62 11.18 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.582 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.93 -169.06 28.74 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.124 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.63 -84.32 0.88 Allowed Glycine 0 N--CA 1.445 -0.701 0 O-C-N 124.112 0.536 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 -78.62 74.41 5.16 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.173 0.989 . . . . 0.0 110.171 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.572 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p -119.73 25.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 47.1 t30 -58.29 104.02 0.18 Allowed 'General case' 0 C--O 1.251 1.14 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.004 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.633 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 36.4 m-70 77.94 -60.97 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 0.0 110.777 -176.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -155.53 177.18 11.66 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 125.248 1.419 . . . . 0.0 107.469 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.09 -54.39 4.66 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.43 98.78 0.02 OUTLIER 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.818 1.647 . . . . 0.0 113.891 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.59 93.44 0.05 OUTLIER Pre-proline 0 C--O 1.243 0.714 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.23 19.19 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.77 2.313 . . . . 0.0 111.958 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 m -66.81 -31.21 71.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.463 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 15.8 m -74.24 115.68 14.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.888 0.344 . . . . 0.0 111.359 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 60.29 28.59 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.927 0.891 . . . . 0.0 112.918 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 25.5 ttt -74.85 -44.16 50.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.878 0.37 . . . . 0.0 110.5 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 m120 61.4 105.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.462 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.65 32.38 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.895 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -74.1 114.88 12.94 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.437 HD11 ' H ' ' B' ' 157' ' ' ILE . 3.1 mp -62.54 120.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.201 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.437 ' HB2' ' NH2' ' B' ' 162' ' ' ARG . 93.7 mt -98.89 126.8 44.65 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' B' ' 161' ' ' ARG . 33.2 mmtp -67.85 -171.88 0.24 Allowed 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.69 8.13 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 128.086 2.554 . . . . 0.0 113.474 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' B' ' 159' ' ' LYS . 98.4 mtt180 -88.59 -11.47 45.42 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.924 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' B' ' 158' ' ' LEU . 15.1 ptp180 -69.17 -46.03 68.52 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 122.391 1.091 . . . . 0.0 110.812 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -164.05 151.12 11.87 Favored 'General case' 0 C--N 1.256 -3.466 0 C-N-CA 129.667 3.187 . . . . 0.0 103.376 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' B' ' 254' ' ' GLN . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.448 HD23 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 39' ' ' HIS . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.412 HG21 HG22 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.412 HG22 HG21 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.4 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.506 ' HG2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.506 ' HB1' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.421 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.4 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.409 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.448 ' CB ' HD23 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.595 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.04 167.04 22.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 131.5 36.28 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.673 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' B' ' 164' ' ' TYR 0.274 3.8 pm0 -84.17 99.44 10.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt . . . . . 0 CA--C 1.491 -1.316 0 C-N-CA 128.331 2.653 . . . . 0.0 105.634 173.817 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -117.04 96.02 48.23 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 122.296 -0.253 . . . . 0.0 110.629 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -102.9 -150.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.371 0 C-N-CA 123.089 2.526 . . . . 0.0 107.995 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.28 122.2 4.09 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' B' ' 244' ' ' ASP . 31.2 Cg_exo -62.14 94.26 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.991 1.794 . . . . 0.0 108.338 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 153.0 31.84 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.398 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -82.63 125.54 31.3 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.52 -158.62 26.6 Favored Glycine 0 C--N 1.284 -2.352 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 -67.17 3.75 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.075 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -129.83 95.82 4.06 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.404 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p -116.64 17.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -62.07 139.6 58.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.458 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 2.8 t60 -57.89 -19.35 28.87 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.528 1.131 . . . . 0.0 113.266 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -70.35 81.26 0.55 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.464 1.126 . . . . 0.0 111.681 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.49 93.39 4.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.92 -29.28 65.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.716 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.1 103.32 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.697 0 O-C-N 124.517 1.136 . . . . 0.0 110.658 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.56 99.58 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.063 1.842 . . . . 0.0 110.058 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.9 m -157.52 131.89 8.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--N 1.29 -1.988 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.646 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -150.55 -54.31 0.15 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.541 ' CD2' ' HG3' ' B' ' 153' ' ' MET . 42.2 t60 -110.5 126.47 54.4 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' MET . . . . . 0.541 ' HG3' ' CD2' ' B' ' 152' ' ' HIS . 57.2 mtm 70.94 73.13 0.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 124.811 1.244 . . . . 0.0 112.531 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -106.57 16.5 24.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.29 1.519 . . . . 0.0 107.203 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.23 92.29 6.89 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.865 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.53 118.48 23.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.445 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.08 136.73 24.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.77 162.11 13.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.037 0.446 . . . . 0.0 110.215 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -84.41 75.5 10.24 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.662 0.744 . . . . 0.0 111.291 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -96.86 116.71 29.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.59 141.85 58.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.587 0.555 . . . . 0.0 110.572 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -82.89 -7.26 59.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.059 0.933 . . . . 0.0 110.808 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 -83.6 120.06 25.5 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.163 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.547 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.434 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.41 HG22 HG22 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.414 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.41 HG22 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.422 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.548 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.548 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.442 HD21 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.434 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . 0.543 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . 0.504 ' OD1' ' HG2' ' A' ' 28' ' ' PRO . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -72.29 134.03 45.33 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 164.76 25.45 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.406 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -66.14 99.97 0.56 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--O 1.259 1.599 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.842 -173.523 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -142.17 92.82 7.45 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.53 95.6 0.99 Allowed 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.906 1.737 . . . . 0.0 111.506 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 93.5 6.18 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.862 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.38 124.13 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.147 1.898 . . . . 0.0 111.549 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -147.99 173.92 12.42 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -62.93 153.68 32.74 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.189 0.518 . . . . 0.0 112.204 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.4 -157.63 33.87 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.006 -1.093 . . . . 0.0 112.177 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.67 58.11 0.71 Allowed Glycine 0 CA--C 1.476 -2.35 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.62 39.46 3.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.894 -1.153 . . . . 0.0 108.238 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CD2' ' HB1' ' B' ' 170' ' ' ALA . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -115.63 95.92 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -142.06 129.78 21.61 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 43.17 62.77 1.72 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.002 1.321 . . . . 0.0 111.327 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -86.27 92.01 8.65 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.36 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.02 -20.67 28.49 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.92 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -51.51 93.18 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.546 1.538 . . . . 0.0 112.391 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 113.56 62.46 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.19 87.65 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.138 1.892 . . . . 0.0 111.654 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 m -79.95 -30.93 39.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.855 1.262 . . . . 0.0 111.739 172.341 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m 68.31 159.46 0.16 Allowed 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.345 1.058 . . . . 0.0 112.011 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 74.46 125.36 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.096 1.358 . . . . 0.0 111.602 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.54 118.52 14.46 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 73.68 81.95 0.12 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 109.171 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.4 141.74 57.42 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.233 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -82.69 115.68 21.73 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -105.55 136.72 38.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.04 -178.16 4.97 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -124.02 173.08 8.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -143.56 143.46 31.53 Favored 'General case' 0 C--O 1.201 -1.452 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 43.99 -100.0 0.03 OUTLIER 'General case' 0 C--O 1.236 0.382 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -132.56 19.3 4.29 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 -74.76 116.86 15.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.925 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.452 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.448 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.413 HD23 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.491 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . 0.548 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.421 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.413 ' CB ' HD23 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.531 ' CB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -84.33 111.04 19.06 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -67.99 150.21 48.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.388 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -95.18 117.28 29.95 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.499 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -154.05 93.85 2.92 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -96.48 3.21 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.323 2.015 . . . . 0.0 110.994 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 136.13 34.76 Favored Pre-proline 0 C--O 1.244 0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.749 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.65 141.97 35.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 0.0 112.662 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -137.08 -177.01 4.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -91.28 131.03 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.542 0.687 . . . . 0.0 110.669 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.4 -157.26 27.33 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.19 -68.89 3.44 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -128.58 95.53 4.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 122.319 0.247 . . . . 0.0 111.264 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.502 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.3 18.95 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -76.35 93.39 3.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.216 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.4 t60 61.51 80.41 0.22 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 122.023 0.916 . . . . 0.0 112.539 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -132.79 24.4 4.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.93 1.348 . . . . 0.0 108.137 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.3 -40.49 17.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -91.91 -68.69 0.78 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.544 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.48 85.53 0.19 Allowed Pre-proline 0 C--N 1.342 0.264 0 O-C-N 124.492 1.12 . . . . 0.0 111.518 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.51 -65.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.6 2.2 . . . . 0.0 112.369 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -141.3 101.2 3.96 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.253 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.506 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.8 p -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.259 -0.554 . . . . 0.0 110.732 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.1 m80 71.36 13.52 6.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.535 1.134 . . . . 0.0 110.803 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 27.1 ttt -79.78 98.99 7.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.28 23.63 5.68 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.74 1.257 . . . . 0.0 111.177 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.44 170.15 10.26 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.053 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -93.63 172.65 8.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.6 mt -89.09 108.92 19.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.478 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.1 pt? -94.49 132.92 38.65 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.745 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -97.79 179.0 4.96 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.98 139.23 55.01 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 123.456 0.702 . . . . 0.0 111.021 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -130.6 178.36 6.68 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -97.35 4.68 50.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 109.645 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 -73.62 108.49 6.49 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . 0.414 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' B' ' 228' ' ' THR . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . 0.414 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.413 HD13 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.413 ' HG ' HD13 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' B' ' 190' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.442 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -73.1 133.72 44.25 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -70.15 159.38 34.04 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -90.3 99.59 12.58 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 C--N 1.285 -2.203 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.902 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -133.11 117.99 14.99 Favored Pre-proline 0 N--CA 1.426 -1.629 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.2 96.7 0.96 Allowed 'Trans proline' 0 N--CA 1.422 -2.718 0 C-N-CA 121.15 1.233 . . . . 0.0 111.423 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.43 146.13 80.51 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.01 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.35 151.48 54.05 Favored 'Trans proline' 0 C--O 1.256 1.405 0 C-N-CA 122.628 2.219 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 72.23 -70.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.602 1.161 . . . . 0.0 112.858 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.453 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 50.5 p90 -124.94 134.69 52.55 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.414 0.626 . . . . 0.0 110.926 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.15 -163.66 31.1 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 -57.97 4.83 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 -124.88 92.99 3.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 122.376 0.27 . . . . 0.0 110.732 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB3' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p -133.94 28.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.04 89.22 0.08 Allowed 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.31 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 55.38 86.92 0.05 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 111.452 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' B' ' 181' ' ' SER . 73.6 m-85 87.24 129.23 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.753 1.621 . . . . 0.0 112.868 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 -28.22 30.99 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.28 21.19 4.57 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.53 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.86 103.86 12.85 Favored Pre-proline 0 N--CA 1.446 -0.647 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.26 121.45 6.49 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.491 2.128 . . . . 0.0 112.848 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -103.87 -30.72 10.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.359 0.6 . . . . 0.0 109.644 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.433 -1.288 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.755 177.512 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 24.7 p -116.16 -12.6 11.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.873 0.336 . . . . 0.0 111.065 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m170 66.36 18.35 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.024 0.93 . . . . 0.0 111.463 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.03 136.3 50.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.91 128.71 36.27 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.063 0.459 . . . . 0.0 109.969 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.62 104.92 15.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -87.27 122.88 31.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 53.0 mt -76.5 106.05 6.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 94.1 mt -71.63 130.26 40.76 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.068 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -114.52 104.12 11.7 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.893 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.7 136.27 52.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.701 0.762 . . . . 0.0 109.571 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' ARG . . . . . 0.63 ' HD3' ' OD2' ' B' ' 186' ' ' ASP . 76.7 mtt180 -88.53 172.66 9.16 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.21 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -96.43 84.63 3.75 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.427 0.632 . . . . 0.0 109.431 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -74.7 129.89 38.53 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.548 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' TYR . . . . . 0.483 ' OH ' ' HA ' ' B' ' 254' ' ' GLN . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' THR . . . . . 0.54 ' OG1' HG21 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.54 HG21 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.63 ' OD2' ' HD3' ' B' ' 161' ' ' ARG . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.437 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.541 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD12 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' B' ' 190' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.541 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' HIS . . . . . 0.458 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.436 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -67.61 148.26 51.63 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.71 145.38 15.72 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.162 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' GLN . . . . . 0.483 ' HA ' ' OH ' ' B' ' 164' ' ' TYR . 25.1 mt-30 -79.42 98.78 6.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.92 0.866 . . . . 0.0 110.09 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--N 1.289 -2.048 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.339 -178.22 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 . . . . . 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 37' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.569 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.404 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.404 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' B' ' 180' ' ' PRO . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' B' ' 179' ' ' ILE . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.454 HG23 HG22 ' B' ' 183' ' ' VAL . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.426 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 211' ' ' GLU . . . . . 0.466 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.494 ' CB ' HD22 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.427 HG13 ' HB ' ' B' ' 171' ' ' THR . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 . . . . . 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 13.6 p . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.636 0.255 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.447 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.401 HG21 HG12 ' B' ' 179' ' ' ILE . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.493 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 179' ' ' ILE . . . . . 0.401 HG12 HG21 ' B' ' 171' ' ' THR . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.498 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.465 HG21 HG21 ' B' ' 222' ' ' THR . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 207' ' ' VAL . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.611 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 . . . . . 0 CA--C 1.502 -0.866 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.476 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 164' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.504 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.491 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.491 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' B' ' 192' ' ' ILE . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 188' ' ' LYS . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.404 ' CD1' HG12 ' B' ' 230' ' ' ILE . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.547 HG23 HG22 ' B' ' 183' ' ' VAL . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.417 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' ARG . . . . . 0.406 ' HE ' ' CG1' ' B' ' 246' ' ' VAL . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.472 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.406 ' CG1' ' HE ' ' B' ' 241' ' ' ARG . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 . . . . . 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 . . . . . 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.438 HG21 HG12 ' B' ' 179' ' ' ILE . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.555 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.4 HD22 ' CB ' ' B' ' 242' ' ' HIS . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 179' ' ' ILE . . . . . 0.438 HG12 HG21 ' B' ' 171' ' ' THR . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.435 HG22 HG23 ' B' ' 192' ' ' ILE . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.435 HG23 HG22 ' B' ' 183' ' ' VAL . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.515 HG11 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.545 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' B' ' 213' ' ' GLU . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.545 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.515 HG21 HG11 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.434 HG21 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.4 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 120.822 0.344 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.426 ' HA ' HG23 ' B' ' 234' ' ' THR . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.659 HG23 HG22 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.527 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.541 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.417 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.509 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' THR . . . . . 0.426 HG23 ' HA ' ' B' ' 188' ' ' LYS . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ASP . . . . . 0.415 ' C ' HD22 ' B' ' 245' ' ' ASN . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ASN . . . . . 0.415 HD22 ' C ' ' B' ' 244' ' ' ASP . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.494 HD13 HG11 ' B' ' 183' ' ' VAL . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 . . . . . 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' B' ' 163' ' ' TYR . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.564 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.483 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.571 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.475 HG22 HG23 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.488 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.475 HG23 HG22 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' B' ' 229' ' ' LEU . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 199' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' B' ' 251' ' ' ARG . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.486 ' CB ' HD22 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' B' ' 236' ' ' PRO . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 . . . . . 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.451 HG22 HG23 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.451 HG23 HG22 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.495 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.519 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.455 HG21 HG21 ' B' ' 207' ' ' VAL . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.515 HD13 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.457 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.614 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 . . . . . 0 N--CA 1.43 -1.452 0 CA-C-O 120.813 0.339 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' HG ' ' B' ' 178' ' ' LEU . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.535 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' B' ' 175' ' ' LYS . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 192' ' ' ILE . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 183' ' ' VAL . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.481 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.464 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.453 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG21 ' B' ' 207' ' ' VAL . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' B' ' 196' ' ' LEU . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.393 0.139 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 12.4 p . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.464 HG21 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.637 ' HB ' ' ND2' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 179' ' ' ILE . . . . . 0.464 HG12 HG21 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' B' ' 247' ' ' VAL . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.56 HG22 HG23 ' B' ' 192' ' ' ILE . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' VAL . . . . . 0.435 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ASN . . . . . 0.435 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.441 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ASN . . . . . 0.637 ' ND2' ' HB ' ' B' ' 173' ' ' THR . 4.5 t-20 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.431 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.433 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.43 HG22 HG23 ' B' ' 192' ' ' ILE . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 184' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 222' ' ' THR . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.433 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.62 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.507 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 . . . . . 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.409 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.409 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.595 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.465 HG22 HG23 ' B' ' 192' ' ' ILE . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.529 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' B' ' 230' ' ' ILE . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.465 HG23 HG22 ' B' ' 183' ' ' VAL . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.461 ' CG2' HD13 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' B' ' 212' ' ' LYS . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ASN . . . . . 0.429 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.45 HG21 HG21 ' B' ' 207' ' ' VAL . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.42 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.204 0.526 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' B' ' 252' ' ' ASN . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.482 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.5 HG22 HG23 ' B' ' 192' ' ' ILE . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.606 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.577 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.5 HG23 HG22 ' B' ' 183' ' ' VAL . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.446 HG23 HG22 ' B' ' 240' ' ' VAL . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.432 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.44 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.412 ' HB2' ' CG ' ' B' ' 166' ' ' ASP . 61.9 m-80 . . . . . 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 120.787 0.327 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 178' ' ' LEU . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' B' ' 175' ' ' LYS . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.563 HG22 HG23 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' B' ' 191' ' ' TYR . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' B' ' 233' ' ' GLY . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.563 HG23 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.665 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.533 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.54 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.473 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.533 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' B' ' 188' ' ' LYS . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p . . . . . 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 86.2 m-85 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' B' ' 164' ' ' TYR . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.674 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.409 ' OG1' HG22 ' B' ' 173' ' ' THR . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.409 HG22 ' OG1' ' B' ' 171' ' ' THR . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LYS . . . . . 0.462 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.459 HG22 HG23 ' B' ' 192' ' ' ILE . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.459 HG23 HG22 ' B' ' 183' ' ' VAL . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.652 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' HIS . . . . . 0.489 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 222' ' ' THR . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.527 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.478 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 110.811 -0.07 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.447 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.455 HG21 HG12 ' B' ' 179' ' ' ILE . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.508 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' ILE . . . . . 0.455 HG12 HG21 ' B' ' 171' ' ' THR . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.576 HG22 HG23 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.576 HG23 HG22 ' B' ' 183' ' ' VAL . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 202' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.534 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.447 HG11 HG21 ' B' ' 222' ' ' THR . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.468 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.447 HG21 HG11 ' B' ' 207' ' ' VAL . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.49 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' B' ' 212' ' ' LYS . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 . . . . . 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 . . . . . 0 C--O 1.211 -0.97 0 CA-C-O 120.765 0.317 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 45.5 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.494 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.494 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.637 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.484 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' B' ' 196' ' ' LEU . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? . . . . . 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.559 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.663 HG22 HG23 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 187' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 188' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.427 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.663 HG23 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.451 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.459 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.468 HG11 HG21 ' B' ' 222' ' ' THR . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.559 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG11 ' B' ' 207' ' ' VAL . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.456 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 . . . . . 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.433 -1.311 0 CA-C-O 122.055 0.931 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 167' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.465 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.608 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.646 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' ASP . . . . . 0.576 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.44 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.428 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.539 0.209 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 164' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.438 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 168' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.447 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.454 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 192' ' ' ILE . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 195' ' ' ASP . . . . . 0.447 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.474 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.454 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.559 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 75.9 m-85 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' THR . . . . . 0.551 ' OG1' HG22 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.551 HG22 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 177' ' ' TRP . . . . . 0.407 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.424 HG22 HG23 ' B' ' 192' ' ' ILE . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 190' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 191' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 192' ' ' ILE . . . . . 0.424 HG23 HG22 ' B' ' 183' ' ' VAL . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 193' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.478 HG11 HG21 ' B' ' 222' ' ' THR . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.478 HG21 HG11 ' B' ' 207' ' ' VAL . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 222' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.548 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' HIS . . . . . 0.456 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 91.3 m-20 . . . . . 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.94 95.51 15.28 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.37 31.65 0.52 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 123.172 2.581 . . . . 0.0 112.971 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.97 154.96 23.46 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -59.56 126.54 20.94 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 122.002 1.801 . . . . 0.0 109.781 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.72 -55.47 9.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 109.566 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' CD2' ' HA3' ' B' ' 248' ' ' GLY . 27.7 p90 -118.13 148.38 42.39 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.649 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.46 -160.35 31.71 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.31 -62.34 4.33 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -143.99 97.37 3.04 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p -131.19 16.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -44.96 139.91 2.89 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.022 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 22.3 t-160 -59.28 90.89 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.405 1.098 . . . . 0.0 113.102 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -141.79 74.21 1.44 Allowed 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 167.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.76 -21.68 24.99 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.687 -168.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -167.66 -39.54 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.77 169.05 13.96 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.86 -32.33 84.63 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.403 2.069 . . . . 0.0 111.755 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -153.88 -58.6 0.12 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.969 0 C-N-CA 127.152 2.181 . . . . 0.0 105.638 176.735 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.506 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -74.25 104.11 4.9 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 73.19 -55.58 0.68 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.115 1.366 . . . . 0.0 111.821 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -175.18 3.4 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.955 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -115.57 112.47 22.22 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.177 0.591 . . . . 0.0 109.579 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.34 99.67 12.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -97.65 116.06 29.13 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.828 0.823 . . . . 0.0 112.378 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.48 134.4 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.344 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 91.4 mt 58.89 -167.33 0.15 Allowed 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.677 1.191 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.22 158.07 17.4 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.38 131.25 37.95 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -112.12 138.13 49.21 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -153.53 100.48 2.42 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.671 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 -80.44 105.72 11.91 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 37' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.569 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.404 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.404 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' B' ' 180' ' ' PRO . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' B' ' 179' ' ' ILE . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.454 HG23 HG22 ' B' ' 183' ' ' VAL . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.426 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' GLU . . . . . 0.466 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.494 ' CB ' HD22 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.427 HG13 ' HB ' ' B' ' 171' ' ' THR . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 30' ' ' PHE . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -100.63 123.55 45.0 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 165.51 7.78 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.643 0.589 . . . . 0.0 112.066 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -103.41 113.28 26.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.417 -179.459 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.621 0.248 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.85 90.86 50.28 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.39 161.49 8.22 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.77 1.646 . . . . 0.0 111.378 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.02 105.68 54.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.596 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.32 98.42 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.908 2.406 . . . . 0.0 110.469 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' H ' HG21 ' B' ' 246' ' ' VAL . 5.4 t70 -106.69 3.87 27.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.011 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -74.05 140.82 45.63 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.939 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.04 -153.0 23.06 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 108.146 -1.981 . . . . 0.0 108.146 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.59 -81.53 1.74 Allowed Glycine 0 C--N 1.288 -2.09 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.515 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -122.52 95.27 4.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 13.6 p -132.28 36.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' CB ' ' HA ' ' B' ' 166' ' ' ASP . 28.3 p-10 -64.29 108.27 1.55 Allowed 'General case' 0 C--O 1.25 1.105 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.384 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.648 ' O ' ' HA ' ' B' ' 182' ' ' ARG . 20.0 t-160 69.8 -95.4 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.957 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.762 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -152.77 9.41 0.46 Allowed 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -112.91 -161.14 0.74 Allowed 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.43 16.85 1.86 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.815 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.0 137.84 92.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.54 17.53 1.7 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.728 2.285 . . . . 0.0 115.153 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.258 9.6 t 40.24 74.39 0.1 Allowed 'General case' 0 C--O 1.253 1.273 0 C-N-CA 124.519 1.127 . . . . 0.0 113.211 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' HZ3' ' B' ' 255' ' ' LYS . 5.5 tp10 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.656 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.1 m -92.08 -27.55 17.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.61 -45.64 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 91.1 mtp 60.52 -93.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 113.056 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -143.68 169.12 18.34 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 122.911 0.484 . . . . 0.0 110.23 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.06 126.83 46.32 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.397 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -77.87 120.63 23.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.7 mt -81.47 135.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 72.4 mt 60.18 75.66 0.4 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.034 0.921 . . . . 0.0 109.924 -172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -51.28 112.3 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.364 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.0 t70 172.26 -159.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -83.33 -172.68 4.28 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -120.74 40.45 3.52 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.818 0.818 . . . . 0.0 109.849 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 -69.95 121.0 16.53 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.692 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.471 ' HA ' ' CB ' ' A' ' 38' ' ' ASN . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.447 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.401 HG21 HG12 ' B' ' 179' ' ' ILE . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.493 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' ILE . . . . . 0.401 HG12 HG21 ' B' ' 171' ' ' THR . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.498 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.465 HG21 HG21 ' B' ' 222' ' ' THR . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 207' ' ' VAL . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.611 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.547 HG21 ' H ' ' A' ' 29' ' ' ASP . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -79.31 152.41 30.51 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -91.27 152.33 20.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 166.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -87.31 98.32 11.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.054 -1.459 . . . . 0.0 110.445 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' A' ' 46' ' ' GLU . 50.6 pttt . . . . . 0 C--O 1.259 1.572 0 C-N-CA 127.056 2.142 . . . . 0.0 115.406 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -150.58 100.42 3.13 Favored Pre-proline 0 N--CA 1.434 -1.231 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 123.33 8.68 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.729 1.62 . . . . 0.0 111.239 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 135.77 25.8 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.697 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' HG13 ' B' ' 246' ' ' VAL . 47.8 Cg_exo -59.36 165.65 8.87 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.375 2.05 . . . . 0.0 112.205 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -107.3 133.91 51.15 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.996 -173.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -83.22 153.26 24.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.615 ' O ' ' HB1' ' B' ' 170' ' ' ALA . . . -108.51 144.36 16.28 Favored Glycine 0 CA--C 1.461 -3.339 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.242 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.58 51.68 2.26 Favored Glycine 0 C--O 1.219 -0.841 0 CA-C-N 117.175 0.487 . . . . 0.0 113.011 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -101.42 27.72 6.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.476 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p -104.14 21.9 2.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -71.24 109.91 5.57 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.459 ' HB3' ' HG3' ' B' ' 182' ' ' ARG . 32.5 t60 -108.23 8.04 27.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.285 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -89.95 84.0 6.17 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.974 0.892 . . . . 0.0 108.949 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -152.62 -69.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -155.05 145.22 21.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.09 115.78 64.56 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.46 -54.57 3.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.65 2.233 . . . . 0.0 110.755 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -92.14 80.14 5.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.89 0.852 . . . . 0.0 109.868 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.426 -1.652 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.437 -178.448 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 35.6 t -142.6 170.59 15.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -120.6 6.32 10.55 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 -173.96 3.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.774 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 77.19 98.57 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.53 1.132 . . . . 0.0 110.182 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 68.3 -175.75 0.2 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.028 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -100.19 125.05 46.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.495 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.4 140.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.591 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -61.14 118.75 7.22 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.13 -165.31 1.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.211 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -68.41 140.86 55.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -76.55 87.91 3.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.957 1.36 . . . . 0.0 111.334 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -136.75 88.31 2.36 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.205 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -124.67 135.01 52.69 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.504 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 31' ' ' GLY . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.491 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.491 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 39' ' ' HIS . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' B' ' 192' ' ' ILE . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 188' ' ' LYS . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.404 ' CD1' HG12 ' B' ' 230' ' ' ILE . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.547 HG23 HG22 ' B' ' 183' ' ' VAL . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.417 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' ARG . . . . . 0.406 ' HE ' ' CG1' ' B' ' 246' ' ' VAL . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.472 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 28' ' ' PRO . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -77.31 159.22 29.72 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -126.19 171.48 10.86 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.79 105.13 7.67 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--N 1.323 -0.578 0 C-N-CA 126.579 1.951 . . . . 0.0 109.191 -176.683 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -151.26 83.38 5.53 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.26 117.59 2.5 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.532 2.155 . . . . 0.0 110.846 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.98 95.73 48.81 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.203 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.84 -42.59 24.11 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.014 -1.572 . . . . 0.0 108.014 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.9 t70 68.24 -60.53 0.41 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.698 1.999 . . . . 0.0 110.071 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 38.7 p90 -101.2 172.68 6.85 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.458 1.103 . . . . 0.0 108.852 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' HB1' ' B' ' 170' ' ' ALA . . . 132.55 -155.25 21.46 Favored Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.028 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.41 -72.3 2.37 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 -110.95 91.47 3.67 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.22 90.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.05 154.93 50.22 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.501 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 73.65 -86.68 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.483 1.113 . . . . 0.0 112.644 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.37 168.52 19.58 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.508 0.671 . . . . 0.0 112.222 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 42' ' ' GLU . 6.5 p-10 -107.97 -99.0 0.37 Allowed 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.626 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 15.9 mm-40 -95.31 -33.99 12.33 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 65.2 98.46 0.04 OUTLIER Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.997 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.33 100.26 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.718 1.612 . . . . 0.0 108.851 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.7 p -77.69 136.58 38.21 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-O 121.75 0.786 . . . . 0.0 112.669 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.411 -2.398 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.6 t -92.5 95.24 9.51 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -84.32 -40.16 18.28 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.51 104.88 16.73 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -75.07 87.08 2.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.93 96.54 10.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.07 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -118.05 135.19 54.34 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.0 mt -74.62 115.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.594 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.9 pt? -98.32 -16.49 19.33 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.965 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 58.7 pttt 32.03 75.34 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.955 2.034 . . . . 0.0 112.754 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.67 15.78 19.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.966 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -73.27 96.82 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.163 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -110.07 -138.92 0.38 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 -65.29 124.47 22.3 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.438 HG21 HG12 ' B' ' 179' ' ' ILE . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.555 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.4 HD22 ' CB ' ' B' ' 242' ' ' HIS . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' ILE . . . . . 0.438 HG12 HG21 ' B' ' 171' ' ' THR . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' SER . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' ASP . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.435 HG22 HG23 ' B' ' 192' ' ' ILE . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.435 HG23 HG22 ' B' ' 183' ' ' VAL . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.515 HG11 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.545 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' B' ' 213' ' ' GLU . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.545 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.515 HG21 HG11 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.434 HG21 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.4 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.583 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 -76.98 156.63 31.78 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -68.59 176.26 3.03 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.382 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -69.91 103.79 2.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.288 -2.102 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.373 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -140.76 99.61 6.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 111.469 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -96.85 172.97 0.8 Allowed 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.362 2.042 . . . . 0.0 110.514 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.53 139.42 86.54 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' B' ' 172' ' ' ARG . 4.2 Cg_endo -49.13 -34.78 31.4 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.983 2.455 . . . . 0.0 113.812 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 66.3 166.07 0.2 Allowed 'General case' 0 C--O 1.248 1.023 0 O-C-N 124.088 0.868 . . . . 0.0 110.536 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -92.42 131.17 37.8 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.033 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.44 -152.36 24.07 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.27 -69.89 3.25 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -130.4 95.41 3.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 122.869 0.468 . . . . 0.0 110.143 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.73 9.75 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 12.6 p-10 -81.19 111.35 17.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.455 0.645 . . . . 0.0 111.399 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -108.57 110.24 21.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.1 t80 72.47 121.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.825 1.328 . . . . 0.0 111.252 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -120.15 -153.15 0.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.64 138.85 31.11 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.74 103.91 7.59 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.75 107.44 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.37 2.047 . . . . 0.0 110.773 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 p -93.31 89.4 6.36 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.861 0.839 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -178.877 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 21.7 p -98.72 -83.29 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -114.05 -1.25 13.8 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 78.8 mtp -155.33 154.22 31.71 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -113.12 112.94 24.68 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.19 136.02 33.17 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -93.69 73.8 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mt -92.84 113.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 92.7 mt -92.75 165.7 12.81 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -84.73 50.62 1.95 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.337 1.065 . . . . 0.0 111.781 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -122.3 117.12 25.34 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' B' ' 163' ' ' TYR . 14.0 ptp180 -81.41 -21.02 39.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 1.2 tpm_? 71.6 11.21 6.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.957 1.303 . . . . 0.0 111.4 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.501 ' H ' ' HG3' ' B' ' 161' ' ' ARG . 72.9 m-85 -99.1 123.79 43.65 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.716 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 28' ' ' PRO . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.426 ' HA ' HG23 ' B' ' 234' ' ' THR . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.659 HG23 HG22 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.527 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.541 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.417 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.509 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' THR . . . . . 0.426 HG23 ' HA ' ' B' ' 188' ' ' LYS . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ASP . . . . . 0.415 ' C ' HD22 ' B' ' 245' ' ' ASN . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ASN . . . . . 0.415 HD22 ' C ' ' B' ' 244' ' ' ASP . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.494 HD13 HG11 ' B' ' 183' ' ' VAL . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 -98.68 145.49 26.83 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -66.77 173.27 3.62 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.547 0.689 . . . . 0.0 112.338 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' B' ' 254' ' ' GLN . 15.0 mm-40 -88.36 116.42 26.57 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.01 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 126.038 1.735 . . . . 0.0 109.933 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm 72.17 100.27 0.04 OUTLIER Pre-proline 0 C--N 1.345 0.412 0 C-N-CA 123.929 0.892 . . . . 0.0 109.821 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.04 0.48 8.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.237 2.625 . . . . 0.0 113.389 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.89 90.63 47.22 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.21 135.41 59.72 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.67 2.913 . . . . 0.0 113.393 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.33 156.82 19.53 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.995 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 38.1 p90 -66.05 162.03 20.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.892 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' B' ' 171' ' ' THR . . . -86.84 -166.31 42.34 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.21 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.34 8.35 26.66 Favored Glycine 0 N--CA 1.42 -2.38 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -87.75 70.43 9.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB3' ' OD1' ' A' ' 38' ' ' ASN . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p -129.75 25.57 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 20.0 p-10 -68.23 94.08 0.5 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.703 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 70.25 -81.27 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 110.906 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -158.51 113.6 2.59 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 125.564 1.546 . . . . 0.0 109.301 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -94.82 -16.5 22.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 63.59 83.06 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.983 1.313 . . . . 0.0 113.13 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.18 97.05 5.28 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.423 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.29 101.51 0.99 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.396 2.064 . . . . 0.0 111.22 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -114.62 93.65 4.43 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.888 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.947 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 151' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 155' ' ' ALA . 16.5 t 61.85 23.59 13.89 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.953 0.901 . . . . 0.0 112.658 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -109.22 120.76 43.48 Favored 'General case' 0 C--O 1.246 0.911 0 O-C-N 121.528 -0.732 . . . . 0.0 111.325 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 94.7 mmm 68.47 -80.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.072 1.749 . . . . 0.0 110.677 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.14 83.25 1.87 Allowed 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' B' ' 151' ' ' SER . . . -155.61 155.02 32.55 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.979 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.94 -165.01 0.98 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 45.7 mt -94.16 128.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.638 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.1 pt? -80.77 116.82 20.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.411 0.624 . . . . 0.0 110.016 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -86.7 126.65 34.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 19.1 t70 74.02 94.97 0.07 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.645 1.212 . . . . 0.0 107.857 -166.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.59 172.53 2.05 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.972 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.595 ' HA ' ' NE ' ' B' ' 162' ' ' ARG . 0.6 OUTLIER -112.47 -154.11 0.54 Allowed 'General case' 0 N--CA 1.385 -3.708 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 -104.63 152.53 22.35 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.564 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.483 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.571 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.475 HG22 HG23 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.488 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.475 HG23 HG22 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' B' ' 229' ' ' LEU . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' B' ' 251' ' ' ARG . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.486 ' CB ' HD22 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' B' ' 236' ' ' PRO . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 -90.72 108.67 19.97 Favored 'General case' 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -71.03 134.32 47.02 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.346 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -76.58 122.31 24.43 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.193 0 C-N-CA 127.065 2.146 . . . . 0.0 108.797 -173.571 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 120.685 0.279 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -127.43 92.35 43.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.43 146.9 19.77 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.397 2.065 . . . . 0.0 113.957 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 67.77 105.16 0.03 OUTLIER Pre-proline 0 C--O 1.252 1.214 0 C-N-CA 125.722 1.609 . . . . 0.0 112.798 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.57 63.31 5.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.069 2.512 . . . . 0.0 110.115 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -132.16 -176.96 4.24 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -89.8 172.17 9.09 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.762 0.71 . . . . 0.0 111.293 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 -158.38 27.42 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.72 -75.31 2.39 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER -123.06 92.98 3.82 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -177.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p -153.9 85.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -137.06 155.37 49.74 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.297 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.455 ' HB2' ' HG3' ' B' ' 182' ' ' ARG . 8.5 t60 -104.95 85.55 2.3 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.117 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.31 71.17 0.74 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.288 1.042 . . . . 0.0 108.789 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -157.23 112.06 2.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.648 -1.615 . . . . 0.0 107.714 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.29 25.75 1.34 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.66 134.12 26.96 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.69 126.5 22.62 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.5 2.133 . . . . 0.0 110.356 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -137.86 179.59 6.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.715 0.293 . . . . 0.0 110.309 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.4 p -82.3 -55.66 4.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.496 0.665 . . . . 0.0 109.747 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -92.4 -30.0 16.0 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.866 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 60.2 ttp -97.54 76.74 2.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.677 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -155.48 70.09 0.72 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.685 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 175.12 177.2 0.17 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.09 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.91 95.58 6.48 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.45 128.59 35.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.416 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.426 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.5 pt? -137.41 167.77 20.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.98 97.21 10.13 Favored 'General case' 0 N--CA 1.388 -3.568 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.44 103.78 13.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -77.72 128.44 34.06 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 13.5 ttm180 -166.66 94.96 0.52 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 -92.54 107.07 18.94 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.451 HG22 HG23 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.451 HG23 HG22 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.495 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.519 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.455 HG21 HG21 ' B' ' 207' ' ' VAL . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.515 HD13 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.457 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.614 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -74.03 170.67 14.97 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -68.96 146.03 53.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.401 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' GLN . . . . . 0.436 ' OE1' ' HD3' ' B' ' 162' ' ' ARG . 47.9 mt-30 -83.68 108.93 17.06 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 tptp . . . . . 0 C--O 1.244 0.766 0 C-N-CA 124.982 1.313 . . . . 0.0 110.355 -176.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 25' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 24' ' ' THR . 25.6 mtpp -129.26 100.26 20.49 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.45 -14.52 10.41 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.518 2.145 . . . . 0.0 112.225 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.65 136.18 6.51 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.99 151.97 46.6 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.687 2.258 . . . . 0.0 111.535 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -104.8 130.98 52.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.781 0.801 . . . . 0.0 112.776 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -87.98 152.25 22.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.5 -150.62 22.67 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.48 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.81 -66.31 3.14 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -144.18 102.5 3.87 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.79 101.73 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -134.62 165.52 25.03 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.45 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.9 117.65 13.76 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -86.73 103.25 15.0 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.36 -19.42 42.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.16 109.67 6.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.51 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.71 88.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.83 -10.89 25.38 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.416 2.078 . . . . 0.0 112.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.4 m -149.43 99.59 2.92 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.167 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.244 0.792 0 C-N-CA 124.945 1.298 . . . . 0.0 112.492 175.848 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.744 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.0 m -63.64 154.54 32.56 Favored 'General case' 0 C--O 1.249 1.028 0 C-N-CA 123.475 0.71 . . . . 0.0 111.162 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -67.17 -35.42 79.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.352 0.596 . . . . 0.0 109.945 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 88.2 mtp -93.13 21.21 6.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.036 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 49.0 t30 79.47 137.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.333 1.453 . . . . 0.0 110.52 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.11 97.49 2.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.498 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.71 38.36 0.74 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.38 108.4 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.59 95.87 6.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.519 1.152 . . . . 0.0 113.537 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' B' ' 159' ' ' LYS . 17.9 mmmt -138.29 147.89 44.09 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.051 175.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.78 103.64 5.11 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.806 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -151.98 2.4 0.37 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -138.99 92.84 2.63 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.813 0.34 . . . . 0.0 110.586 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 -76.76 112.53 13.44 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.401 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' HG ' ' B' ' 178' ' ' LEU . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.535 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' B' ' 175' ' ' LYS . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 192' ' ' ILE . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 183' ' ' VAL . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.481 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.464 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.453 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG21 ' B' ' 207' ' ' VAL . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' B' ' 196' ' ' LEU . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -76.4 160.04 29.92 Favored 'General case' 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 162.65 13.88 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.193 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -85.35 104.04 14.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.941 1.296 . . . . 0.0 111.856 178.219 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.756 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -151.34 100.49 2.99 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -86.49 154.46 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.298 1.999 . . . . 0.0 111.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 110.0 57.84 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.88 82.63 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.473 2.116 . . . . 0.0 110.859 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.94 -174.05 2.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 35.4 p90 -73.61 149.68 41.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 119.045 0.839 . . . . 0.0 112.563 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.74 -159.36 28.0 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.13 -61.82 4.43 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 -133.41 98.21 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.878 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 12.4 p -94.56 -35.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' HB2' ' H ' ' B' ' 183' ' ' VAL . 65.0 t30 -134.47 176.48 8.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.205 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 76.66 4.17 3.48 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.636 1.574 . . . . 0.0 106.819 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -78.32 -24.1 46.77 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.723 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.56 89.01 2.87 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.58 118.74 16.89 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.233 -1.348 . . . . 0.0 110.296 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.39 110.36 50.27 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.205 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 117.29 4.21 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.467 2.112 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -128.78 15.8 6.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.329 -176.55 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.561 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 54.0 m -87.1 92.69 9.14 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.283 0.564 . . . . 0.0 112.032 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -95.19 -37.93 10.81 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 14.4 tpt -150.46 86.91 1.42 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -80.62 144.84 32.03 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.858 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.39 121.28 29.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -82.07 128.05 33.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.476 0.655 . . . . 0.0 109.956 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.99 137.5 28.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 63.0 mt -92.46 54.58 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.523 0.677 . . . . 0.0 109.784 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt 53.73 29.23 9.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.643 1.977 . . . . 0.0 113.039 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -83.67 108.39 16.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -139.73 83.92 1.95 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.531 0.682 . . . . 0.0 112.456 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -167.09 81.11 0.22 Allowed 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.723 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.61 120.87 22.36 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.409 ' HD1' HD21 ' A' ' 38' ' ' ASN . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.464 HG21 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.637 ' HB ' ' ND2' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' ILE . . . . . 0.464 HG12 HG21 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' B' ' 247' ' ' VAL . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.56 HG22 HG23 ' B' ' 192' ' ' ILE . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' VAL . . . . . 0.435 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASN . . . . . 0.435 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.441 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ASN . . . . . 0.637 ' ND2' ' HB ' ' B' ' 173' ' ' THR . 4.5 t-20 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.431 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -86.36 175.72 8.27 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -125.25 142.22 51.63 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.552 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -112.55 112.23 23.62 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.258 1.508 0 O-C-N 125.149 1.53 . . . . 0.0 108.563 -173.87 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 175.14 130.42 0.14 Allowed Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 124.839 1.255 . . . . 0.0 107.639 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -86.68 -12.54 5.27 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.769 1.646 . . . . 0.0 112.27 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -145.29 126.33 7.53 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.0 Cg_endo -81.77 89.45 1.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.808 1.672 . . . . 0.0 109.959 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.07 144.84 50.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.277 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.251 30.3 p90 41.39 -158.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.995 1.718 . . . . 0.0 114.854 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.77 -124.57 2.7 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.57 -4.71 0.1 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.161 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -86.85 79.67 8.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.25 81.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 25.2 t-20 -113.64 111.55 22.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.125 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.53 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 69.2 m80 74.7 -58.78 0.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.195 0.998 . . . . 0.0 111.699 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -173.71 156.93 3.0 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.497 ' CG ' ' HD3' ' A' ' 35' ' ' LYS . 32.2 t70 -109.79 94.06 4.83 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 121.617 0.722 . . . . 0.0 109.432 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -130.53 21.25 5.13 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . . . -106.52 141.5 22.94 Favored Pre-proline 0 N--CA 1.435 -1.189 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.626 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 20.4 Cg_exo -67.76 14.75 0.15 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 123.168 2.579 . . . . 0.0 114.265 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -74.17 109.51 7.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.582 0.753 . . . . 0.0 109.998 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.291 1.436 . . . . 0.0 111.596 -179.544 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLY . . . . . 0.63 ' N ' HD22 ' B' ' 154' ' ' ASN . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m -80.43 -40.24 26.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.803 0.335 . . . . 0.0 111.005 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -118.23 168.74 10.31 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 38.0 tpp 70.04 -62.41 0.43 Allowed 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 126.862 2.065 . . . . 0.0 110.543 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASN . . . . . 0.63 HD22 ' N ' ' B' ' 150' ' ' GLY . 1.9 p-10 -96.51 89.93 5.19 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.16 102.28 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.349 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.35 125.35 29.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 49.5 mm -59.72 137.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.665 0.603 . . . . 0.0 110.951 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 49.8 mt 73.86 108.09 0.07 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.122 1.769 . . . . 0.0 112.923 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -74.95 127.22 32.72 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.611 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.61 114.65 3.69 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 123.717 0.636 . . . . 0.0 109.556 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -77.41 147.13 36.17 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.21 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -87.23 82.24 7.7 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.188 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 -77.64 111.22 13.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.433 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.43 HG22 HG23 ' B' ' 192' ' ' ILE . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 222' ' ' THR . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.433 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.62 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.507 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -59.79 118.42 6.15 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.547 ' HD3' ' H ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -67.46 154.9 40.31 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.11 -1.404 . . . . 0.0 108.168 173.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -86.92 98.69 11.37 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -175.162 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 25' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 24' ' ' THR . 11.3 ptmm? -121.62 89.99 47.81 Favored Pre-proline 0 N--CA 1.448 -0.551 0 CA-C-N 118.728 0.694 . . . . 0.0 109.732 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.2 -14.23 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.534 2.156 . . . . 0.0 113.104 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.08 93.4 47.9 Favored Pre-proline 0 N--CA 1.426 -1.635 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.79 84.26 1.94 Allowed 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.854 1.703 . . . . 0.0 109.762 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -128.96 -173.95 3.12 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -80.58 176.05 10.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.157 0.503 . . . . 0.0 112.344 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.94 -166.03 30.32 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.316 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.4 -4.31 22.01 Favored Glycine 0 N--CA 1.409 -3.142 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -78.73 77.18 5.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.64 14.24 7.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.85 123.78 20.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.961 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.492 ' CG ' ' HG3' ' B' ' 182' ' ' ARG . 28.1 t-80 -87.07 127.95 35.11 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.51 81.07 8.89 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.304 0.573 . . . . 0.0 112.212 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -100.14 81.81 2.45 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -107.68 129.28 55.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.768 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.43 63.27 7.51 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.298 1.039 . . . . 0.0 110.583 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -95.69 17.53 0.75 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.838 2.359 . . . . 0.0 111.784 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.8 m 72.28 -25.96 0.18 Allowed 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.817 1.247 . . . . 0.0 112.982 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.153 179.124 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.622 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 14.8 m -57.51 -18.97 21.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.145 . . . . 0.0 112.359 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -73.38 -28.48 62.04 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.415 0.686 . . . . 0.0 110.724 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 63.1 mtt -120.01 15.15 12.44 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.603 0.716 . . . . 0.0 110.44 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -126.94 169.55 13.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.1 129.27 34.48 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -174.04 4.5 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 61.7 mt -69.6 131.4 34.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.12 167.67 18.52 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.583 0.706 . . . . 0.0 111.712 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -88.4 45.78 1.32 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.459 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.04 175.71 5.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.002 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -101.15 -133.38 0.28 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -143.12 158.32 43.72 Favored 'General case' 1 N--CA 1.37 -4.432 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 177.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -69.29 111.26 5.08 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.355 1.034 . . . . 0.0 109.244 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.409 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.409 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.595 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.465 HG22 HG23 ' B' ' 192' ' ' ILE . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.529 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' B' ' 230' ' ' ILE . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.465 HG23 HG22 ' B' ' 183' ' ' VAL . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.461 ' CG2' HD13 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' B' ' 212' ' ' LYS . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASN . . . . . 0.429 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.45 HG21 HG21 ' B' ' 207' ' ' VAL . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.42 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -67.26 119.73 12.62 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 153.84 42.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.292 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.54 99.1 8.62 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.137 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 113.349 -1.75 . . . . 0.0 106.589 179.472 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -134.89 103.22 10.91 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -90.61 -176.17 0.98 Allowed 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.382 2.055 . . . . 0.0 112.67 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.07 151.9 84.1 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.058 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.12 -56.77 2.72 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.948 2.432 . . . . 0.0 112.672 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.79 171.12 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.679 1.191 . . . . 0.0 114.006 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -98.92 135.43 40.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.22 -157.03 27.02 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.05 -61.44 4.01 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -145.64 102.91 3.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.83 8.91 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.35 99.28 1.18 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.875 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.11 142.19 30.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.952 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.27 82.8 4.55 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -101.74 -73.68 0.64 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.784 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -100.25 -78.05 0.52 Allowed 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.44 101.76 2.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 O-C-N 122.361 -0.212 . . . . 0.0 110.598 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.74 25.77 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.986 2.457 . . . . 0.0 112.378 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -119.1 -37.14 3.25 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -175.646 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.759 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -68.92 -35.95 77.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -104.05 117.1 33.48 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 97.0 mmm 69.84 93.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.495 1.122 . . . . 0.0 110.715 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -113.55 140.82 47.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.427 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.26 145.03 30.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.81 58.61 4.74 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.957 0.884 . . . . 0.0 111.789 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.0 111.43 19.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 81.9 mt 56.41 -167.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.934 1.396 . . . . 0.0 111.254 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.83 -168.49 2.1 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' B' ' 161' ' ' ARG . 7.9 t70 -73.32 -161.22 0.09 Allowed 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' B' ' 162' ' ' ARG . 14.1 ptt-85 -61.48 142.47 57.0 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.5 0.72 . . . . 0.0 112.739 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' B' ' 161' ' ' ARG . 19.9 mmm180 -125.69 27.01 6.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.012 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 -66.05 128.45 36.12 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.229 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' B' ' 252' ' ' ASN . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.482 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.5 HG22 HG23 ' B' ' 192' ' ' ILE . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.606 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.577 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.5 HG23 HG22 ' B' ' 183' ' ' VAL . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.446 HG23 HG22 ' B' ' 240' ' ' VAL . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.432 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.44 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.412 ' HB2' ' CG ' ' B' ' 166' ' ' ASP . 61.9 m-80 -85.83 109.32 18.6 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 162.76 11.25 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.96 143.22 26.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 125.442 1.497 . . . . 0.0 110.368 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.436 -1.168 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -152.62 93.46 3.28 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.64 -68.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.259 1.972 . . . . 0.0 111.944 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 133.23 4.15 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.79 100.16 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.815 1.677 . . . . 0.0 112.594 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' O ' HG13 ' B' ' 246' ' ' VAL . 11.3 m-20 -77.99 -34.31 50.94 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.338 1.066 . . . . 0.0 108.298 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.03 153.47 42.99 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.655 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.37 -171.78 27.93 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.23 4.06 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 -124.35 92.03 3.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 122.137 0.175 . . . . 0.0 110.769 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p -128.67 19.85 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 3.1 t-20 -62.4 102.26 0.3 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.684 ' NE2' ' HA ' ' A' ' 42' ' ' GLU . 18.9 t-160 -144.42 99.25 3.34 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 118.77 -1.172 . . . . 0.0 112.733 -166.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 41' ' ' ASP . 49.4 t80 -138.99 -17.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.208 1.004 . . . . 0.0 109.132 170.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' PHE . 9.2 p-10 -87.51 -0.61 57.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.684 ' HA ' ' NE2' ' A' ' 39' ' ' HIS . 34.3 mm-40 55.58 86.19 0.06 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.045 1.338 . . . . 0.0 113.362 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.42 154.78 38.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.818 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -69.68 95.1 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.188 1.925 . . . . 0.0 112.443 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -85.9 -68.1 0.76 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.423 -1.795 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.003 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -117.04 156.54 27.35 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 76.56 -41.38 0.4 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.231 1.012 . . . . 0.0 111.173 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 44.0 tpp -140.78 136.59 32.62 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -84.61 170.73 13.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -130.91 153.45 49.15 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -77.43 134.1 38.48 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.3 130.54 33.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.0 -169.7 2.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.6 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -61.24 142.56 56.72 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.628 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -81.02 102.69 10.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.94 0.876 . . . . 0.0 110.17 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -110.6 145.94 36.99 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 19.1 mtm180 -87.1 -1.0 57.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -83.96 112.32 20.06 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.186 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 178' ' ' LEU . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' B' ' 175' ' ' LYS . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.563 HG22 HG23 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.657 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' B' ' 233' ' ' GLY . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.563 HG23 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.665 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.533 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.54 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.473 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.533 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' B' ' 188' ' ' LYS . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 29' ' ' ASP . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 -76.09 109.46 9.77 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -73.98 147.92 42.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.828 175.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.5 100.58 13.31 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.428 -1.55 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.419 -177.174 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.897 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -154.6 98.8 2.46 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.2 -174.66 2.07 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.16 1.907 . . . . 0.0 111.136 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' B' ' 172' ' ' ARG . . . -99.53 107.57 46.16 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.36 153.3 10.65 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.192 1.928 . . . . 0.0 110.692 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 63.63 -160.84 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.21 0.604 . . . . 0.0 110.456 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.07 143.5 30.54 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.62 -159.51 28.1 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.029 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.28 -61.4 4.24 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -136.07 95.99 3.31 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 -179.005 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p -122.04 71.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 16.8 p30 -142.94 141.97 31.57 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.224 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB3' ' HD3' ' B' ' 182' ' ' ARG . 52.9 t-80 -118.36 105.45 11.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 172.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -87.29 76.71 9.11 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.8 0.81 . . . . 0.0 111.406 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -125.15 89.34 3.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 123.009 1.385 . . . . 0.0 110.146 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.23 -31.86 55.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.103 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.53 164.29 18.45 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.01 148.57 76.1 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 121.927 1.751 . . . . 0.0 110.737 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -73.53 93.4 2.0 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.322 0.582 . . . . 0.0 110.97 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.703 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.2 p -91.75 161.33 14.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 117.657 0.729 . . . . 0.0 109.52 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -89.91 -80.68 0.31 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -142.47 109.81 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.85 100.83 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 110.666 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -126.11 164.14 21.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.142 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -65.58 154.82 37.65 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 122.092 0.949 . . . . 0.0 111.273 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.68 133.79 34.36 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.554 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.709 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -90.8 131.53 36.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -128.3 -177.67 4.25 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.612 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' B' ' 161' ' ' ARG . 20.7 t70 67.65 -156.14 0.21 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' B' ' 160' ' ' ASP . 4.3 mtp180 -74.1 -37.24 64.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.488 ' HA ' ' NE ' ' B' ' 162' ' ' ARG . 0.1 OUTLIER 67.97 110.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 112.76 -2.018 . . . . 0.0 113.663 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 86.2 m-85 -70.13 117.39 11.63 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.434 ' HA ' HD22 ' A' ' 38' ' ' ASN . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.674 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.409 ' OG1' HG22 ' B' ' 173' ' ' THR . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.409 HG22 ' OG1' ' B' ' 171' ' ' THR . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LYS . . . . . 0.462 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.459 HG22 HG23 ' B' ' 192' ' ' ILE . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.459 HG23 HG22 ' B' ' 183' ' ' VAL . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.652 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' HIS . . . . . 0.489 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 222' ' ' THR . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.527 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.478 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.61 154.93 41.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' B' ' 254' ' ' GLN . 13.2 tmtt? -66.62 143.96 56.69 Favored 'General case' 0 N--CA 1.416 -2.153 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.915 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' GLN . . . . . 0.473 ' N ' ' HD3' ' B' ' 253' ' ' LYS . 78.8 mt-30 -80.93 100.47 8.91 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.582 1.182 . . . . 0.0 111.148 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? . . . . . 0 C--N 1.29 -2.006 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.228 -178.853 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.553 1.071 0 CA-C-O 121.277 0.561 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -133.75 109.46 12.04 Favored Pre-proline 0 N--CA 1.434 -1.242 0 O-C-N 121.227 -0.92 . . . . 0.0 110.061 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -95.79 34.76 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.813 2.342 . . . . 0.0 110.097 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.1 146.89 95.35 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.887 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.86 105.27 0.15 Allowed 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 122.274 1.983 . . . . 0.0 112.915 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.504 ' H ' HG11 ' B' ' 246' ' ' VAL . 4.4 m-20 -67.74 84.87 0.2 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -121.25 135.22 55.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.91 166.32 13.93 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.356 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 -71.15 2.95 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 -84.76 69.09 10.65 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.811 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.39 21.55 5.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 31.4 t-20 -67.58 100.56 0.89 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.952 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 182' ' ' ARG . 30.5 t-80 70.52 -7.18 1.06 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.484 1.114 . . . . 0.0 112.911 173.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 181' ' ' SER . 70.0 t80 68.77 93.01 0.08 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -168.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.87 -31.56 14.28 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.628 -168.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 1.4 mp0 -60.74 106.96 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.149 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.56 117.4 57.08 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.285 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.03 -49.14 7.01 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.124 1.883 . . . . 0.0 110.648 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 1.2 p -119.06 94.44 4.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.329 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 45' ' ' THR . 14.6 mm-40 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.716 2.007 . . . . 0.0 107.759 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.965 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 26.1 t -88.26 82.9 6.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -94.16 104.82 16.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 56.6 ttp -108.63 118.9 37.97 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -76.84 97.3 4.51 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.531 0.681 . . . . 0.0 109.459 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.38 106.17 17.76 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.419 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -109.33 120.93 44.0 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.418 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.61 136.95 23.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.324 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.21 171.76 8.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.806 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -76.59 142.99 40.54 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.646 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -134.07 149.69 51.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -79.15 102.92 8.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -100.33 11.33 39.65 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.392 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 -69.14 116.98 10.21 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.447 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.455 HG21 HG12 ' B' ' 179' ' ' ILE . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.508 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' ILE . . . . . 0.455 HG12 HG21 ' B' ' 171' ' ' THR . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 181' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 39' ' ' HIS . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.576 HG22 HG23 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.576 HG23 HG22 ' B' ' 183' ' ' VAL . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.534 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.447 HG11 HG21 ' B' ' 222' ' ' THR . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.468 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.447 HG21 HG11 ' B' ' 207' ' ' VAL . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.49 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' B' ' 212' ' ' LYS . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.504 HG11 ' H ' ' A' ' 29' ' ' ASP . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 -85.99 138.26 32.11 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 154.44 30.1 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.135 173.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -60.27 101.73 0.14 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 124.312 1.008 . . . . 0.0 112.387 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--N 1.289 -2.043 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.796 174.546 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -133.79 106.2 11.7 Favored Pre-proline 0 N--CA 1.428 -1.553 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.235 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -94.92 -172.01 0.24 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.152 1.902 . . . . 0.0 109.948 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.05 111.4 38.03 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -84.47 96.33 0.7 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.111 1.874 . . . . 0.0 110.194 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -102.64 174.2 6.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.436 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 31.0 p90 -117.69 167.62 11.18 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.582 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.93 -169.06 28.74 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.124 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.63 -84.32 0.88 Allowed Glycine 0 N--CA 1.445 -0.701 0 O-C-N 124.112 0.536 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 -78.62 74.41 5.16 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.173 0.989 . . . . 0.0 110.171 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p -119.73 25.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 47.1 t30 -58.29 104.02 0.18 Allowed 'General case' 0 C--O 1.251 1.14 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.004 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 61.4 m80 77.94 -60.97 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 0.0 110.777 -176.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -155.53 177.18 11.66 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 125.248 1.419 . . . . 0.0 107.469 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.09 -54.39 4.66 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.43 98.78 0.02 OUTLIER 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.818 1.647 . . . . 0.0 113.891 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.59 93.44 0.05 OUTLIER Pre-proline 0 C--O 1.243 0.714 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.23 19.19 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.77 2.313 . . . . 0.0 111.958 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 m -66.81 -31.21 71.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.904 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.463 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 15.8 m -74.24 115.68 14.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.888 0.344 . . . . 0.0 111.359 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 60.29 28.59 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.927 0.891 . . . . 0.0 112.918 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 25.5 ttt -74.85 -44.16 50.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.878 0.37 . . . . 0.0 110.5 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 m120 61.4 105.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.462 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.65 32.38 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.895 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -74.1 114.88 12.94 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 157' ' ' ILE . 3.1 mp -62.54 120.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.201 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.467 ' HB2' HH21 ' B' ' 162' ' ' ARG . 93.7 mt -98.89 126.8 44.65 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' B' ' 161' ' ' ARG . 33.2 mmtp -67.85 -171.88 0.24 Allowed 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.69 8.13 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 128.086 2.554 . . . . 0.0 113.474 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.473 ' H ' ' C ' ' B' ' 159' ' ' LYS . 98.4 mtt180 -88.59 -11.47 45.42 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.924 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.467 HH21 ' HB2' ' B' ' 158' ' ' LEU . 15.1 ptp180 -69.17 -46.03 68.52 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 122.391 1.091 . . . . 0.0 110.812 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 45.5 m-85 -164.05 151.12 11.87 Favored 'General case' 0 C--N 1.256 -3.466 0 C-N-CA 129.667 3.187 . . . . 0.0 103.376 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' B' ' 254' ' ' GLN . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.643 ' HG3' ' O ' ' A' ' 39' ' ' HIS . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.494 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.494 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.637 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.484 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' B' ' 196' ' ' LEU . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.04 167.04 22.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 131.5 36.28 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.673 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' B' ' 164' ' ' TYR 0.274 3.8 pm0 -84.17 99.44 10.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt . . . . . 0 CA--C 1.491 -1.316 0 C-N-CA 128.331 2.653 . . . . 0.0 105.634 173.817 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -117.04 96.02 48.23 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 122.296 -0.253 . . . . 0.0 110.629 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -102.9 -150.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.371 0 C-N-CA 123.089 2.526 . . . . 0.0 107.995 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.28 122.2 4.09 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' B' ' 244' ' ' ASP . 31.2 Cg_exo -62.14 94.26 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.991 1.794 . . . . 0.0 108.338 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 153.0 31.84 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.398 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -82.63 125.54 31.3 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.52 -158.62 26.6 Favored Glycine 0 C--N 1.284 -2.352 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 -67.17 3.75 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.075 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -129.83 95.82 4.06 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.559 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p -116.64 17.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -62.07 139.6 58.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.458 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 2.8 t60 -57.89 -19.35 28.87 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.528 1.131 . . . . 0.0 113.266 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -70.35 81.26 0.55 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.464 1.126 . . . . 0.0 111.681 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.49 93.39 4.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.92 -29.28 65.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.716 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.1 103.32 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.697 0 O-C-N 124.517 1.136 . . . . 0.0 110.658 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.56 99.58 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.063 1.842 . . . . 0.0 110.058 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.9 m -157.52 131.89 8.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--N 1.29 -1.988 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.646 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -150.55 -54.31 0.15 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -110.5 126.47 54.4 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 57.2 mtm 70.94 73.13 0.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 124.811 1.244 . . . . 0.0 112.531 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -106.57 16.5 24.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.29 1.519 . . . . 0.0 107.203 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.23 92.29 6.89 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.865 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.53 118.48 23.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.445 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.08 136.73 24.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.77 162.11 13.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.037 0.446 . . . . 0.0 110.215 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -84.41 75.5 10.24 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.662 0.744 . . . . 0.0 111.291 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -96.86 116.71 29.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.59 141.85 58.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.587 0.555 . . . . 0.0 110.572 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -82.89 -7.26 59.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.059 0.933 . . . . 0.0 110.808 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 -83.6 120.06 25.5 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.163 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.663 HG22 HG23 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 188' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.427 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.663 HG23 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.451 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.459 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.468 HG11 HG21 ' B' ' 222' ' ' THR . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.559 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG11 ' B' ' 207' ' ' VAL . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.456 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ASP . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 245' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 28' ' ' PRO . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -72.29 134.03 45.33 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 164.76 25.45 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.406 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -66.14 99.97 0.56 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--O 1.259 1.599 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.842 -173.523 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -142.17 92.82 7.45 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.53 95.6 0.99 Allowed 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.906 1.737 . . . . 0.0 111.506 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 93.5 6.18 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.862 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.38 124.13 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.147 1.898 . . . . 0.0 111.549 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -147.99 173.92 12.42 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -62.93 153.68 32.74 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.189 0.518 . . . . 0.0 112.204 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.4 -157.63 33.87 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.006 -1.093 . . . . 0.0 112.177 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.67 58.11 0.71 Allowed Glycine 0 CA--C 1.476 -2.35 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.62 39.46 3.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.894 -1.153 . . . . 0.0 108.238 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -115.63 95.92 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -142.06 129.78 21.61 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' B' ' 157' ' ' ILE . 47.1 t60 43.17 62.77 1.72 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.002 1.321 . . . . 0.0 111.327 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -86.27 92.01 8.65 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.36 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.02 -20.67 28.49 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.92 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -51.51 93.18 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.546 1.538 . . . . 0.0 112.391 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 113.56 62.46 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.19 87.65 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.138 1.892 . . . . 0.0 111.654 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 m -79.95 -30.93 39.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.855 1.262 . . . . 0.0 111.739 172.341 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m 68.31 159.46 0.16 Allowed 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.345 1.058 . . . . 0.0 112.011 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 74.46 125.36 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.096 1.358 . . . . 0.0 111.602 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.54 118.52 14.46 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 73.68 81.95 0.12 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 109.171 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.4 141.74 57.42 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.233 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -82.69 115.68 21.73 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 39' ' ' HIS . 77.7 mt -105.55 136.72 38.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.04 -178.16 4.97 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -124.02 173.08 8.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -143.56 143.46 31.53 Favored 'General case' 0 C--O 1.201 -1.452 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 43.99 -100.0 0.03 OUTLIER 'General case' 0 C--O 1.236 0.382 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -132.56 19.3 4.29 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 -74.76 116.86 15.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.925 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.465 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.608 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.646 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' ASP . . . . . 0.576 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.44 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.428 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -84.33 111.04 19.06 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -67.99 150.21 48.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.388 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.18 117.28 29.95 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.499 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -154.05 93.85 2.92 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -96.48 3.21 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.323 2.015 . . . . 0.0 110.994 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 136.13 34.76 Favored Pre-proline 0 C--O 1.244 0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.749 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.65 141.97 35.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 0.0 112.662 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -137.08 -177.01 4.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -91.28 131.03 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.542 0.687 . . . . 0.0 110.669 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.4 -157.26 27.33 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.19 -68.89 3.44 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -128.58 95.53 4.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 122.319 0.247 . . . . 0.0 111.264 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.3 18.95 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -76.35 93.39 3.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.216 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.4 t60 61.51 80.41 0.22 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 122.023 0.916 . . . . 0.0 112.539 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -132.79 24.4 4.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.93 1.348 . . . . 0.0 108.137 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.3 -40.49 17.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -91.91 -68.69 0.78 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.544 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.48 85.53 0.19 Allowed Pre-proline 0 C--N 1.342 0.264 0 O-C-N 124.492 1.12 . . . . 0.0 111.518 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.51 -65.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.6 2.2 . . . . 0.0 112.369 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -141.3 101.2 3.96 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.253 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.506 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.8 p -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.259 -0.554 . . . . 0.0 110.732 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.1 m80 71.36 13.52 6.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.535 1.134 . . . . 0.0 110.803 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 27.1 ttt -79.78 98.99 7.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.28 23.63 5.68 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.74 1.257 . . . . 0.0 111.177 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.44 170.15 10.26 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.053 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -93.63 172.65 8.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.6 mt -89.09 108.92 19.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.682 ' H ' HD23 ' B' ' 158' ' ' LEU . 2.1 pt? -94.49 132.92 38.65 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.745 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -97.79 179.0 4.96 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.98 139.23 55.01 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 123.456 0.702 . . . . 0.0 111.021 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 161' ' ' ARG . 23.9 mmt180 -130.6 178.36 6.68 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -97.35 4.68 50.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 109.645 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 -73.62 108.49 6.49 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.438 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 168' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.447 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.454 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 192' ' ' ILE . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 195' ' ' ASP . . . . . 0.447 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.474 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.454 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -73.1 133.72 44.25 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -70.15 159.38 34.04 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -90.3 99.59 12.58 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 C--N 1.285 -2.203 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.902 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -133.11 117.99 14.99 Favored Pre-proline 0 N--CA 1.426 -1.629 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.2 96.7 0.96 Allowed 'Trans proline' 0 N--CA 1.422 -2.718 0 C-N-CA 121.15 1.233 . . . . 0.0 111.423 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.43 146.13 80.51 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.01 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.35 151.48 54.05 Favored 'Trans proline' 0 C--O 1.256 1.405 0 C-N-CA 122.628 2.219 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 72.23 -70.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.602 1.161 . . . . 0.0 112.858 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 50.5 p90 -124.94 134.69 52.55 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.414 0.626 . . . . 0.0 110.926 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.15 -163.66 31.1 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 -57.97 4.83 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 -124.88 92.99 3.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 122.376 0.27 . . . . 0.0 110.732 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.559 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p -133.94 28.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 33.5 t-20 -65.04 89.22 0.08 Allowed 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.31 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 55.38 86.92 0.05 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 111.452 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 87.24 129.23 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.753 1.621 . . . . 0.0 112.868 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 -28.22 30.99 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.28 21.19 4.57 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.53 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.86 103.86 12.85 Favored Pre-proline 0 N--CA 1.446 -0.647 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.26 121.45 6.49 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.491 2.128 . . . . 0.0 112.848 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -103.87 -30.72 10.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.359 0.6 . . . . 0.0 109.644 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.433 -1.288 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.755 177.512 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 24.7 p -116.16 -12.6 11.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.873 0.336 . . . . 0.0 111.065 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m170 66.36 18.35 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.024 0.93 . . . . 0.0 111.463 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.03 136.3 50.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.91 128.71 36.27 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.063 0.459 . . . . 0.0 109.969 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.62 104.92 15.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -87.27 122.88 31.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 53.0 mt -76.5 106.05 6.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 94.1 mt -71.63 130.26 40.76 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.068 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -114.52 104.12 11.7 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.893 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.7 136.27 52.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.701 0.762 . . . . 0.0 109.571 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' ARG . . . . . 0.645 ' HD3' ' OD2' ' B' ' 186' ' ' ASP . 76.7 mtt180 -88.53 172.66 9.16 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.21 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -96.43 84.63 3.75 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.427 0.632 . . . . 0.0 109.431 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 75.9 m-85 -74.7 129.89 38.53 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.548 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' B' ' 254' ' ' GLN . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' THR . . . . . 0.551 ' OG1' HG22 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.551 HG22 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' TRP . . . . . 0.407 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.424 HG22 HG23 ' B' ' 192' ' ' ILE . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.645 ' OD2' ' HD3' ' B' ' 161' ' ' ARG . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 190' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 192' ' ' ILE . . . . . 0.424 HG23 HG22 ' B' ' 183' ' ' VAL . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 193' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.478 HG11 HG21 ' B' ' 222' ' ' THR . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.478 HG21 HG11 ' B' ' 207' ' ' VAL . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 222' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.548 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' HIS . . . . . 0.456 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 91.3 m-20 -67.61 148.26 51.63 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.71 145.38 15.72 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.162 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' GLN . . . . . 0.477 ' HA ' ' OH ' ' B' ' 164' ' ' TYR . 25.1 mt-30 -79.42 98.78 6.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.92 0.866 . . . . 0.0 110.09 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--N 1.289 -2.048 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.339 -178.22 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 . . . . . 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 37' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.569 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.404 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.404 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' B' ' 180' ' ' PRO . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' B' ' 179' ' ' ILE . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.454 HG23 HG22 ' B' ' 183' ' ' VAL . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.426 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . 0.466 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.494 ' CB ' HD22 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.427 HG13 ' HB ' ' B' ' 171' ' ' THR . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 . . . . . 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 13.6 p . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 120.636 0.255 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.447 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.401 HG21 HG12 ' B' ' 179' ' ' ILE . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.493 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . 0.401 HG12 HG21 ' B' ' 171' ' ' THR . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.498 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.465 HG21 HG21 ' B' ' 222' ' ' THR . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 207' ' ' VAL . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.611 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 . . . . . 0 CA--C 1.502 -0.866 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.476 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.504 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.476 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.491 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.491 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' B' ' 192' ' ' ILE . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 188' ' ' LYS . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.404 ' CD1' HG12 ' B' ' 230' ' ' ILE . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.547 HG23 HG22 ' B' ' 183' ' ' VAL . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.417 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . 0.406 ' HE ' ' CG1' ' B' ' 246' ' ' VAL . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.472 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.406 ' CG1' ' HE ' ' B' ' 241' ' ' ARG . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 . . . . . 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 . . . . . 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.438 HG21 HG12 ' B' ' 179' ' ' ILE . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.555 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.424 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . 0.438 HG12 HG21 ' B' ' 171' ' ' THR . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.435 HG22 HG23 ' B' ' 192' ' ' ILE . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.435 HG23 HG22 ' B' ' 183' ' ' VAL . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.515 HG11 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.545 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.52 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 19.9 m170 -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.545 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.515 HG21 HG11 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.434 HG21 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.564 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.1 t30 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 120.822 0.344 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.426 ' HA ' HG23 ' B' ' 234' ' ' THR . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.659 HG23 HG22 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.527 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.541 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.417 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.509 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' B' ' 214' ' ' HIS . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 213' ' ' GLU . 32.9 m170 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . 0.426 HG23 ' HA ' ' B' ' 188' ' ' LYS . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . 0.415 ' C ' HD22 ' B' ' 245' ' ' ASN . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.415 HD22 ' C ' ' B' ' 244' ' ' ASP . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.494 HD13 HG11 ' B' ' 183' ' ' VAL . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 . . . . . 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' B' ' 163' ' ' TYR . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.564 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.483 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.571 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.475 HG22 HG23 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.488 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.475 HG23 HG22 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' B' ' 229' ' ' LEU . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' B' ' 251' ' ' ARG . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.486 ' CB ' HD22 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.437 HD22 ' N ' ' B' ' 245' ' ' ASN . 0.7 OUTLIER -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' B' ' 236' ' ' PRO . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 . . . . . 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.451 HG22 HG23 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.451 HG23 HG22 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.495 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.519 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.455 HG21 HG21 ' B' ' 207' ' ' VAL . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.515 HD13 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.457 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.614 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 N--CA 1.424 -1.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 . . . . . 0 N--CA 1.43 -1.452 0 CA-C-O 120.813 0.339 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' HG ' ' B' ' 178' ' ' LEU . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.535 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' B' ' 175' ' ' LYS . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 192' ' ' ILE . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 183' ' ' VAL . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.481 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.526 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.526 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 26.7 m170 -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.464 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.453 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG21 ' B' ' 207' ' ' VAL . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' B' ' 196' ' ' LEU . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.393 0.139 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 12.4 p . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.464 HG21 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . 0.464 HG12 HG21 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' B' ' 247' ' ' VAL . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.56 HG22 HG23 ' B' ' 192' ' ' ILE . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.527 ' H ' ' CD2' ' B' ' 214' ' ' HIS . 3.1 p80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . 0.435 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . 0.435 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.474 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.477 ' OD1' ' HB ' ' B' ' 173' ' ' THR . 2.8 t30 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.431 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.433 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.43 HG22 HG23 ' B' ' 192' ' ' ILE . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 222' ' ' THR . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.433 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.62 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.507 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 . . . . . 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.409 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.409 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.595 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.465 HG22 HG23 ' B' ' 192' ' ' ILE . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.529 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' B' ' 230' ' ' ILE . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.465 HG23 HG22 ' B' ' 183' ' ' VAL . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.461 ' CG2' HD13 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' B' ' 212' ' ' LYS . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . 0.429 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.45 HG21 HG21 ' B' ' 207' ' ' VAL . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.42 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.204 0.526 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' B' ' 252' ' ' ASN . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.482 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.5 HG22 HG23 ' B' ' 192' ' ' ILE . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.606 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.577 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.5 HG23 HG22 ' B' ' 183' ' ' VAL . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.446 HG23 HG22 ' B' ' 240' ' ' VAL . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.432 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.44 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.412 ' HB2' ' CG ' ' B' ' 166' ' ' ASP . 61.9 m-80 . . . . . 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 110.769 -0.085 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 120.787 0.327 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 178' ' ' LEU . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' B' ' 175' ' ' LYS . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.563 HG22 HG23 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' B' ' 191' ' ' TYR . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' B' ' 233' ' ' GLY . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.563 HG23 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.665 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.533 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.54 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.473 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.533 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' B' ' 188' ' ' LYS . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.47 ' HB2' HD22 ' B' ' 245' ' ' ASN . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.9 t30 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p . . . . . 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 86.2 m-85 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' B' ' 164' ' ' TYR . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.674 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.409 ' OG1' HG22 ' B' ' 173' ' ' THR . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.409 HG22 ' OG1' ' B' ' 171' ' ' THR . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . 0.462 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.459 HG22 HG23 ' B' ' 192' ' ' ILE . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.459 HG23 HG22 ' B' ' 183' ' ' VAL . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.652 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.489 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 222' ' ' THR . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.527 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.478 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 . . . . . 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 110.811 -0.07 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.447 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.455 HG21 HG12 ' B' ' 179' ' ' ILE . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.508 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.495 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . 0.455 HG12 HG21 ' B' ' 171' ' ' THR . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.576 HG22 HG23 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.576 HG23 HG22 ' B' ' 183' ' ' VAL . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.534 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.447 HG11 HG21 ' B' ' 222' ' ' THR . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.468 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.447 HG21 HG11 ' B' ' 207' ' ' VAL . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.49 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' B' ' 212' ' ' LYS . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.569 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . 0.569 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.8 t30 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 . . . . . 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 . . . . . 0 C--O 1.211 -0.97 0 CA-C-O 120.765 0.317 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 45.5 m-85 . . . . . 0 CA--C 1.485 -1.532 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.494 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.494 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.637 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.484 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' B' ' 196' ' ' LEU . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 . . . . . 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? . . . . . 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.559 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 . . . . . 0 N--CA 1.426 -1.649 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.663 HG22 HG23 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.427 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.663 HG23 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.451 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.459 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.468 HG11 HG21 ' B' ' 222' ' ' THR . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.415 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 18.0 m170 -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.559 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG11 ' B' ' 207' ' ' VAL . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.456 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 . . . . . 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.433 -1.311 0 CA-C-O 122.055 0.931 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.465 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.608 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.646 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . 0.576 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.44 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.428 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 120.539 0.209 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.438 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.447 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.454 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 192' ' ' ILE . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . 0.447 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.474 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.454 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.559 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 75.9 m-85 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' THR . . . . . 0.551 ' OG1' HG22 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.551 HG22 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' TRP . . . . . 0.407 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.424 HG22 HG23 ' B' ' 192' ' ' ILE . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 190' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 191' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . 0.424 HG23 HG22 ' B' ' 183' ' ' VAL . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 193' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.478 HG11 HG21 ' B' ' 222' ' ' THR . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.478 HG21 HG11 ' B' ' 207' ' ' VAL . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 222' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.548 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' HIS . . . . . 0.456 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 91.3 m-20 . . . . . 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.94 95.51 15.28 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.37 31.65 0.52 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 123.172 2.581 . . . . 0.0 112.971 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.97 154.96 23.46 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -59.56 126.54 20.94 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 122.002 1.801 . . . . 0.0 109.781 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.72 -55.47 9.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.208 1.004 . . . . 0.0 109.566 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' CD2' ' HA3' ' B' ' 248' ' ' GLY . 27.7 p90 -118.13 148.38 42.39 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.649 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.46 -160.35 31.71 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.31 -62.34 4.33 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -143.99 97.37 3.04 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 120.966 0.413 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 40.7 m95 -77.48 99.1 5.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.029 171.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -116.76 143.15 46.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.164 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -66.26 143.96 56.9 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 123.425 0.453 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' B' ' 167' ' ' TYR . 1.8 p -131.19 16.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 122.627 1.203 . . . . 0.0 109.083 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -44.96 139.91 2.89 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.022 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 22.3 t-160 -59.28 90.89 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.405 1.098 . . . . 0.0 113.102 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -141.79 74.21 1.44 Allowed 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 167.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.76 -21.68 24.99 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.687 -168.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -167.66 -39.54 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.77 169.05 13.96 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.86 -32.33 84.63 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.403 2.069 . . . . 0.0 111.755 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -153.88 -58.6 0.12 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 N--CA 1.44 -0.969 0 C-N-CA 127.152 2.181 . . . . 0.0 105.638 176.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.506 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -74.25 104.11 4.9 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 73.19 -55.58 0.68 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.115 1.366 . . . . 0.0 111.821 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -175.18 3.4 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.955 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -115.57 112.47 22.22 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 123.177 0.591 . . . . 0.0 109.579 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.34 99.67 12.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -97.65 116.06 29.13 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.828 0.823 . . . . 0.0 112.378 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.48 134.4 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.344 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 91.4 mt 58.89 -167.33 0.15 Allowed 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.677 1.191 . . . . 0.0 111.55 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -90.22 158.07 17.4 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.38 131.25 37.95 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -112.12 138.13 49.21 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.524 0.678 . . . . 0.0 110.902 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -153.53 100.48 2.42 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.671 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.5 m-85 -80.44 105.72 11.91 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -76.95 113.08 14.25 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.123 -172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 47.6 m-85 -103.56 16.0 27.55 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -108.02 111.3 23.29 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 116.744 -1.983 . . . . 0.0 109.422 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 37' ' ' VAL . 23.5 p90 -155.72 150.52 26.3 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 125.318 1.447 . . . . 0.0 108.116 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -127.75 159.46 34.72 Favored 'General case' 0 C--N 1.272 -2.771 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -125.39 149.41 48.18 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.449 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.49 143.22 39.47 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 172.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.569 ' OG1' HG22 ' B' ' 173' ' ' THR . 9.8 t -157.65 151.46 24.14 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.532 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -105.17 8.66 34.15 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.592 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.8 t -103.39 158.93 16.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -119.45 15.1 12.92 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.59 0.709 . . . . 0.0 110.81 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.404 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.3 mmtt -87.04 119.71 27.53 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.494 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 4.8 p -69.18 -19.84 63.99 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.404 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 24.5 p-90 -86.62 5.7 34.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.622 0.725 . . . . 0.0 111.968 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' B' ' 242' ' ' HIS . 53.9 mt -115.12 -16.04 11.63 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.859 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' B' ' 180' ' ' PRO . 77.0 mt -94.59 127.47 43.7 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.598 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' B' ' 179' ' ' ILE . 17.6 Cg_endo -59.9 140.16 91.63 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.196 2.598 . . . . 0.0 112.292 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.3 m -94.5 -26.55 16.4 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.05 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.2 ttm180 -151.26 139.22 19.98 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' B' ' 167' ' ' TYR . 62.1 t -135.83 142.02 40.29 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.659 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -164.28 138.12 5.36 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.124 -0.985 . . . . 0.0 111.324 165.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -109.63 160.88 15.9 Favored 'General case' 0 C--N 1.274 -2.689 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.231 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 19.7 t70 -139.58 111.24 7.21 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.69 -62.31 0.67 Allowed Glycine 0 N--CA 1.44 -1.044 0 O-C-N 124.315 1.009 . . . . 0.0 114.037 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -144.81 -42.11 0.24 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 123.412 0.685 . . . . 0.0 110.53 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.79 120.4 25.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.376 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 16.8 m -102.89 118.9 37.84 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -97.21 116.96 30.35 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.487 0.715 . . . . 0.0 109.205 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.454 HG23 HG22 ' B' ' 183' ' ' VAL . 13.8 mt -116.17 107.97 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.886 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 19.8 m120 -85.83 115.74 23.65 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.426 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 43.2 mtm -133.21 176.15 8.76 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.856 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -85.71 55.27 3.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.326 1.06 . . . . 0.0 108.986 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.5 -10.8 59.63 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.808 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.3 t -67.52 -8.66 35.64 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.793 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.9 mmt180 -88.35 -4.43 58.67 Favored 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 121.651 -0.655 . . . . 0.0 109.805 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.2 m-85 -112.97 96.78 39.72 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.143 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.9 Cg_endo -93.41 175.51 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.605 2.87 . . . . 0.0 111.847 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 9.1 m 69.65 12.01 8.01 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.418 1.087 . . . . 0.0 110.209 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.48 17.16 80.24 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 7.6 t30 -89.15 61.98 6.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.06 0.933 . . . . 0.0 108.916 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -77.67 153.34 80.96 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.658 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.15 168.75 18.31 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.203 2.602 . . . . 0.0 112.744 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.63 143.68 30.52 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.948 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.64 141.86 45.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.0 m-85 -130.28 160.89 32.54 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.13 150.8 36.81 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 94.0 mtt180 -132.54 143.84 50.0 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.11 0.481 . . . . 0.0 111.351 175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . 0.466 ' HG3' ' CE1' ' B' ' 218' ' ' PHE . 39.8 mt-10 -83.68 -18.89 36.48 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.509 0.671 . . . . 0.0 110.032 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.9 ttpt -152.15 159.95 43.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -61.59 -31.12 71.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -114.16 30.1 7.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.0 -174.77 5.08 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.7 pt-20 -79.34 154.98 28.66 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.213 0.53 . . . . 0.0 110.249 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.38 113.47 21.7 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.461 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . 0.466 ' CE1' ' HG3' ' B' ' 211' ' ' GLU . 81.2 m-85 -90.43 128.04 36.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.17 -31.63 72.9 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.976 0.911 . . . . 0.0 111.804 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.8 m 40.39 -167.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 126.806 2.042 . . . . 0.0 115.044 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -111.63 133.43 53.89 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 24.2 m -141.57 137.42 31.93 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.587 0.232 . . . . 0.0 110.68 -177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -114.5 145.73 41.56 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.8 p -113.75 109.01 26.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.742 0.782 . . . . 0.0 111.623 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -109.46 100.81 9.84 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.052 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.83 -98.74 0.5 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.659 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 194' ' ' MET . 38.3 p30 -120.07 14.39 12.28 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.204 0.526 . . . . 0.0 110.148 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 2.7 m -117.5 127.55 54.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.729 -175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.9 mt -94.42 126.12 39.49 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 67.7 mt -101.8 102.84 14.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.94 119.39 34.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -81.12 100.74 9.21 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.02 133.7 4.14 Favored Glycine 0 C--N 1.297 -1.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.097 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 126.59 36.11 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.833 0.825 . . . . 0.0 112.215 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -130.24 149.2 72.64 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.57 -20.16 47.58 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.953 1.769 . . . . 0.0 113.013 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -140.33 144.35 36.27 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.15 151.36 51.98 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.8 t -131.82 129.0 60.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.52 136.54 52.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -130.21 116.69 18.77 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.518 0.675 . . . . 0.0 109.499 -176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.494 ' CB ' HD22 ' B' ' 178' ' ' LEU . 14.6 m-70 -108.24 101.52 10.73 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.61 -112.99 5.17 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -116.81 22.0 12.95 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.685 0.755 . . . . 0.0 110.338 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -106.95 151.28 25.5 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.45 141.98 25.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.726 -173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.427 HG13 ' HB ' ' B' ' 171' ' ' THR . 62.6 t -128.46 142.67 43.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 30' ' ' PHE . . . -119.14 136.41 11.97 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.092 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.02 148.58 41.36 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.884 0.874 . . . . 0.0 109.253 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 28.8 ptt180 -135.48 139.62 44.18 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.8 ttt-85 -99.72 124.01 44.54 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -100.63 123.55 45.0 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.419 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 165.51 7.78 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 123.643 0.589 . . . . 0.0 112.066 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -103.41 113.28 26.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--O 1.248 0.975 0 C-N-CA 125.442 1.497 . . . . 0.0 114.417 -179.459 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 120.621 0.248 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.85 90.86 50.28 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.39 161.49 8.22 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.77 1.646 . . . . 0.0 111.378 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.02 105.68 54.07 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.596 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.32 98.42 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.908 2.406 . . . . 0.0 110.469 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' H ' HG21 ' B' ' 246' ' ' VAL . 5.4 t70 -106.69 3.87 27.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.011 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -74.05 140.82 45.63 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.939 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.04 -153.0 23.06 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 108.146 -1.981 . . . . 0.0 108.146 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.59 -81.53 1.74 Allowed Glycine 0 C--N 1.288 -2.09 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.515 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -122.52 95.27 4.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.519 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 50.9 m95 -76.54 103.48 6.55 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.358 172.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -125.58 142.11 51.68 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.372 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -67.06 134.85 52.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.793 0.683 . . . . 0.0 111.076 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 13.6 p -132.28 36.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' CB ' ' HA ' ' B' ' 166' ' ' ASP . 28.3 p-10 -64.29 108.27 1.55 Allowed 'General case' 0 C--O 1.25 1.105 0 CA-C-N 113.647 -1.615 . . . . 0.0 111.384 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.648 ' O ' ' HA ' ' B' ' 182' ' ' ARG . 20.0 t-160 69.8 -95.4 0.03 OUTLIER 'General case' 0 C--O 1.192 -1.957 0 CA-C-N 113.907 -1.497 . . . . 0.0 107.762 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -152.77 9.41 0.46 Allowed 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -112.91 -161.14 0.74 Allowed 'General case' 0 N--CA 1.394 -3.262 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -143.43 16.85 1.86 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.815 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.0 137.84 92.33 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -87.54 17.53 1.7 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.728 2.285 . . . . 0.0 115.153 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.258 9.6 t 40.24 74.39 0.1 Allowed 'General case' 0 C--O 1.253 1.273 0 C-N-CA 124.519 1.127 . . . . 0.0 113.211 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' HA ' ' HZ3' ' B' ' 255' ' ' LYS . 5.5 tp10 . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.656 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.1 m -92.08 -27.55 17.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -76.61 -45.64 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 91.1 mtp 60.52 -93.35 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.455 1.102 . . . . 0.0 113.056 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -143.68 169.12 18.34 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 122.911 0.484 . . . . 0.0 110.23 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -100.06 126.83 46.32 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.397 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 ptpp? -77.87 120.63 23.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 58.7 mt -81.47 135.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 72.4 mt 60.18 75.66 0.4 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.034 0.921 . . . . 0.0 109.924 -172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -51.28 112.3 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.364 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.0 t70 172.26 -159.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -83.33 -172.68 4.28 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -120.74 40.45 3.52 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.818 0.818 . . . . 0.0 109.849 -173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 67.9 m-85 -69.95 121.0 16.53 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.692 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -106.34 127.15 53.05 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 90.8 m-85 -108.9 -11.98 14.94 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.471 ' HA ' ' CB ' ' A' ' 38' ' ' ASN . 22.4 m-20 -87.07 112.95 22.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -147.13 158.8 44.06 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.898 1.279 . . . . 0.0 109.984 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 2.2 m-20 -127.65 159.47 34.6 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.447 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 35.1 p90 -124.74 148.6 47.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.27 134.23 34.1 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.401 HG21 HG12 ' B' ' 179' ' ' ILE . 8.9 t -168.09 164.05 13.5 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -102.39 -5.44 24.14 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.872 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 5.7 t -84.12 148.46 26.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -114.21 8.57 16.88 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.046 0.45 . . . . 0.0 110.136 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.77 118.99 18.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.783 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.6 p -72.52 -2.53 20.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.493 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 18.0 p-90 -102.29 3.71 38.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.818 0.818 . . . . 0.0 110.65 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' B' ' 242' ' ' HIS . 75.1 mt -117.43 -24.99 7.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.914 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . 0.401 HG12 HG21 ' B' ' 171' ' ' THR . 94.0 mt -94.58 140.01 22.5 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.928 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.78 140.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.334 2.022 . . . . 0.0 110.914 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 16.1 p -99.78 -28.79 12.98 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.429 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 13.6 ttm180 -138.8 132.61 30.9 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.9 125.78 18.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -161.36 153.11 19.3 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 109.967 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -123.56 167.77 13.49 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 27.0 t70 -138.18 110.75 7.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.56 -59.65 0.67 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.095 0.872 . . . . 0.0 114.89 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -146.5 -42.48 0.19 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 124.52 1.128 . . . . 0.0 109.985 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -82.53 119.05 23.74 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.233 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -101.02 122.15 43.03 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -101.35 115.19 29.95 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.869 0.868 . . . . 0.0 109.405 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.27 108.41 24.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.608 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.5 m120 -84.58 115.12 22.45 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 51.5 mtp -132.98 179.71 6.01 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.55 66.92 2.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.696 -1.201 . . . . 0.0 109.521 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.498 HD11 ' HG ' ' B' ' 229' ' ' LEU . 44.8 mt -73.91 -11.35 60.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.309 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.73 -10.44 56.45 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.433 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 8.4 mmt180 -88.62 -2.79 58.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.597 175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.05 87.81 39.71 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.265 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -94.02 176.31 1.26 Allowed 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 123.513 2.809 . . . . 0.0 109.99 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 8.5 m 72.84 12.04 5.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 121.896 0.855 . . . . 0.0 111.009 174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 89.49 10.81 65.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.028 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -79.95 27.87 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.1 143.68 84.03 Favored Pre-proline 0 C--O 1.25 1.09 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.182 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.8 164.92 25.11 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.23 2.62 . . . . 0.0 112.642 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.38 122.24 39.04 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.465 HG21 HG21 ' B' ' 222' ' ' THR . 18.2 t -99.13 136.92 28.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.917 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -133.38 159.63 39.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.55 151.79 38.94 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 74.8 mtt180 -132.6 143.7 49.87 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.059 0.457 . . . . 0.0 111.082 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.13 -16.63 34.91 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.366 0.603 . . . . 0.0 110.124 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.3 mtmt -147.21 162.26 39.26 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.88 -30.23 71.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.837 0.351 . . . . 0.0 111.328 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -109.27 25.88 11.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.006 0.432 . . . . 0.0 111.455 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -86.75 175.34 8.29 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.57 158.48 29.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.05 117.36 22.19 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.32 129.75 37.27 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.14 -22.37 63.95 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.812 0.695 . . . . 0.0 111.772 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.2 m 35.02 -163.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 127.028 2.131 . . . . 0.0 115.525 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.04 126.76 52.46 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 207' ' ' VAL . 56.4 m -139.8 136.43 34.06 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.153 0.502 . . . . 0.0 110.749 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 48.4 m -110.95 147.34 34.88 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.4 109.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.0 101.78 10.57 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.124 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 67.49 -94.95 0.29 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.1 p-10 -133.32 24.97 4.16 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.796 0.808 . . . . 0.0 110.002 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.0 m -115.35 131.4 56.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.335 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' B' ' 196' ' ' LEU . 97.2 mt -95.03 124.42 39.06 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.3 mt -104.74 100.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.32 122.36 38.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.52 100.9 9.6 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.49 131.3 4.35 Favored Glycine 0 C--N 1.287 -2.139 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.969 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 7.3 p -87.79 119.19 27.87 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.396 0.617 . . . . 0.0 111.649 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -118.56 147.35 41.81 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -66.76 -16.22 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.149 1.9 . . . . 0.0 112.973 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -143.92 142.74 30.93 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -131.2 155.04 47.75 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.69 122.52 20.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.65 137.95 47.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -115.69 117.43 30.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.611 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.6 m-70 -117.81 101.7 8.51 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.2 -109.75 3.07 Favored Glycine 0 C--N 1.31 -0.91 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.66 -2.52 17.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.188 0.518 . . . . 0.0 109.893 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.73 154.17 20.85 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.547 HG21 ' H ' ' A' ' 29' ' ' ASP . 27.4 m -138.67 147.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.85 127.73 75.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.96 127.12 9.12 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.6 mp -114.0 137.12 52.13 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.7 ptt180 -117.55 140.15 50.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -92.61 119.83 32.44 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -79.31 152.41 30.51 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.482 0.658 . . . . 0.0 112.483 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -91.27 152.33 20.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 166.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -87.31 98.32 11.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.054 -1.459 . . . . 0.0 110.445 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' A' ' 46' ' ' GLU . 50.6 pttt . . . . . 0 C--O 1.259 1.572 0 C-N-CA 127.056 2.142 . . . . 0.0 115.406 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -150.58 100.42 3.13 Favored Pre-proline 0 N--CA 1.434 -1.231 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.26 123.33 8.68 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.729 1.62 . . . . 0.0 111.239 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 135.77 25.8 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.697 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' HG13 ' B' ' 246' ' ' VAL . 47.8 Cg_exo -59.36 165.65 8.87 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.375 2.05 . . . . 0.0 112.205 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -107.3 133.91 51.15 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.996 -173.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -83.22 153.26 24.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.615 ' O ' ' HB1' ' B' ' 170' ' ' ALA . . . -108.51 144.36 16.28 Favored Glycine 0 CA--C 1.461 -3.339 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.242 -173.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.58 51.68 2.26 Favored Glycine 0 C--O 1.219 -0.841 0 CA-C-N 117.175 0.487 . . . . 0.0 113.011 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -101.42 27.72 6.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.476 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 81.3 m95 -35.91 100.32 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 125.774 1.921 . . . . 0.0 113.991 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -131.56 140.95 49.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HA ' ' HA ' ' B' ' 168' ' ' ASP . 2.3 p-80 -65.74 133.4 50.97 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 p -104.14 21.9 2.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.965 1.364 . . . . 0.0 108.841 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -71.24 109.91 5.57 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.459 ' HB3' ' HG3' ' B' ' 182' ' ' ARG . 32.5 t60 -108.23 8.04 27.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.285 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -89.95 84.0 6.17 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.974 0.892 . . . . 0.0 108.949 -178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -152.62 -69.82 0.15 Allowed 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -155.05 145.22 21.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.09 115.78 64.56 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.46 -54.57 3.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.65 2.233 . . . . 0.0 110.755 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -92.14 80.14 5.09 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.89 0.852 . . . . 0.0 109.868 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.426 -1.652 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.437 -178.448 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.286 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 35.6 t -142.6 170.59 15.42 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -120.6 6.32 10.55 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 -173.96 3.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.774 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 77.19 98.57 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.53 1.132 . . . . 0.0 110.182 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 68.3 -175.75 0.2 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.028 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -100.19 125.05 46.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.495 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.4 140.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.591 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -61.14 118.75 7.22 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.13 -165.31 1.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.211 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -68.41 140.86 55.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -76.55 87.91 3.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.957 1.36 . . . . 0.0 111.334 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -136.75 88.31 2.36 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.205 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -124.67 135.01 52.69 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 23.8 t80 -103.31 118.88 37.78 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -108.39 -2.51 19.05 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.504 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 23.1 m-20 -86.29 110.85 19.93 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.31 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -151.22 147.86 27.52 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 124.482 1.113 . . . . 0.0 108.165 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 5.0 m-20 -126.4 149.57 49.16 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -117.27 144.36 44.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 123.812 0.695 . . . . 0.0 109.138 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.615 ' HB1' ' O ' ' A' ' 31' ' ' GLY . . . -138.09 120.36 15.8 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.099 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.491 ' OG1' HG22 ' B' ' 173' ' ' THR . 11.6 t -152.17 161.39 42.69 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.192 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -93.79 -14.82 25.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.302 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.491 HG22 ' OG1' ' B' ' 171' ' ' THR . 14.1 t -83.08 155.11 24.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.641 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -110.99 -0.46 16.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.09 115.74 20.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.028 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 16.0 m -77.89 -0.55 27.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.552 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 20.1 p-90 -94.61 0.65 55.33 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.915 0.864 . . . . 0.0 110.417 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 242' ' ' HIS . 64.7 mt -112.65 -19.2 12.15 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.917 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 133.4 28.39 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -63.39 144.63 91.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.325 2.017 . . . . 0.0 111.25 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 14.4 m -92.15 -32.87 14.95 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 39' ' ' HIS . 29.2 ttp180 -151.82 132.37 13.89 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' B' ' 192' ' ' ILE . 19.4 t -133.54 126.79 52.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.14 149.83 17.95 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -122.75 167.5 13.4 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.17 109.84 10.73 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.66 -62.02 0.18 Allowed Glycine 0 CA--C 1.542 1.726 0 CA-C-N 114.882 -1.054 . . . . 0.0 114.942 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' B' ' 188' ' ' LYS . 33.5 ttpt -141.36 -45.08 0.37 Allowed 'General case' 0 N--CA 1.398 -3.025 0 C-N-CA 124.984 1.314 . . . . 0.0 110.569 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.63 121.46 25.31 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.0 m -102.34 129.92 48.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.404 ' CD1' HG12 ' B' ' 230' ' ' ILE . 63.1 m-85 -109.5 117.9 35.19 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 123.686 0.794 . . . . 0.0 109.012 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.547 HG23 HG22 ' B' ' 183' ' ' VAL . 8.0 mt -116.88 106.52 20.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -81.66 111.14 17.66 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.417 ' SD ' HG11 ' B' ' 240' ' ' VAL . 60.2 mtp -128.76 170.99 12.66 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 59.5 5.63 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 122.161 0.981 . . . . 0.0 108.978 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.7 mt -73.67 -10.85 60.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.791 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -13.77 59.77 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.493 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 11.1 mmt180 -90.23 -3.79 57.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.395 0.617 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -118.07 89.3 34.35 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.177 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.83 174.13 1.57 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.887 2.391 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.8 m 61.51 27.03 16.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 122.52 1.152 . . . . 0.0 111.462 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.34 18.09 72.26 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.709 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 36.01 0.75 Allowed 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.5 -0.412 . . . . 0.0 111.461 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.01 145.54 96.55 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.842 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.32 168.88 23.01 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 123.123 2.549 . . . . 0.0 111.94 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -103.09 141.64 35.5 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.05 135.4 63.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.447 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.2 m-85 -123.91 164.4 19.36 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -116.57 152.85 33.31 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.983 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 92.2 mtt180 -136.58 144.27 44.05 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.397 0.618 . . . . 0.0 111.695 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -90.74 -15.48 30.16 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.34 0.59 . . . . 0.0 111.176 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.3 mtmm -147.7 168.49 21.95 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.34 -39.63 94.26 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 109.213 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -99.89 18.57 18.01 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.679 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -79.23 173.84 12.17 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.05 155.73 20.71 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.8 p30 -95.24 122.86 38.37 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-O 122.001 0.905 . . . . 0.0 111.271 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -97.1 138.84 33.99 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.278 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -71.93 -18.88 61.99 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.7 -170.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.17 118.57 36.97 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 63.2 m -139.56 135.38 33.34 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 19.6 m -110.99 147.07 35.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.22 118.64 59.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.37 90.15 3.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.16 0.505 . . . . 0.0 110.922 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.82 -83.09 0.22 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.031 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.8 p-10 -127.68 14.59 7.0 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.276 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 26.3 m -130.43 129.83 43.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.597 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.2 mt -93.04 125.03 37.43 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.4 mt -106.78 101.41 12.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.03 122.22 38.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.38 100.61 11.4 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.79 130.41 3.87 Favored Glycine 0 C--N 1.289 -2.08 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.218 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.3 p -92.51 122.59 35.1 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.787 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -118.85 152.83 52.14 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.35 -28.08 83.82 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.579 2.186 . . . . 0.0 112.989 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -140.8 145.79 36.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.96 154.5 50.41 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.0 115.2 16.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 ' SD ' ' B' ' 194' ' ' MET . 5.6 t -96.58 144.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . 0.406 ' HE ' ' CG1' ' B' ' 246' ' ' VAL . 34.7 ttm180 -132.72 117.24 17.59 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.427 0.632 . . . . 0.0 110.876 -171.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.472 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -125.43 101.42 6.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.919 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.24 -107.15 1.34 Allowed Glycine 0 C--N 1.305 -1.139 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.155 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -96.66 -9.47 29.11 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.689 0.395 . . . . 0.0 111.457 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -117.33 162.81 17.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 28' ' ' PRO . 22.0 m -140.85 150.33 20.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.529 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.88 121.58 68.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -92.76 119.79 5.97 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 89.5 mt -108.68 138.66 44.64 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 27.8 ptt180 -119.72 137.15 54.11 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.761 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -94.05 121.93 36.04 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -77.31 159.22 29.72 Favored 'General case' 0 C--N 1.276 -2.624 0 C-N-CA 119.136 -1.026 . . . . 0.0 109.282 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -126.19 171.48 10.86 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.79 105.13 7.67 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--N 1.323 -0.578 0 C-N-CA 126.579 1.951 . . . . 0.0 109.191 -176.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -151.26 83.38 5.53 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.26 117.59 2.5 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.532 2.155 . . . . 0.0 110.846 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.98 95.73 48.81 Favored Pre-proline 0 N--CA 1.42 -1.935 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.203 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.84 -42.59 24.11 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.014 -1.572 . . . . 0.0 108.014 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.9 t70 68.24 -60.53 0.41 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.698 1.999 . . . . 0.0 110.071 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 38.7 p90 -101.2 172.68 6.85 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.458 1.103 . . . . 0.0 108.852 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' HA2' ' HB1' ' B' ' 170' ' ' ALA . . . 132.55 -155.25 21.46 Favored Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.028 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.41 -72.3 2.37 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 15.3 tpp180 -110.95 91.47 3.67 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.335 0.588 . . . . 0.0 110.857 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 69.0 m95 -81.93 118.46 22.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.223 172.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -137.41 134.62 36.09 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -65.36 140.36 58.65 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.358 0.599 . . . . 0.0 111.428 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.22 90.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 122.501 1.143 . . . . 0.0 108.807 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.05 154.93 50.22 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.501 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 73.65 -86.68 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.483 1.113 . . . . 0.0 112.644 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.37 168.52 19.58 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.508 0.671 . . . . 0.0 112.222 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 42' ' ' GLU . 6.5 p-10 -107.97 -99.0 0.37 Allowed 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.626 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 15.9 mm-40 -95.31 -33.99 12.33 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 65.2 98.46 0.04 OUTLIER Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.997 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.33 100.26 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.718 1.612 . . . . 0.0 108.851 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.7 p -77.69 136.58 38.21 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-O 121.75 0.786 . . . . 0.0 112.669 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.411 -2.398 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.6 t -92.5 95.24 9.51 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -84.32 -40.16 18.28 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.51 104.88 16.73 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -75.07 87.08 2.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.93 96.54 10.53 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.07 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -118.05 135.19 54.34 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.0 mt -74.62 115.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.594 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.9 pt? -98.32 -16.49 19.33 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.965 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 58.7 pttt 32.03 75.34 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 125.955 2.034 . . . . 0.0 112.754 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.67 15.78 19.09 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.966 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -73.27 96.82 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.163 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -110.07 -138.92 0.38 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 90.9 m-85 -65.29 124.47 22.3 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.503 0.668 . . . . 0.0 110.963 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -89.0 111.96 22.79 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -98.15 -17.66 18.91 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.9 m-20 -74.73 110.34 8.94 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.04 -173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -153.22 154.77 35.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 124.714 1.206 . . . . 0.0 109.264 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.15 151.52 49.84 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.79 153.71 37.93 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.3 136.11 36.11 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.638 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.438 HG21 HG12 ' B' ' 179' ' ' ILE . 9.5 t -168.56 167.36 11.61 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -115.19 12.32 16.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.661 0.743 . . . . 0.0 109.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -99.5 167.14 10.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -131.87 18.47 4.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.94 0.876 . . . . 0.0 109.964 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -85.27 123.24 30.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.525 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.1 t -72.96 -9.01 58.26 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.774 0.797 . . . . 0.0 110.64 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.555 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.2 p-90 -101.37 4.99 42.02 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.791 0.805 . . . . 0.0 111.6 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.424 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 82.7 mt -118.66 -24.74 6.61 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.397 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . 0.438 HG12 HG21 ' B' ' 171' ' ' THR . 87.8 mt -94.37 138.29 22.48 Favored Pre-proline 0 N--CA 1.434 -1.245 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.213 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.21 131.31 20.34 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.618 1.545 . . . . 0.0 110.214 174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . 0.458 ' HB2' ' CB ' ' A' ' 41' ' ' ASP . 10.6 p -85.21 -33.21 22.3 Favored 'General case' 0 N--CA 1.405 -2.683 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.126 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 24.9 ttm180 -142.29 133.76 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.435 HG22 HG23 ' B' ' 192' ' ' ILE . 22.8 t -137.68 125.85 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -160.92 142.1 11.77 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 123.314 0.384 . . . . 0.0 110.342 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.97 167.58 10.54 Favored 'General case' 0 CA--C 1.474 -1.944 0 CA-C-O 121.129 0.49 . . . . 0.0 110.489 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 16.8 t70 -135.51 110.07 8.56 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.66 -64.36 0.3 Allowed Glycine 0 CA--C 1.535 1.306 0 O-C-N 124.551 1.157 . . . . 0.0 114.019 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -142.34 -39.26 0.36 Allowed 'General case' 0 C--O 1.207 -1.179 0 C-N-CA 124.419 1.088 . . . . 0.0 110.973 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.44 118.85 24.02 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.422 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.6 m -100.07 120.46 39.87 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -98.35 110.42 23.01 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.048 0.539 . . . . 0.0 109.753 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.435 HG23 HG22 ' B' ' 183' ' ' VAL . 10.9 mt -112.18 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.268 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.3 m120 -81.68 120.07 24.64 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 52.5 mtp -130.95 179.52 5.94 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.7 t0 -97.67 61.65 1.62 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.061 0.934 . . . . 0.0 108.846 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.92 -11.48 60.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.245 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 9.7 t -66.93 -13.06 61.38 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -88.8 -1.4 58.07 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.448 0.642 . . . . 0.0 110.227 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -117.15 95.5 47.31 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.696 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -93.82 175.26 1.44 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 123.105 2.537 . . . . 0.0 111.552 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.6 m 72.71 3.43 4.69 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.029 0.919 . . . . 0.0 112.239 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 92.64 17.07 46.53 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.43 39.76 0.89 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.062 0.458 . . . . 0.0 110.924 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -61.16 146.91 87.59 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.474 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.91 167.58 15.5 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 123.334 2.69 . . . . 0.0 113.336 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -91.42 123.92 35.21 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.342 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.515 HG11 HG21 ' B' ' 222' ' ' THR . 3.5 p -112.64 131.39 64.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.545 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 80.0 m-85 -132.13 167.6 19.46 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.984 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.61 154.09 41.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.604 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.3 mtt180 -136.74 144.24 43.72 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.055 0.455 . . . . 0.0 111.34 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.07 -24.63 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.321 0.582 . . . . 0.0 110.031 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.539 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 20.2 ptmt -152.07 169.22 22.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.52 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.0 OUTLIER -63.77 -34.42 77.85 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.106 0.562 . . . . 0.0 111.485 -173.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.52 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 19.9 m170 -101.24 20.13 16.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.539 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -83.09 173.28 11.86 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.5 pt-20 -75.08 154.0 38.1 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.545 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 47.9 m-20 -78.5 113.52 16.59 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -89.91 126.69 35.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.65 -20.55 64.46 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 123.74 0.65 . . . . 0.0 111.706 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 16.7 m 35.79 -165.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -114.19 124.54 52.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.924 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.515 HG21 HG11 ' B' ' 207' ' ' VAL . 41.4 m -138.77 139.55 38.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.5 m -111.16 141.0 45.25 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 35.4 t -105.19 111.18 33.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -115.12 96.14 5.54 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.864 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.71 -91.65 0.34 Allowed Glycine 0 C--N 1.309 -0.932 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.156 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.4 p30 -123.47 9.85 9.1 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.7 m -114.77 126.91 55.39 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.74 116.81 29.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 190' ' ' THR . 64.2 mt -97.79 99.2 8.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.91 118.92 32.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.82 100.5 9.61 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.1 131.77 3.97 Favored Glycine 0 C--N 1.293 -1.854 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.9 p -96.5 119.86 35.75 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.794 0.807 . . . . 0.0 112.098 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -120.16 154.94 56.15 Favored Pre-proline 0 C--N 1.294 -1.821 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.88 -24.97 60.41 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.316 2.01 . . . . 0.0 112.63 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 90.1 m-85 -139.45 139.38 37.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -127.22 154.77 44.43 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.434 HG21 ' NE ' ' B' ' 210' ' ' ARG . 99.6 t -138.32 125.73 28.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.29 138.09 41.15 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.89 117.44 21.8 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.564 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.3 m-70 -119.3 100.53 7.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.62 -92.97 0.02 OUTLIER Glycine 0 CA--C 1.532 1.111 0 O-C-N 124.1 0.875 . . . . 0.0 114.625 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -109.01 -4.76 16.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.882 1.325 . . . . 0.0 109.412 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.1 t30 -108.79 146.81 33.01 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 114.02 -1.445 . . . . 0.0 111.673 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.94 142.99 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.58 130.1 66.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.583 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -109.15 129.52 9.54 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' B' ' 237' ' ' PHE . 5.5 mp -110.75 134.51 52.42 Favored 'General case' 0 C--N 1.266 -3.041 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.12 126.09 54.7 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.788 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -87.79 124.81 34.0 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 35.3 m-80 -76.98 156.63 31.78 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -68.59 176.26 3.03 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.382 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -69.91 103.79 2.32 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.288 -2.102 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.373 179.559 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -140.76 99.61 6.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 111.469 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -96.85 172.97 0.8 Allowed 'Trans proline' 0 N--CA 1.438 -1.777 0 C-N-CA 122.362 2.042 . . . . 0.0 110.514 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.53 139.42 86.54 Favored Pre-proline 0 C--N 1.308 -1.209 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' B' ' 172' ' ' ARG . 4.2 Cg_endo -49.13 -34.78 31.4 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.983 2.455 . . . . 0.0 113.812 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 66.3 166.07 0.2 Allowed 'General case' 0 C--O 1.248 1.023 0 O-C-N 124.088 0.868 . . . . 0.0 110.536 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -92.42 131.17 37.8 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.033 -177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.44 -152.36 24.07 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.27 -69.89 3.25 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -130.4 95.41 3.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 122.869 0.468 . . . . 0.0 110.143 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 51.3 m95 -79.43 106.91 11.8 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.258 173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.85 147.99 52.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -66.6 140.12 57.93 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.268 0.355 . . . . 0.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.73 9.75 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.178 0.989 . . . . 0.0 110.871 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 12.6 p-10 -81.19 111.35 17.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.455 0.645 . . . . 0.0 111.399 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -108.57 110.24 21.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.1 t80 72.47 121.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.825 1.328 . . . . 0.0 111.252 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -120.15 -153.15 0.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.64 138.85 31.11 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.74 103.91 7.59 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.75 107.44 1.47 Allowed 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.37 2.047 . . . . 0.0 110.773 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 p -93.31 89.4 6.36 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.861 0.839 . . . . 0.0 110.977 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -178.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 21.7 p -98.72 -83.29 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -114.05 -1.25 13.8 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 78.8 mtp -155.33 154.22 31.71 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.469 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -113.12 112.94 24.68 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -88.19 136.02 33.17 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -93.69 73.8 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 44.5 mt -92.84 113.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 92.7 mt -92.75 165.7 12.81 Favored 'General case' 0 C--N 1.268 -2.97 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -84.73 50.62 1.95 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.337 1.065 . . . . 0.0 111.781 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -122.3 117.12 25.34 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' B' ' 163' ' ' TYR . 14.0 ptp180 -81.41 -21.02 39.21 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 1.2 tpm_? 71.6 11.21 6.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.957 1.303 . . . . 0.0 111.4 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.501 ' H ' ' HG3' ' B' ' 161' ' ' ARG . 72.9 m-85 -99.1 123.79 43.65 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.716 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.72 113.1 25.97 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 97.8 m-85 -102.34 -12.69 17.74 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 2.7 m-20 -74.22 108.76 7.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.651 -1.22 . . . . 0.0 110.509 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 30.0 m-85 -155.38 149.92 26.2 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.113 1.365 . . . . 0.0 110.174 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -123.42 155.39 37.51 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -118.39 142.24 47.74 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.78 133.0 31.55 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -166.27 152.49 8.96 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 28' ' ' PRO . 62.1 mtt85 -105.44 30.49 5.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.726 0.774 . . . . 0.0 109.781 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -118.04 157.7 26.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -118.22 11.08 13.08 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.934 0.397 . . . . 0.0 110.22 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.04 114.56 11.34 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.4 p -67.39 -21.22 65.61 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.676 0.75 . . . . 0.0 111.975 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 21.0 p-90 -87.28 4.37 43.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.588 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -119.64 -20.99 7.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.854 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.2 mt -93.84 124.41 56.68 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.241 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.22 145.5 93.38 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.853 2.369 . . . . 0.0 111.581 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -96.62 -29.84 13.61 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.292 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.01 131.32 14.61 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -133.66 125.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.6 143.9 13.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.674 0.609 . . . . 0.0 109.848 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -109.96 163.28 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.655 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 0.0 OUTLIER -141.18 111.44 6.78 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.76 -60.39 2.53 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.372 -1.285 . . . . 0.0 113.67 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.426 ' HA ' HG23 ' B' ' 234' ' ' THR . 5.8 tmmm? -155.18 -34.12 0.09 Allowed 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 123.921 0.888 . . . . 0.0 108.946 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -82.28 128.97 34.72 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.478 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 23.0 m -106.15 119.5 39.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -99.91 122.91 43.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.526 0.73 . . . . 0.0 109.804 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.659 HG23 HG22 ' B' ' 183' ' ' VAL . 8.8 mt -120.06 103.72 14.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.8 113.17 20.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.527 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 61.2 mtp -132.95 -179.18 5.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 12.1 t0 -95.07 54.51 1.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.175 0.988 . . . . 0.0 108.86 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.541 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.4 mt -69.23 -11.59 60.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.756 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 10.0 t -66.04 -9.73 33.36 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.417 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 27.0 mmt180 -88.25 -5.33 58.43 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 120.952 0.406 . . . . 0.0 110.072 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -110.57 95.12 21.52 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.643 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 45.3 Cg_endo -86.83 174.93 5.35 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 122.631 2.221 . . . . 0.0 112.008 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 23.6 m 71.26 -2.51 2.37 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.262 1.025 . . . . 0.0 111.6 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.22 16.77 55.1 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -83.07 48.27 1.35 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.661 . . . . 0.0 110.117 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.75 152.26 96.47 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.76 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 60.7 Cg_endo -68.21 169.53 16.57 Favored 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.047 2.498 . . . . 0.0 112.933 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.43 128.07 49.18 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.86 134.8 54.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.458 0.647 . . . . 0.0 109.365 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.509 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 84.6 m-85 -120.94 164.24 17.01 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.842 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.48 32.41 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.751 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 88.2 mtt180 -136.59 143.68 43.73 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.561 0.696 . . . . 0.0 112.005 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.8 -22.99 27.39 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.528 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -145.46 163.62 34.11 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' B' ' 214' ' ' HIS . 9.0 pt-20 -72.37 -26.21 61.82 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.571 0.7 . . . . 0.0 109.619 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 213' ' ' GLU . 32.9 m170 -98.9 11.89 37.5 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.516 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -88.06 176.78 7.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.39 157.29 17.17 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.931 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.509 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 3.1 p-10 -82.29 122.01 27.39 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.602 0.715 . . . . 0.0 110.973 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.43 137.19 37.48 Favored 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.383 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.96 -25.61 64.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m 37.97 -169.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 126.644 1.978 . . . . 0.0 116.215 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -102.75 132.18 49.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.0 m -142.23 140.08 32.18 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.205 -0.309 . . . . 0.0 111.826 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 29.6 m -115.9 143.25 45.69 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 172.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.67 114.57 47.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.633 0.73 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -114.51 100.42 8.28 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.607 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.56 -95.39 0.38 Allowed Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.66 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' B' ' 194' ' ' MET . 9.3 p30 -128.47 19.09 6.3 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.232 0.539 . . . . 0.0 110.213 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 5.6 m -116.93 126.73 53.4 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.643 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.9 mt -91.29 124.27 35.36 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.18 99.83 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 58.3 t -85.42 120.32 35.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -81.3 100.34 9.13 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.47 132.19 3.52 Favored Glycine 0 C--N 1.291 -1.921 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.777 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . 0.426 HG23 ' HA ' ' B' ' 188' ' ' LYS . 24.6 p -90.12 136.16 33.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -140.6 148.41 53.08 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -65.38 -21.98 60.33 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.159 1.906 . . . . 0.0 112.296 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.9 139.26 36.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.49 153.84 46.73 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.66 119.86 22.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.99 131.26 57.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -120.46 121.38 38.37 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.2 m-70 -119.81 99.1 6.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 51.46 -103.67 0.12 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.247 0.967 . . . . 0.0 114.424 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . 0.415 ' C ' HD22 ' B' ' 245' ' ' ASN . 22.3 t70 -92.57 -7.88 45.91 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 110.331 -174.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.415 HD22 ' C ' ' B' ' 244' ' ' ASP . 0.9 OUTLIER -119.75 165.81 14.05 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.822 -0.549 . . . . 0.0 110.621 -174.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 9.1 p -154.39 149.43 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.39 140.79 47.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.68 144.71 18.26 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.494 HD13 HG11 ' B' ' 183' ' ' VAL . 81.1 mt -121.24 136.38 54.98 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.324 0.65 . . . . 0.0 109.82 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 61.9 ttp180 -115.82 120.22 38.54 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.337 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -83.19 126.29 32.46 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 47.2 m-80 -98.68 145.49 26.83 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.086 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -66.77 173.27 3.62 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.547 0.689 . . . . 0.0 112.338 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' B' ' 254' ' ' GLN . 15.0 mm-40 -88.36 116.42 26.57 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.01 175.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--N 1.316 -0.875 0 C-N-CA 126.038 1.735 . . . . 0.0 109.933 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm 72.17 100.27 0.04 OUTLIER Pre-proline 0 C--N 1.345 0.412 0 C-N-CA 123.929 0.892 . . . . 0.0 109.821 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.04 0.48 8.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.237 2.625 . . . . 0.0 113.389 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.89 90.63 47.22 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.21 135.41 59.72 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.67 2.913 . . . . 0.0 113.393 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.33 156.82 19.53 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.995 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 170' ' ' ALA . 38.1 p90 -66.05 162.03 20.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.892 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' B' ' 171' ' ' THR . . . -86.84 -166.31 42.34 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.21 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.34 8.35 26.66 Favored Glycine 0 N--CA 1.42 -2.38 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -87.75 70.43 9.63 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.539 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 60.8 m95 -71.0 107.67 4.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.509 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -129.81 140.03 51.11 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.678 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.407 ' HB3' ' OD1' ' A' ' 38' ' ' ASN . 92.0 m-70 -64.68 141.46 58.77 Favored 'General case' 0 C--O 1.252 1.199 0 O-C-N 123.778 0.674 . . . . 0.0 110.79 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 13.0 p -129.75 25.57 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.665 1.222 . . . . 0.0 108.132 174.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 20.0 p-10 -68.23 94.08 0.5 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.703 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 70.25 -81.27 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 110.906 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -158.51 113.6 2.59 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 125.564 1.546 . . . . 0.0 109.301 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -94.82 -16.5 22.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 63.59 83.06 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.983 1.313 . . . . 0.0 113.13 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.18 97.05 5.28 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.423 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.29 101.51 0.99 Allowed 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.396 2.064 . . . . 0.0 111.22 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -114.62 93.65 4.43 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.888 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 172.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.947 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 155' ' ' ALA . 16.5 t 61.85 23.59 13.89 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.953 0.901 . . . . 0.0 112.658 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -109.22 120.76 43.48 Favored 'General case' 0 C--O 1.246 0.911 0 O-C-N 121.528 -0.732 . . . . 0.0 111.325 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 94.7 mmm 68.47 -80.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.072 1.749 . . . . 0.0 110.677 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.14 83.25 1.87 Allowed 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' B' ' 151' ' ' SER . . . -155.61 155.02 32.55 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.979 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.94 -165.01 0.98 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 45.7 mt -94.16 128.97 45.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.638 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.1 pt? -80.77 116.82 20.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.411 0.624 . . . . 0.0 110.016 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -86.7 126.65 34.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 19.1 t70 74.02 94.97 0.07 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.645 1.212 . . . . 0.0 107.857 -166.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.59 172.53 2.05 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.972 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.595 ' HA ' ' NE ' ' B' ' 162' ' ' ARG . 0.6 OUTLIER -112.47 -154.11 0.54 Allowed 'General case' 0 N--CA 1.385 -3.708 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' B' ' 165' ' ' TYR . 96.4 m-85 -104.63 152.53 22.35 Favored 'General case' 0 C--N 1.262 -3.236 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -97.35 112.8 24.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 98.9 m-85 -104.04 -13.47 16.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.111 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 7.8 m-20 -76.5 109.27 10.09 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.627 -174.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 52.1 m-85 -154.66 159.89 41.06 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.822 1.249 . . . . 0.0 109.711 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -137.1 161.71 35.38 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.564 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 24.3 p90 -128.33 149.51 50.48 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.678 0.611 . . . . 0.0 110.038 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.18 117.35 12.63 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.674 0.75 . . . . 0.0 110.781 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 9.9 t -146.6 175.97 10.19 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -132.21 13.19 4.67 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.916 0.76 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.483 HG22 ' OG1' ' B' ' 171' ' ' THR . 12.4 t -87.92 151.84 22.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -113.99 24.91 11.61 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.055 0.931 . . . . 0.0 110.043 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.62 110.36 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.1 m -70.36 -12.29 61.48 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.093 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.571 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 16.1 p-90 -86.42 3.0 45.65 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.884 0.85 . . . . 0.0 111.462 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' B' ' 242' ' ' HIS . 56.7 mt -116.97 -14.51 10.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.288 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.9 mt -96.3 134.21 23.89 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.848 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.33 129.49 17.08 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.77 1.647 . . . . 0.0 111.459 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.1 m -85.66 -26.46 25.97 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.395 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 60.7 ttt180 -150.63 135.62 17.59 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.475 HG22 HG23 ' B' ' 192' ' ' ILE . 36.5 t -138.64 125.84 26.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.42 149.48 15.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -126.96 167.42 15.9 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.674 0.749 . . . . 0.0 111.702 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -133.28 109.91 9.72 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.61 -64.8 0.44 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 124.336 1.023 . . . . 0.0 113.689 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.488 ' HD3' ' OG1' ' B' ' 234' ' ' THR . 32.3 mmtp -146.88 -37.19 0.22 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 124.65 1.18 . . . . 0.0 109.769 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.46 115.0 13.49 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.1 m -101.79 123.7 46.18 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -102.64 112.54 25.35 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.525 0.73 . . . . 0.0 109.573 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.475 HG23 HG22 ' B' ' 183' ' ' VAL . 11.7 mt -113.49 107.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.23 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.8 m120 -82.68 115.5 21.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 51.9 mtp -132.55 174.81 9.88 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.27 62.24 4.67 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.288 1.042 . . . . 0.0 108.412 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' B' ' 229' ' ' LEU . 66.2 mt -72.91 -12.44 60.96 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.853 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 3.8 t -68.28 -8.66 41.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.187 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 10.2 mmt180 -82.14 -12.88 57.93 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.063 0.459 . . . . 0.0 110.134 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 98.9 m-85 -109.6 93.96 15.38 Favored Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.923 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 69.5 Cg_endo -91.44 174.25 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 123.017 2.478 . . . . 0.0 111.72 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.8 m 67.31 18.23 10.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 122.405 1.098 . . . . 0.0 110.371 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.87 23.41 77.93 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.813 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 3.3 t30 -89.67 55.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.723 0.773 . . . . 0.0 108.934 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -71.27 149.58 94.16 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.702 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 57.1 Cg_endo -67.55 169.39 15.88 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 123.333 2.689 . . . . 0.0 112.93 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -96.4 140.78 30.55 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.237 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.9 141.91 44.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 73.6 m-85 -134.69 159.6 40.76 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -115.36 151.81 33.97 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.989 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 91.4 mtt180 -136.26 143.72 44.42 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.265 0.555 . . . . 0.0 111.86 174.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -73.94 -32.81 63.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.01 0.91 . . . . 0.0 109.924 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 21.0 ptmt -150.6 172.71 15.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -31.44 72.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.161 0.505 . . . . 0.0 111.84 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -104.62 24.5 11.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -89.67 170.96 10.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.1 pt-20 -78.34 157.72 29.04 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.04 113.17 21.26 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 89.5 m-85 -90.82 130.23 36.81 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.83 -29.45 70.18 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.402 0.439 . . . . 0.0 112.17 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.299 20.3 m 41.63 178.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.0 128.55 40.4 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.439 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.1 m -141.68 146.47 36.16 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.615 0.245 . . . . 0.0 110.407 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.8 m -123.11 141.73 51.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.29 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.012 0.911 . . . . 0.0 111.269 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -114.61 111.23 21.0 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.04 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 63.39 -93.13 0.11 Allowed Glycine 0 C--N 1.314 -0.68 0 O-C-N 124.328 1.018 . . . . 0.0 112.782 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.5 p30 -132.59 17.55 4.34 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.303 0.573 . . . . 0.0 109.863 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 15.3 m -118.22 126.67 52.65 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.977 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.3 mt -90.55 120.9 32.01 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' B' ' 190' ' ' THR . 62.3 mt -101.12 100.76 11.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 44.6 t -85.86 119.4 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -85.54 99.84 11.51 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 126.22 126.88 3.0 Favored Glycine 0 C--N 1.29 -2.022 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.123 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' B' ' 188' ' ' LYS . 2.5 p -92.25 126.4 37.32 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -125.79 153.56 73.29 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' B' ' 251' ' ' ARG . 28.6 Cg_endo -65.36 -25.88 56.22 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.449 2.1 . . . . 0.0 112.817 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.64 138.49 39.51 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -129.14 159.06 37.22 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 76.5 t -137.54 129.68 41.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.2 134.93 61.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -133.14 117.07 17.05 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.683 0.754 . . . . 0.0 109.508 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.486 ' CB ' HD22 ' B' ' 178' ' ' LEU . 15.1 m-70 -109.82 101.42 10.29 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.05 -102.51 0.53 Allowed Glycine 0 C--N 1.308 -1.028 0 O-C-N 123.736 0.647 . . . . 0.0 112.027 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -114.23 3.36 15.12 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.976 0.893 . . . . 0.0 110.454 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.437 HD22 ' N ' ' B' ' 245' ' ' ASN . 0.7 OUTLIER -111.59 144.36 40.96 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.344 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -134.02 137.52 51.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.792 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.02 143.82 15.77 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.96 135.37 54.18 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.2 ttp180 -115.2 123.09 47.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.996 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' B' ' 236' ' ' PRO . 26.4 ttt85 -84.8 122.18 28.77 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 43.9 m-80 -90.72 108.67 19.97 Favored 'General case' 0 CA--C 1.467 -2.248 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.589 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -71.03 134.32 47.02 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.346 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.58 122.31 24.43 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.193 0 C-N-CA 127.065 2.146 . . . . 0.0 108.797 -173.571 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 120.685 0.279 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -127.43 92.35 43.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.43 146.9 19.77 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.397 2.065 . . . . 0.0 113.957 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 67.77 105.16 0.03 OUTLIER Pre-proline 0 C--O 1.252 1.214 0 C-N-CA 125.722 1.609 . . . . 0.0 112.798 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.57 63.31 5.58 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.069 2.512 . . . . 0.0 110.115 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -132.16 -176.96 4.24 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -89.8 172.17 9.09 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 118.762 0.71 . . . . 0.0 111.293 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 -158.38 27.42 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.72 -75.31 2.39 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 0.0 OUTLIER -123.06 92.98 3.82 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -177.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 1.3 m95 -86.03 102.38 13.76 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.861 175.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' TRP . 18.2 tptp 172.89 151.73 0.07 Allowed 'General case' 0 C--O 1.214 -0.763 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 172.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 60.26 96.21 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 160.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.251 14.2 p -153.9 85.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.484 1.135 . . . . 0.0 109.526 163.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -137.06 155.37 49.74 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.297 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.455 ' HB2' ' HG3' ' B' ' 182' ' ' ARG . 8.5 t60 -104.95 85.55 2.3 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.117 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.31 71.17 0.74 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.288 1.042 . . . . 0.0 108.789 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -157.23 112.06 2.75 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 113.648 -1.615 . . . . 0.0 107.714 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.29 25.75 1.34 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.66 134.12 26.96 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.69 126.5 22.62 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.5 2.133 . . . . 0.0 110.356 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -137.86 179.59 6.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.715 0.293 . . . . 0.0 110.309 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.83 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.4 p -82.3 -55.66 4.39 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.496 0.665 . . . . 0.0 109.747 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -92.4 -30.0 16.0 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.866 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 60.2 ttp -97.54 76.74 2.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.677 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -155.48 70.09 0.72 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.685 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . 175.12 177.2 0.17 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.09 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.91 95.58 6.48 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.45 128.59 35.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.416 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.426 HD23 ' H ' ' B' ' 158' ' ' LEU . 2.5 pt? -137.41 167.77 20.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -85.98 97.21 10.13 Favored 'General case' 0 N--CA 1.388 -3.568 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.44 103.78 13.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -77.72 128.44 34.06 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.987 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 13.5 ttm180 -166.66 94.96 0.52 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 82.0 m-85 -92.54 107.07 18.94 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -105.04 120.93 42.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -106.73 -18.83 13.83 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.309 -173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -82.14 111.97 18.75 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.134 0.969 . . . . 0.0 112.97 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.9 m-85 -142.63 156.14 45.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.333 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -125.76 152.76 44.94 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -118.22 154.22 32.58 Favored 'General case' 0 C--O 1.206 -1.197 0 C-N-CA 117.243 -1.783 . . . . 0.0 111.416 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.0 132.9 32.93 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 15.3 t -176.46 165.14 2.66 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -124.85 42.31 3.3 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.702 1.239 . . . . 0.0 109.369 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 t -125.31 147.64 49.04 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -117.87 30.42 7.27 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.657 0.742 . . . . 0.0 110.237 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -98.68 116.46 30.95 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.378 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 21.1 m -74.1 -1.0 18.33 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.359 0.599 . . . . 0.0 111.872 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -102.57 5.73 39.45 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.9 0.857 . . . . 0.0 110.607 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' B' ' 242' ' ' HIS . 70.4 mt -118.47 -28.29 5.75 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.668 176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.43 132.19 29.47 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -62.0 148.59 92.85 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.466 2.11 . . . . 0.0 112.946 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.6 m -95.2 -27.3 15.6 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.293 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 31.9 ttm180 -149.35 137.58 20.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.451 HG22 HG23 ' B' ' 192' ' ' ILE . 38.4 t -140.09 126.05 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -160.83 140.79 11.01 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.0 p-10 -111.6 166.04 11.5 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 120.89 0.376 . . . . 0.0 110.143 174.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 6.6 t70 -137.52 110.0 7.46 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.074 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.418 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 73.06 -62.64 1.69 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.389 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 0.6 OUTLIER -147.46 -38.59 0.2 Allowed 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 125.127 1.371 . . . . 0.0 109.307 -175.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.72 119.85 24.85 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.117 -0.365 . . . . 0.0 110.361 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 22.1 m -98.51 122.22 41.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.42 120.27 39.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.451 HG23 HG22 ' B' ' 183' ' ' VAL . 10.5 mt -119.16 113.19 40.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.6 m120 -90.26 115.1 27.21 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 69.8 mtp -133.06 171.14 14.38 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.005 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -85.31 59.82 5.87 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.315 1.055 . . . . 0.0 108.573 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.495 HD11 ' HG ' ' B' ' 229' ' ' LEU . 56.6 mt -73.38 -10.91 60.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.943 0.878 . . . . 0.0 109.809 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.316 1.846 . . . . 0.0 112.527 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -82.19 -19.56 39.56 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.305 0.574 . . . . 0.0 109.96 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.0 95.55 38.54 Favored Pre-proline 0 C--N 1.291 -1.953 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.107 -174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.1 175.24 2.05 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 122.605 2.204 . . . . 0.0 111.324 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.4 m 67.02 18.17 10.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 110.127 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.79 22.82 71.16 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.156 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.78 42.15 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.095 0.95 . . . . 0.0 109.617 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -70.65 147.29 94.49 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.174 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.95 169.12 12.34 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 124.206 3.271 . . . . 0.0 113.625 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -98.09 128.98 44.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.406 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' B' ' 229' ' ' LEU . 17.6 t -104.09 144.15 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 67.4 m-85 -136.51 159.25 42.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.407 0.622 . . . . 0.0 109.404 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.51 148.66 43.02 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.112 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 93.7 mtt180 -131.9 144.22 50.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -79.74 -27.99 40.51 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.957 0.884 . . . . 0.0 109.599 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.519 ' HG2' ' OE1' ' B' ' 213' ' ' GLU . 18.7 ttpp -152.31 167.74 27.69 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.519 ' OE1' ' HG2' ' B' ' 212' ' ' LYS . 0.0 OUTLIER -65.41 -35.65 81.57 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.351 0.596 . . . . 0.0 110.76 -172.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -106.66 21.72 17.02 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.692 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -85.24 175.75 8.75 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -73.06 149.15 43.42 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.1 p30 -88.94 129.23 35.66 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.393 0.615 . . . . 0.0 110.576 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 81.4 m-85 -103.39 133.26 48.74 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.722 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.06 -23.23 64.02 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 19.7 m 37.75 -175.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 127.228 2.211 . . . . 0.0 116.787 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -97.32 123.86 41.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.455 HG21 HG21 ' B' ' 207' ' ' VAL . 32.8 m -139.08 136.12 34.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -111.22 144.45 40.35 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.76 105.53 18.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 122.266 1.032 . . . . 0.0 111.528 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -100.32 85.1 2.92 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.56 -94.6 0.24 Allowed Glycine 0 C--N 1.307 -1.073 0 CA-C-N 113.795 -1.548 . . . . 0.0 112.084 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 4.0 p-10 -117.13 19.6 14.14 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.355 0.597 . . . . 0.0 110.699 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.5 m -127.53 127.24 43.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.515 HD13 ' CG2' ' B' ' 207' ' ' VAL . 87.2 mt -94.05 127.19 39.71 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -108.46 103.67 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 40.9 t -87.39 122.69 39.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -81.86 100.91 9.87 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.99 133.32 5.04 Favored Glycine 0 C--N 1.291 -1.971 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.847 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 17.3 p -91.85 127.88 37.48 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -124.27 151.7 66.55 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -63.71 -20.82 69.55 Favored 'Trans proline' 0 C--O 1.246 0.919 0 C-N-CA 122.493 2.129 . . . . 0.0 113.171 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -143.65 146.19 33.05 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -131.64 156.89 45.04 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.75 127.92 30.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.2 t -112.8 139.96 35.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -122.59 117.74 26.56 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 120.954 0.407 . . . . 0.0 109.976 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.457 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.7 m-70 -117.5 100.44 7.65 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.0 -99.68 0.25 Allowed Glycine 0 C--N 1.308 -0.996 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.808 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.42 -16.32 16.23 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.397 0.618 . . . . 0.0 110.359 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 153.28 25.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.103 0.478 . . . . 0.0 111.838 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 23.6 m -134.87 149.82 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.444 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.6 t -128.21 130.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.96 132.09 10.81 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.1 125.81 54.78 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 123.922 0.889 . . . . 0.0 109.502 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.614 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 59.3 ttp180 -104.79 124.39 49.35 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -83.2 122.79 28.85 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -74.03 170.67 14.97 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -68.96 146.03 53.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.401 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . 0.436 ' OE1' ' HD3' ' B' ' 162' ' ' ARG . 47.9 mt-30 -83.68 108.93 17.06 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 24.9 tptp . . . . . 0 C--O 1.244 0.766 0 C-N-CA 124.982 1.313 . . . . 0.0 110.355 -176.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 25' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 24' ' ' THR . 25.6 mtpp -129.26 100.26 20.49 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.45 -14.52 10.41 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.518 2.145 . . . . 0.0 112.225 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.65 136.18 6.51 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.99 151.97 46.6 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 122.687 2.258 . . . . 0.0 111.535 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -104.8 130.98 52.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.781 0.801 . . . . 0.0 112.776 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -87.98 152.25 22.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.5 -150.62 22.67 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.48 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.81 -66.31 3.14 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -144.18 102.5 3.87 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -69.3 95.08 0.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.611 0.719 . . . . 0.0 109.56 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -101.88 130.29 48.32 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.003 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -78.16 136.49 37.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 117.869 -1.532 . . . . 0.0 110.233 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.79 101.73 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 CA-C-O 122.212 1.006 . . . . 0.0 109.447 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -134.62 165.52 25.03 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 114.305 -1.316 . . . . 0.0 107.45 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.9 117.65 13.76 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -86.73 103.25 15.0 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -81.36 -19.42 42.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -72.16 109.67 6.1 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.51 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.71 88.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.83 -10.89 25.38 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.416 2.078 . . . . 0.0 112.106 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.4 m -149.43 99.59 2.92 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.167 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.244 0.792 0 C-N-CA 124.945 1.298 . . . . 0.0 112.492 175.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.744 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 12.0 m -63.64 154.54 32.56 Favored 'General case' 0 C--O 1.249 1.028 0 C-N-CA 123.475 0.71 . . . . 0.0 111.162 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -67.17 -35.42 79.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.352 0.596 . . . . 0.0 109.945 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 88.2 mtp -93.13 21.21 6.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.036 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 49.0 t30 79.47 137.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.333 1.453 . . . . 0.0 110.52 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.11 97.49 2.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.498 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.71 38.36 0.74 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.38 108.4 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 104.1 -2.556 . . . . 0.0 104.1 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.59 95.87 6.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-O 122.519 1.152 . . . . 0.0 113.537 -171.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' B' ' 159' ' ' LYS . 17.9 mmmt -138.29 147.89 44.09 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.051 175.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.78 103.64 5.11 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.806 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -151.98 2.4 0.37 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -138.99 92.84 2.63 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.813 0.34 . . . . 0.0 110.586 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 93.8 m-85 -76.76 112.53 13.44 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.401 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -94.74 115.73 27.88 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.44 -15.27 19.7 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -81.56 112.15 18.52 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 118.655 -1.218 . . . . 0.0 113.541 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -140.37 167.86 21.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.472 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 7.9 m-20 -134.64 147.15 50.11 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -126.32 143.73 51.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.61 134.49 33.82 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 9.0 t -160.78 157.79 27.42 Favored 'General case' 0 N--CA 1.403 -2.823 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -104.15 12.16 34.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.742 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.1 t -93.56 160.65 14.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -119.3 -1.96 10.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.557 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.433 ' HB2' ' HG ' ' B' ' 178' ' ' LEU . 46.3 mmtm -73.13 119.27 17.14 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.246 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 8.7 m -67.27 -13.84 62.36 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.738 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.535 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 9.7 p-90 -96.76 4.47 51.77 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.042 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' B' ' 175' ' ' LYS . 53.4 mt -115.74 -18.4 10.83 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.291 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -94.7 129.84 35.07 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.656 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.93 138.83 38.2 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.457 2.105 . . . . 0.0 111.867 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 48.6 m -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 33.4 ttm180 -154.67 135.62 13.77 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 192' ' ' ILE . 15.0 t -139.82 129.85 29.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -161.0 150.68 17.16 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.105 0.253 . . . . 0.0 111.217 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.9 p-10 -115.77 163.69 15.47 Favored 'General case' 0 CA--C 1.46 -2.488 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.817 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 56.2 t0 -140.27 111.12 6.89 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 170.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.01 -65.85 0.49 Allowed Glycine 0 CA--C 1.535 1.316 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.61 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -143.22 -38.34 0.34 Allowed 'General case' 0 C--O 1.195 -1.771 0 C-N-CA 124.82 1.248 . . . . 0.0 110.539 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -83.16 119.19 24.21 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.603 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 16.7 m -101.05 114.77 29.01 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.612 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -97.76 122.17 40.54 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.757 0.823 . . . . 0.0 110.591 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 183' ' ' VAL . 10.6 mt -118.61 109.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 14.6 m120 -85.45 113.78 21.99 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' B' ' 227' ' ' ASN . 65.5 mtp -132.54 -173.41 3.16 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.7 t70 -103.28 52.39 0.78 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.295 1.045 . . . . 0.0 108.338 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' B' ' 229' ' ' LEU . 47.7 mt -67.34 -14.44 62.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.955 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 14.8 t -61.44 -8.54 4.21 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.478 0.711 . . . . 0.0 111.966 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -89.43 0.28 56.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.256 0.551 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.82 95.65 34.37 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -89.62 175.62 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 123.447 2.765 . . . . 0.0 111.467 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.1 m 68.16 16.72 9.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.06 0.933 . . . . 0.0 110.347 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 70.41 17.76 74.7 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.93 44.77 1.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 109.905 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.58 149.17 98.36 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.85 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.481 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 45.1 Cg_endo -63.73 168.3 12.04 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.024 2.482 . . . . 0.0 113.063 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.81 133.5 46.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.524 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.596 ' CG2' HD13 ' B' ' 229' ' ' LEU . 38.7 t -107.06 140.36 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 86.7 m-85 -131.14 157.47 43.05 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.915 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -114.23 154.96 27.0 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.327 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.1 mtt180 -138.29 144.31 40.39 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' B' ' 212' ' ' LYS . 8.2 pt-20 -82.49 -23.2 34.79 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.215 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' B' ' 237' ' ' PHE . 1.2 ptpt -153.57 170.93 19.61 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 170.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.526 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.5 OUTLIER -71.36 -27.0 63.05 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.485 0.659 . . . . 0.0 110.407 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.526 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 26.7 m170 -98.53 17.39 19.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.424 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -97.27 175.63 6.2 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 10.7 pt-20 -84.21 160.2 20.85 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.464 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.7 p30 -87.99 128.23 35.39 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -100.33 132.96 45.41 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.229 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.453 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.5 pt? -55.49 -33.54 63.8 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 22.2 m 38.68 -173.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.42 123.72 50.74 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.361 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG21 ' B' ' 207' ' ' VAL . 25.8 m -137.68 134.91 35.96 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 17.3 m -112.31 147.47 36.26 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.65 120.43 64.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.589 0.709 . . . . 0.0 111.503 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -116.22 99.51 7.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.55 -96.11 0.41 Allowed Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.532 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' B' ' 194' ' ' MET . 36.0 m-80 -123.6 17.16 9.6 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.038 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.8 m -116.28 130.27 56.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.803 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' B' ' 196' ' ' LEU . 84.8 mt -95.03 120.7 35.69 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 173.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 190' ' ' THR . 59.4 mt -104.74 104.69 17.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.5 122.67 39.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.9 101.16 8.42 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.139 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.18 142.15 6.94 Favored Glycine 0 C--N 1.287 -2.181 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.23 127.75 43.48 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 120.929 0.395 . . . . 0.0 111.15 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -128.33 149.88 72.65 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.43 -21.82 53.03 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.229 1.953 . . . . 0.0 113.122 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' B' ' 212' ' ' LYS . 93.4 m-85 -142.91 144.24 32.34 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -134.62 154.48 51.48 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.6 t -137.84 123.63 25.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.53 137.87 33.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -127.18 117.42 22.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.279 0.561 . . . . 0.0 110.683 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' B' ' 205' ' ' PRO . 15.9 m-70 -122.09 100.98 7.26 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.27 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 59.83 -111.14 3.28 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.651 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.51 4.85 39.04 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.278 0.561 . . . . 0.0 110.852 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -118.08 148.32 42.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.724 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.23 149.82 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.36 125.91 74.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.84 118.24 5.79 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.4 mp -109.24 129.38 55.51 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.55 0.69 . . . . 0.0 110.337 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -111.28 126.03 54.45 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.928 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -91.43 125.67 36.26 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -76.4 160.04 29.92 Favored 'General case' 0 C--N 1.288 -2.084 0 O-C-N 123.467 0.479 . . . . 0.0 111.071 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 162.65 13.88 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.193 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -85.35 104.04 14.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 124.941 1.296 . . . . 0.0 111.856 178.219 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.756 0.312 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -151.34 100.49 2.99 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -86.49 154.46 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.298 1.999 . . . . 0.0 111.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.56 110.0 57.84 Favored Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.88 82.63 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.473 2.116 . . . . 0.0 110.859 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.94 -174.05 2.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 35.4 p90 -73.61 149.68 41.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 119.045 0.839 . . . . 0.0 112.563 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.74 -159.36 28.0 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.13 -61.82 4.43 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 43.1 mmt-85 -133.41 98.21 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.878 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 51.9 m95 -82.82 100.82 10.56 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.77 136.0 50.89 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.442 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -58.44 126.52 27.92 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.5 0.5 . . . . 0.0 110.573 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 169' ' ' TYR . 12.4 p -94.56 -35.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.14 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' HB2' ' H ' ' B' ' 183' ' ' VAL . 65.0 t30 -134.47 176.48 8.58 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.205 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 76.66 4.17 3.48 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.636 1.574 . . . . 0.0 106.819 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -78.32 -24.1 46.77 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.723 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -107.56 89.01 2.87 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.58 118.74 16.89 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.233 -1.348 . . . . 0.0 110.296 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.39 110.36 50.27 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.205 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 117.29 4.21 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.467 2.112 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -128.78 15.8 6.39 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.329 -176.55 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.561 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 54.0 m -87.1 92.69 9.14 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.283 0.564 . . . . 0.0 112.032 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -95.19 -37.93 10.81 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 14.4 tpt -150.46 86.91 1.42 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -80.62 144.84 32.03 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.858 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.39 121.28 29.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -82.07 128.05 33.72 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.476 0.655 . . . . 0.0 109.956 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.99 137.5 28.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 63.0 mt -92.46 54.58 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.523 0.677 . . . . 0.0 109.784 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt 53.73 29.23 9.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.643 1.977 . . . . 0.0 113.039 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -83.67 108.39 16.72 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -139.73 83.92 1.95 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.531 0.682 . . . . 0.0 112.456 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -167.09 81.11 0.22 Allowed 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.723 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.61 120.87 22.36 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -87.79 114.96 24.9 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.409 ' HD1' HD21 ' A' ' 38' ' ' ASN . 79.3 m-85 -95.74 -12.93 24.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.34 111.69 19.23 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.931 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -152.94 149.09 27.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 125.252 1.421 . . . . 0.0 108.526 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.1 156.48 36.54 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 37' ' ' VAL . 30.3 p90 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.15 134.29 34.39 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.464 HG21 HG12 ' B' ' 179' ' ' ILE . 8.8 t -161.5 167.07 26.17 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.596 -177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -108.56 -1.17 19.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.335 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' B' ' 245' ' ' ASN . 13.9 t -93.84 168.48 10.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.201 0.524 . . . . 0.0 111.555 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.43 -3.22 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 123.789 0.836 . . . . 0.0 109.194 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.36 118.61 29.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.351 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 17.4 m -70.47 -18.16 62.98 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.763 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -84.34 5.6 26.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.928 0.871 . . . . 0.0 111.886 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.5 mt -115.22 -19.74 10.67 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.747 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . 0.464 HG12 HG21 ' B' ' 171' ' ' THR . 62.6 mt -97.81 134.78 21.95 Favored Pre-proline 0 N--CA 1.433 -1.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.115 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' B' ' 247' ' ' VAL . 14.6 Cg_endo -62.38 147.45 94.89 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.704 2.269 . . . . 0.0 111.904 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 8.4 m -98.35 -30.33 12.64 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.334 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -154.28 136.68 14.97 Favored 'General case' 0 C--O 1.204 -1.298 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.56 HG22 HG23 ' B' ' 192' ' ' ILE . 24.9 t -140.81 124.52 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -156.66 142.79 18.09 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 122.094 0.158 . . . . 0.0 110.69 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -115.7 160.46 20.03 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.539 0.685 . . . . 0.0 112.836 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.84 110.73 9.95 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.86 -61.03 0.51 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' B' ' 188' ' ' LYS . 6.3 tppt? -151.1 -34.23 0.15 Allowed 'General case' 0 N--CA 1.399 -3.0 0 C-N-CA 123.423 0.689 . . . . 0.0 109.262 -171.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -86.85 123.14 31.66 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 19.6 m -104.16 118.28 36.26 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.87 119.66 33.79 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 123.152 0.581 . . . . 0.0 109.988 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.56 HG23 HG22 ' B' ' 183' ' ' VAL . 8.6 mt -117.57 104.74 16.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.287 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.93 113.52 18.15 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 41.2 mtm -129.79 176.2 8.22 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.795 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -90.91 55.89 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.286 1.041 . . . . 0.0 108.501 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.07 -11.48 59.1 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.373 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 23.3 p -65.69 -10.58 37.74 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 124.465 1.106 . . . . 0.0 111.89 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.411 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 19.1 mmt180 -95.62 2.72 54.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -111.59 95.33 26.89 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.082 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 50.6 Cg_endo -86.64 174.19 5.89 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 122.934 2.423 . . . . 0.0 112.454 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 15.2 m 66.76 0.62 1.94 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 125.144 1.377 . . . . 0.0 112.139 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.32 17.86 58.22 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.5 64.02 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -74.87 150.44 86.11 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.297 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.75 168.97 15.51 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 123.171 2.581 . . . . 0.0 111.719 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.48 135.41 46.93 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.52 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.31 143.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 85.3 m-85 -131.89 165.22 24.37 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 124.13 0.972 . . . . 0.0 108.525 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.87 157.83 25.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.978 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 95.9 mtt180 -139.67 144.44 37.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.752 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 -13.05 28.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 37.4 mtmm -144.23 167.7 21.81 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.38 -32.95 74.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.331 1.062 . . . . 0.0 110.341 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.527 ' CD2' ' H ' ' B' ' 214' ' ' HIS . 3.1 p80 -107.95 17.82 21.97 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.246 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.24 173.4 12.31 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.06 156.28 23.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -91.52 118.47 30.61 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.492 0.663 . . . . 0.0 110.388 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -93.77 130.72 39.66 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.234 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 2.2 pt? -54.45 -29.49 49.76 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.927 1.291 . . . . 0.0 114.36 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . 0.435 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 21.1 m 38.02 -156.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.496 1.518 . . . . 0.0 114.134 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . 0.435 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 0.9 OUTLIER -124.47 134.82 52.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 175.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 46.4 m -141.46 137.99 32.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 52.0 m -118.38 149.81 40.58 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.06 115.99 50.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.804 0.812 . . . . 0.0 112.087 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.59 103.69 10.97 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.491 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 70.66 -97.14 0.61 Allowed Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.126 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.86 22.07 5.83 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 13.6 m -119.52 127.63 53.21 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.39 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 65.4 mt -94.36 128.99 41.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' B' ' 222' ' ' THR . 61.7 mt -105.46 105.32 18.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.33 120.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -79.53 101.02 8.02 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 125.74 129.66 3.36 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.379 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 4.6 p -96.29 123.86 40.08 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.55 153.56 81.47 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.1 -29.68 87.79 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.221 1.947 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -137.41 138.69 40.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.16 154.22 43.5 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.55 116.86 19.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.92 145.09 9.44 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.135 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -133.86 117.46 16.84 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.474 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.8 m-70 -117.94 100.85 7.83 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 66.65 -99.96 0.51 Allowed Glycine 0 C--N 1.307 -1.046 0 O-C-N 123.616 0.572 . . . . 0.0 112.403 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.48 8.78 14.12 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.957 0.884 . . . . 0.0 109.129 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.477 ' OD1' ' HB ' ' B' ' 173' ' ' THR . 2.8 t30 -114.36 154.13 28.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.6 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.64 149.66 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' B' ' 180' ' ' PRO . 54.0 t -130.62 130.5 64.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -103.57 136.38 12.9 Favored Glycine 0 N--CA 1.423 -2.22 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.36 134.21 55.14 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 123.279 0.632 . . . . 0.0 109.353 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.431 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 60.8 ttp180 -113.23 121.35 44.21 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.417 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -81.55 122.57 27.74 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -86.36 175.72 8.27 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 121.46 0.648 . . . . 0.0 112.448 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -125.25 142.22 51.63 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.552 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -112.55 112.23 23.62 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.258 1.508 0 O-C-N 125.149 1.53 . . . . 0.0 108.563 -173.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 pttm 175.14 130.42 0.14 Allowed Pre-proline 0 C--O 1.237 0.403 0 C-N-CA 124.839 1.255 . . . . 0.0 107.639 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -86.68 -12.54 5.27 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.769 1.646 . . . . 0.0 112.27 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . . . -145.29 126.33 7.53 Favored Pre-proline 0 N--CA 1.431 -1.396 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' ALA . 2.0 Cg_endo -81.77 89.45 1.23 Allowed 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.808 1.672 . . . . 0.0 109.959 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.07 144.84 50.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.277 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . 0.251 30.3 p90 41.39 -158.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.995 1.718 . . . . 0.0 114.854 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.77 -124.57 2.7 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.57 -4.71 0.1 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.161 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -86.85 79.67 8.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 90.0 m95 -68.16 104.6 1.84 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.061 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' B' ' 169' ' ' TYR . 16.2 ttmm -110.54 139.62 45.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -81.4 125.16 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.25 81.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 123.028 1.394 . . . . 0.0 109.728 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 25.2 t-20 -113.64 111.55 22.02 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.125 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.53 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 69.2 m80 74.7 -58.78 0.57 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.195 0.998 . . . . 0.0 111.699 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -173.71 156.93 3.0 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.497 ' CG ' ' HD3' ' A' ' 35' ' ' LYS . 32.2 t70 -109.79 94.06 4.83 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 121.617 0.722 . . . . 0.0 109.432 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -130.53 21.25 5.13 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . . . -106.52 141.5 22.94 Favored Pre-proline 0 N--CA 1.435 -1.189 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.626 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 20.4 Cg_exo -67.76 14.75 0.15 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 123.168 2.579 . . . . 0.0 114.265 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -74.17 109.51 7.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.582 0.753 . . . . 0.0 109.998 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 125.291 1.436 . . . . 0.0 111.596 -179.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.937 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.4 m -80.43 -40.24 26.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.803 0.335 . . . . 0.0 111.005 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -118.23 168.74 10.31 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 38.0 tpp 70.04 -62.41 0.43 Allowed 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 126.862 2.065 . . . . 0.0 110.543 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -96.51 89.93 5.19 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.16 102.28 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.39 -1.277 . . . . 0.0 113.349 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.35 125.35 29.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 49.5 mm -59.72 137.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.665 0.603 . . . . 0.0 110.951 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 49.8 mt 73.86 108.09 0.07 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.122 1.769 . . . . 0.0 112.923 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -74.95 127.22 32.72 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.611 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.61 114.65 3.69 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 123.717 0.636 . . . . 0.0 109.556 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -77.41 147.13 36.17 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.21 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -87.23 82.24 7.7 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.188 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 88.1 m-85 -77.64 111.22 13.17 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 172.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 8.4 t80 -86.0 111.44 20.28 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 99.0 m-85 -97.82 3.09 49.96 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.058 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -95.62 109.92 22.1 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.335 -1.346 . . . . 0.0 110.481 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -151.47 154.41 36.51 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.951 1.701 . . . . 0.0 106.524 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 20.3 m-20 -128.34 153.12 47.37 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 35' ' ' LYS . 16.9 p90 -127.65 148.09 50.38 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.708 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.31 20.29 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.772 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 8.8 t -146.79 175.68 10.45 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -108.02 -10.74 15.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 t -91.58 160.5 15.37 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.993 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' B' ' 174' ' ' LYS . 5.4 mmpt? -118.76 1.8 11.6 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.531 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -70.62 117.08 11.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 9.9 t -69.95 -14.6 62.79 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.477 0.656 . . . . 0.0 111.182 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.639 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 13.7 p-90 -86.89 -0.33 56.32 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.433 HD22 ' CB ' ' B' ' 242' ' ' HIS . 66.9 mt -116.45 -21.91 9.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.074 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.1 mt -95.86 133.76 24.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.913 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.93 144.98 54.81 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.24 1.96 . . . . 0.0 111.878 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -98.98 -26.82 14.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.94 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 43.2 ttm180 -148.1 133.92 19.01 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.43 HG22 HG23 ' B' ' 192' ' ' ILE . 38.5 t -139.01 125.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 53.0 p90 -160.68 143.8 13.22 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 7.2 p-10 -115.14 166.34 11.94 Favored 'General case' 0 CA--C 1.475 -1.93 0 CA-C-O 121.718 0.771 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -138.24 111.28 7.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.3 -65.15 0.24 Allowed Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.969 0.793 . . . . 0.0 114.026 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -141.05 -44.53 0.38 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 124.39 1.076 . . . . 0.0 109.713 -172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -78.23 119.25 21.34 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.219 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 21.5 m -101.65 118.71 37.49 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -96.02 116.51 29.07 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.52 0.728 . . . . 0.0 109.405 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 228' ' ' THR . 14.7 mt -116.5 107.7 23.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.648 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 0.8 OUTLIER -88.02 115.63 25.63 Favored 'General case' 0 CA--C 1.47 -2.113 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -127.5 -174.42 3.17 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.092 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 0.4 OUTLIER -100.78 45.61 0.97 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 55.4 mt -63.66 -14.92 56.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.074 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 15.1 t -64.13 -10.29 21.8 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.18 0.514 . . . . 0.0 111.449 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -85.1 -7.1 59.24 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.278 0.561 . . . . 0.0 109.778 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -114.03 94.34 33.85 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -97.5 175.46 0.58 Allowed 'Trans proline' 0 N--CA 1.435 -1.958 0 C-N-CA 123.093 2.529 . . . . 0.0 111.458 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 16.5 m 68.03 11.43 8.36 Favored 'General case' 0 CA--C 1.562 1.405 0 CA-C-O 122.044 0.926 . . . . 0.0 111.179 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 93.49 7.01 62.17 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.908 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -78.4 35.09 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -63.95 154.42 81.61 Favored Pre-proline 0 C--N 1.314 -0.947 0 C-N-CA 123.253 0.621 . . . . 0.0 110.51 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.41 168.67 22.84 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.466 2.111 . . . . 0.0 112.672 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -105.28 121.4 43.78 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.703 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 222' ' ' THR . 7.8 p -109.12 140.4 28.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -128.89 165.75 20.44 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 124.128 0.971 . . . . 0.0 108.576 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.26 150.35 40.24 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' B' ' 216' ' ' GLU . 74.6 mtt180 -129.25 143.22 50.77 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.243 0.544 . . . . 0.0 110.373 174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.74 -21.83 28.05 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.337 0.589 . . . . 0.0 110.255 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -146.88 169.27 19.47 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -64.21 -29.22 70.33 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.869 0.731 . . . . 0.0 111.518 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.66 20.38 17.16 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -82.23 173.11 12.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.281 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.9 pt-20 -77.81 163.26 26.25 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -88.46 111.82 22.25 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -90.6 129.15 36.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -66.54 -22.67 66.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.492 0.495 . . . . 0.0 112.326 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 18.9 m 36.14 -166.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 126.76 2.024 . . . . 0.0 115.87 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -103.61 127.06 51.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 91.1 m -141.99 134.5 28.16 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 120.713 0.292 . . . . 0.0 110.547 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.9 m -110.98 144.02 40.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.76 108.35 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.26 95.0 5.37 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.744 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.63 -103.59 1.07 Allowed Glycine 0 N--CA 1.422 -2.288 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.915 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.46 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 86.9 m-20 -116.57 16.48 15.51 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.282 0.633 . . . . 0.0 110.225 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 35.5 m -116.84 130.81 56.95 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.515 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -94.48 125.71 39.29 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' B' ' 222' ' ' THR . 71.9 mt -104.59 101.18 11.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 58.6 t -86.29 121.67 37.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -80.9 100.91 9.12 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 120.84 132.71 4.28 Favored Glycine 0 C--N 1.289 -2.04 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.514 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.7 p -91.41 119.87 31.78 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.367 0.604 . . . . 0.0 111.422 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.25 154.96 65.52 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.866 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.53 -25.26 48.04 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.458 2.105 . . . . 0.0 112.848 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.46 137.82 35.89 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.42 156.28 43.42 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.76 131.39 47.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 t -115.21 128.59 72.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -124.47 117.74 25.08 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.591 0.71 . . . . 0.0 110.045 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.433 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.3 m-70 -116.97 100.1 7.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 56.99 -109.85 1.88 Allowed Glycine 0 C--N 1.304 -1.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.292 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.97 -1.75 33.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.799 0.333 . . . . 0.0 110.577 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.46 142.31 35.44 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.39 141.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.678 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.62 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 5.3 p -131.44 139.74 50.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.05 142.47 16.87 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.452 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.3 mt -109.35 132.58 53.99 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 123.613 0.765 . . . . 0.0 109.143 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.507 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.2 ttp180 -109.68 122.07 46.65 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -74.04 124.19 25.78 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -59.79 118.42 6.15 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.0 112.526 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.547 ' HD3' ' H ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -67.46 154.9 40.31 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.11 -1.404 . . . . 0.0 108.168 173.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -86.92 98.69 11.37 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -175.162 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 25' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' H ' HG22 ' A' ' 24' ' ' THR . 11.3 ptmm? -121.62 89.99 47.81 Favored Pre-proline 0 N--CA 1.448 -0.551 0 CA-C-N 118.728 0.694 . . . . 0.0 109.732 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.2 -14.23 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.534 2.156 . . . . 0.0 113.104 -173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.08 93.4 47.9 Favored Pre-proline 0 N--CA 1.426 -1.635 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.79 84.26 1.94 Allowed 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.854 1.703 . . . . 0.0 109.762 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -128.96 -173.95 3.12 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -80.58 176.05 10.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.157 0.503 . . . . 0.0 112.344 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.94 -166.03 30.32 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.316 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.4 -4.31 22.01 Favored Glycine 0 N--CA 1.409 -3.142 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -78.73 77.18 5.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.448 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 83.7 m95 -73.13 114.69 11.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.046 175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -131.26 146.86 52.48 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -63.25 133.5 54.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 123.81 0.694 . . . . 0.0 111.583 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.64 14.24 7.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 122.775 1.274 . . . . 0.0 107.735 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.85 123.78 20.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.961 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.492 ' CG ' ' HG3' ' B' ' 182' ' ' ARG . 28.1 t-80 -87.07 127.95 35.11 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.51 81.07 8.89 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.304 0.573 . . . . 0.0 112.212 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -100.14 81.81 2.45 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -107.68 129.28 55.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.768 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.43 63.27 7.51 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.298 1.039 . . . . 0.0 110.583 -173.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -95.69 17.53 0.75 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.838 2.359 . . . . 0.0 111.784 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.8 m 72.28 -25.96 0.18 Allowed 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.817 1.247 . . . . 0.0 112.982 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.153 179.124 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.622 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 14.8 m -57.51 -18.97 21.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.145 . . . . 0.0 112.359 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -73.38 -28.48 62.04 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.415 0.686 . . . . 0.0 110.724 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 63.1 mtt -120.01 15.15 12.44 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.603 0.716 . . . . 0.0 110.44 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -126.94 169.55 13.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.1 129.27 34.48 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.12 -174.04 4.5 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 61.7 mt -69.6 131.4 34.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.12 167.67 18.52 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.583 0.706 . . . . 0.0 111.712 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -88.4 45.78 1.32 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.459 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.04 175.71 5.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.002 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -101.15 -133.38 0.28 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -143.12 158.32 43.72 Favored 'General case' 1 N--CA 1.37 -4.432 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 177.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -69.29 111.26 5.08 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.355 1.034 . . . . 0.0 109.244 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -90.01 112.93 24.51 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.21 -11.44 30.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.717 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.03 111.63 12.8 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.862 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -152.45 152.56 32.11 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 125.707 1.603 . . . . 0.0 107.885 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.464 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 10.7 m-20 -132.05 161.33 33.47 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -132.46 153.34 50.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.17 134.99 35.23 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.2 t -171.53 168.43 6.4 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -119.81 14.1 12.45 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 123.439 0.462 . . . . 0.0 110.667 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.3 t -86.3 152.45 22.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.99 -1.14 24.33 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.409 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.2 mmtt -77.05 115.15 16.59 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.992 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 32.4 m -71.42 -8.0 51.0 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.405 0.622 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.409 ' HE1' ' HD2' ' B' ' 175' ' ' LYS . 42.3 p-90 -96.48 5.55 50.59 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.874 0.845 . . . . 0.0 111.13 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' B' ' 242' ' ' HIS . 62.2 mt -117.13 -25.5 7.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.701 176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.85 130.79 33.62 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.97 152.14 76.99 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.484 2.123 . . . . 0.0 112.659 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 21.7 m -104.83 -15.97 15.04 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.025 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.595 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 59.6 ttt180 -158.89 135.21 9.18 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.465 HG22 HG23 ' B' ' 192' ' ' ILE . 14.6 t -142.46 127.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -161.24 152.89 19.25 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 123.41 0.444 . . . . 0.0 110.534 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -131.26 167.54 19.04 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 120.976 0.417 . . . . 0.0 110.004 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.423 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 9.7 t70 -136.78 110.49 8.09 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.529 ' C ' ' HD3' ' B' ' 188' ' ' LYS . . . 66.63 -65.87 0.17 Allowed Glycine 0 N--CA 1.434 -1.452 0 O-C-N 124.396 1.06 . . . . 0.0 115.087 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' B' ' 187' ' ' GLY . 0.2 OUTLIER -133.58 -47.3 0.81 Allowed 'General case' 0 C--O 1.203 -1.381 0 O-C-N 122.648 -0.325 . . . . 0.0 111.499 -169.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -82.9 125.06 30.94 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.262 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 11.9 m -106.64 125.22 50.73 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' B' ' 230' ' ' ILE . 80.6 m-85 -104.89 114.08 28.07 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 123.331 0.652 . . . . 0.0 109.958 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.465 HG23 HG22 ' B' ' 183' ' ' VAL . 6.9 mt -115.01 110.87 33.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.6 m120 -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 68.8 mtp -132.69 175.03 9.68 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.543 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -84.89 65.17 9.05 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.59 1.186 . . . . 0.0 108.3 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.44 -10.7 59.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.648 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -17.75 62.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.137 1.375 . . . . 0.0 112.159 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 19.3 mmt180 -80.47 -9.52 59.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.41 93.13 48.79 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.279 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.41 175.05 1.59 Allowed 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.839 2.359 . . . . 0.0 111.668 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 4.8 m 62.88 24.73 14.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.205 1.002 . . . . 0.0 110.602 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.98 15.81 80.86 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -85.72 37.82 0.72 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -64.93 156.85 78.59 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.22 164.29 26.01 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.854 2.369 . . . . 0.0 112.52 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -97.43 119.15 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.461 ' CG2' HD13 ' B' ' 229' ' ' LEU . 21.7 t -93.83 137.53 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.706 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' B' ' 217' ' ' ASP . 83.4 m-85 -132.74 157.88 43.8 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.487 0.661 . . . . 0.0 109.89 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.23 155.98 29.6 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.858 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 97.6 mtt180 -140.28 149.66 43.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.534 0.683 . . . . 0.0 111.9 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.97 -16.79 20.45 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.757 0.789 . . . . 0.0 110.189 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 46.9 mtmt -138.6 164.41 29.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -60.8 -42.51 97.76 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.183 0.992 . . . . 0.0 108.498 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -107.45 25.45 11.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.874 -1.512 . . . . 0.0 111.029 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' B' ' 212' ' ' LYS . . . -78.11 169.89 17.52 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.69 153.61 34.97 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' B' ' 208' ' ' PHE . 1.7 p30 -91.49 120.28 32.18 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.768 0.794 . . . . 0.0 110.33 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -95.17 134.59 37.74 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.889 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.24 -26.3 66.32 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.38 1.05 . . . . 0.0 113.395 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . 0.429 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 23.9 m 38.1 -163.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.337 1.855 . . . . 0.0 115.935 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . 0.429 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 18.3 m120 -126.06 129.74 49.74 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.978 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.45 HG21 HG21 ' B' ' 207' ' ' VAL . 28.4 m -141.69 139.26 32.9 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 36.0 m -110.5 143.09 41.36 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.42 113.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -127.3 113.81 16.77 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.69 -87.69 0.74 Allowed Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.249 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -142.66 14.08 1.94 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.5 m -113.68 130.31 56.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.461 HD13 ' CG2' ' B' ' 207' ' ' VAL . 92.9 mt -94.19 114.88 27.07 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 190' ' ' THR . 54.2 mt -98.36 99.79 9.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 24.4 t -85.01 124.12 39.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -80.64 101.05 8.98 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.16 134.43 6.54 Favored Glycine 0 C--N 1.28 -2.551 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.766 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.9 p -94.12 138.9 31.65 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.59 151.47 76.03 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.19 -28.51 85.28 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.95 1.766 . . . . 0.0 112.641 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.27 145.44 47.56 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.11 155.26 48.45 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 93.1 t -140.23 121.61 14.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.56 134.36 47.28 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -119.68 117.08 27.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.601 0.715 . . . . 0.0 109.946 -173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.42 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.4 m-70 -117.54 101.07 8.08 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.056 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.41 -100.8 0.45 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.662 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -109.96 -10.51 14.72 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.707 0.765 . . . . 0.0 109.527 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.84 166.24 10.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.326 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.51 150.2 14.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 123.09 0.556 . . . . 0.0 109.689 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.75 126.33 69.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -99.92 123.57 7.96 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.03 140.49 42.49 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -116.11 135.57 53.81 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.24 122.25 32.99 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -67.26 119.73 12.62 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.776 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 153.84 42.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.292 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.54 99.1 8.62 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.137 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 113.349 -1.75 . . . . 0.0 106.589 179.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -134.89 103.22 10.91 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -90.61 -176.17 0.98 Allowed 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.382 2.055 . . . . 0.0 112.67 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.07 151.9 84.1 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.058 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.12 -56.77 2.72 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.948 2.432 . . . . 0.0 112.672 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 57.79 171.12 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.679 1.191 . . . . 0.0 114.006 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -98.92 135.43 40.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.22 -157.03 27.02 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.05 -61.44 4.01 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -145.64 102.91 3.74 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 48.1 m95 -73.93 108.53 6.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -128.14 137.81 52.25 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -60.88 131.02 49.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.349 0.406 . . . . 0.0 110.217 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.83 8.91 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.294 1.045 . . . . 0.0 109.443 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.35 99.28 1.18 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.875 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -84.11 142.19 30.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.952 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.27 82.8 4.55 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -101.74 -73.68 0.64 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.784 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -100.25 -78.05 0.52 Allowed 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.44 101.76 2.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 O-C-N 122.361 -0.212 . . . . 0.0 110.598 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.74 25.77 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.986 2.457 . . . . 0.0 112.378 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 t -119.1 -37.14 3.25 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.367 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -175.646 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.759 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -68.92 -35.95 77.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -104.05 117.1 33.48 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 97.0 mmm 69.84 93.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.495 1.122 . . . . 0.0 110.715 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -113.55 140.82 47.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.427 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -146.26 145.03 30.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.81 58.61 4.74 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.957 0.884 . . . . 0.0 111.789 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.0 111.43 19.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 81.9 mt 56.41 -167.88 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.934 1.396 . . . . 0.0 111.254 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.83 -168.49 2.1 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.484 ' OD2' ' HG2' ' B' ' 161' ' ' ARG . 7.9 t70 -73.32 -161.22 0.09 Allowed 'General case' 0 CA--C 1.566 1.581 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' B' ' 162' ' ' ARG . 14.1 ptt-85 -61.48 142.47 57.0 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.5 0.72 . . . . 0.0 112.739 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' B' ' 161' ' ' ARG . 19.9 mmm180 -125.69 27.01 6.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.012 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' B' ' 186' ' ' ASP . 77.4 m-85 -66.05 128.45 36.12 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.229 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -93.46 112.84 24.84 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -100.59 -15.34 17.83 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' B' ' 252' ' ' ASN . 6.8 t0 -77.45 111.91 13.66 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 117.811 -1.556 . . . . 0.0 111.151 -169.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 31.3 m-85 -153.49 149.72 27.99 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 124.458 1.103 . . . . 0.0 110.399 -175.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 11.8 m-20 -125.37 157.41 36.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -123.95 143.55 50.33 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -134.35 127.34 31.49 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 13.9 t -168.43 163.54 12.67 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -113.8 19.75 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.959 0.885 . . . . 0.0 110.743 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 14.2 t -95.83 155.79 16.6 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -124.33 13.92 8.92 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.913 0.863 . . . . 0.0 109.628 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -89.72 119.92 30.54 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.817 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 14.3 m -66.8 -13.54 61.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.373 0.669 . . . . 0.0 111.354 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.482 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 19.9 p-90 -93.44 5.75 50.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.638 0.732 . . . . 0.0 111.749 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 242' ' ' HIS . 82.1 mt -121.13 -23.89 5.67 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.688 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 85.2 mt -94.84 139.57 22.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.852 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -69.18 143.79 54.83 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.588 2.192 . . . . 0.0 111.764 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 19.4 m -100.49 -25.56 14.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.456 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.8 ttp180 -149.21 131.11 15.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.5 HG22 HG23 ' B' ' 192' ' ' ILE . 21.6 t -139.56 125.26 21.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -161.21 148.8 15.25 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -119.56 167.1 12.32 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.606 ' HB2' ' CE1' ' B' ' 163' ' ' TYR . 7.9 t70 -129.59 108.68 10.41 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.577 ' C ' ' HD2' ' B' ' 188' ' ' LYS . . . 64.62 -64.45 0.07 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 O-C-N 124.868 1.355 . . . . 0.0 115.033 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' B' ' 187' ' ' GLY . 11.3 mptt -140.17 -39.89 0.44 Allowed 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.327 1.051 . . . . 0.0 110.296 -170.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.04 117.69 23.58 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 15.6 m -97.94 125.96 43.11 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.1 109.07 20.5 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.027 0.531 . . . . 0.0 109.748 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.5 HG23 HG22 ' B' ' 183' ' ' VAL . 9.8 mt -112.08 104.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.206 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 16.9 m120 -82.62 114.24 20.87 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 240' ' ' VAL . 58.8 mtp -122.7 -175.98 3.28 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.6 t70 -98.17 50.9 1.02 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -64.64 -13.38 53.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.716 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 21.7 p -63.69 -18.98 64.55 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 123.465 0.706 . . . . 0.0 112.042 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 17.8 mmt180 -85.25 0.41 52.0 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 109.946 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -107.22 94.43 11.18 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.061 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 52.1 Cg_endo -86.76 175.09 5.34 Favored 'Trans proline' 0 N--CA 1.431 -2.204 0 C-N-CA 123.03 2.487 . . . . 0.0 112.037 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 6.0 m 66.53 15.79 10.22 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.404 1.082 . . . . 0.0 109.879 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.23 19.48 74.15 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -94.18 63.93 3.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.306 1.051 . . . . 0.0 109.031 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -66.71 154.32 91.86 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.087 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.22 169.24 15.69 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 123.539 2.826 . . . . 0.0 112.798 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.69 133.04 44.61 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.211 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.446 HG23 HG22 ' B' ' 240' ' ' VAL . 7.4 p -120.85 137.44 54.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.399 0.618 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' B' ' 219' ' ' LEU . 82.1 m-85 -127.91 165.04 20.97 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.35 30.66 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.62 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.3 mtt180 -138.4 143.9 39.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.304 0.573 . . . . 0.0 112.023 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.14 -17.6 34.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.697 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -156.54 159.64 38.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.7 -39.31 65.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -105.33 19.01 21.31 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.677 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -89.48 170.18 10.73 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.25 154.6 27.79 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.869 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.432 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 1.9 p-10 -81.59 129.88 34.84 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.068 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.97 134.35 37.74 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.6 pp -64.68 -27.15 68.73 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 124.099 0.874 . . . . 0.0 112.083 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 16.7 m 39.29 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -109.71 128.91 55.59 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.8 m -139.97 137.06 34.42 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 120.764 0.316 . . . . 0.0 111.161 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 14.0 m -111.84 149.01 32.39 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.8 p -118.38 126.1 74.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.57 110.61 13.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.37 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.14 0.2 Allowed Glycine 0 N--CA 1.446 -0.655 0 O-C-N 124.013 0.821 . . . . 0.0 112.167 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' B' ' 194' ' ' MET . 8.5 p30 -131.38 17.49 4.9 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.939 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 6.6 m -112.04 128.91 56.33 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.954 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' B' ' 196' ' ' LEU . 92.0 mt -94.31 115.08 27.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' B' ' 190' ' ' THR . 67.1 mt -96.78 101.02 11.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 55.3 t -86.6 122.06 38.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.054 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -81.46 101.18 9.73 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 118.91 127.09 3.61 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.579 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.63 123.95 34.67 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.333 0.587 . . . . 0.0 111.593 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.51 152.58 68.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.63 -24.05 63.08 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.25 1.967 . . . . 0.0 113.037 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.07 139.77 39.7 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.31 157.06 42.0 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 84.9 t -137.77 121.02 20.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' SD ' ' B' ' 194' ' ' MET . 12.6 t -114.53 135.96 52.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -125.76 120.0 29.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.736 0.779 . . . . 0.0 111.069 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.44 ' HB3' HD22 ' B' ' 178' ' ' LEU . 10.1 m170 -112.62 100.49 8.76 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.575 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.6 -111.03 2.66 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 121.314 0.397 . . . . 0.0 113.505 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -103.32 17.84 23.16 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.448 1.118 . . . . 0.0 109.654 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -129.9 146.52 51.61 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.1 p -141.61 141.62 29.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.34 131.97 72.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.03 137.29 13.46 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 96.1 mt -115.45 138.63 50.81 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.5 ttp180 -117.43 120.49 38.31 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.128 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -83.82 119.81 25.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.412 ' HB2' ' CG ' ' B' ' 166' ' ' ASP . 61.9 m-80 -85.83 109.32 18.6 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.499 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 162.76 11.25 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.96 143.22 26.45 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 125.442 1.497 . . . . 0.0 110.368 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.436 -1.168 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -152.62 93.46 3.28 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.64 -68.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.259 1.972 . . . . 0.0 111.944 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.29 133.23 4.15 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.79 100.16 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.815 1.677 . . . . 0.0 112.594 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' O ' HG13 ' B' ' 246' ' ' VAL . 11.3 m-20 -77.99 -34.31 50.94 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.338 1.066 . . . . 0.0 108.298 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.03 153.47 42.99 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.655 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.37 -171.78 27.93 Favored Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.23 4.06 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 21.1 mmm180 -124.35 92.03 3.58 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 122.137 0.175 . . . . 0.0 110.769 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 49.9 m95 -80.27 99.86 8.07 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -116.27 138.57 51.19 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.07 140.5 58.83 Favored 'General case' 0 C--O 1.259 1.591 0 O-C-N 123.616 0.573 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 11.3 p -128.67 19.85 2.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.817 1.294 . . . . 0.0 108.542 175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 3.1 t-20 -62.4 102.26 0.3 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.684 ' NE2' ' HA ' ' A' ' 42' ' ' GLU . 18.9 t-160 -144.42 99.25 3.34 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 118.77 -1.172 . . . . 0.0 112.733 -166.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.404 ' H ' ' H ' ' A' ' 41' ' ' ASP . 49.4 t80 -138.99 -17.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.208 1.004 . . . . 0.0 109.132 170.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' PHE . 9.2 p-10 -87.51 -0.61 57.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.246 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.684 ' HA ' ' NE2' ' A' ' 39' ' ' HIS . 34.3 mm-40 55.58 86.19 0.06 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.045 1.338 . . . . 0.0 113.362 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.42 154.78 38.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.818 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -69.68 95.1 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.188 1.925 . . . . 0.0 112.443 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -85.9 -68.1 0.76 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.423 -1.795 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.003 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.726 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -117.04 156.54 27.35 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 76.56 -41.38 0.4 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.231 1.012 . . . . 0.0 111.173 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 44.0 tpp -140.78 136.59 32.62 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -84.61 170.73 13.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -130.91 153.45 49.15 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -77.43 134.1 38.48 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.3 130.54 33.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.0 -169.7 2.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.6 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -61.24 142.56 56.72 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.628 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -81.02 102.69 10.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.94 0.876 . . . . 0.0 110.17 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -110.6 145.94 36.99 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' B' ' 186' ' ' ASP . 19.1 mtm180 -87.1 -1.0 57.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 91.4 m-85 -83.96 112.32 20.06 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.186 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -106.69 113.91 27.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 90.8 m-85 -102.79 1.35 34.09 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -170.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 6.9 m-20 -90.91 111.59 23.09 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.67 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 25.3 m-85 -152.98 158.93 42.79 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.569 1.147 . . . . 0.0 109.819 -175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -135.14 161.21 35.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 11.0 p90 -130.83 150.43 52.0 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.61 139.67 38.66 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.9 t -173.4 164.17 4.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -99.2 -10.68 22.14 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 123.718 0.637 . . . . 0.0 110.594 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -75.41 149.86 38.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.32 0.581 . . . . 0.0 109.975 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.11 0.63 15.02 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.775 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.477 ' HB2' HD12 ' B' ' 178' ' ' LEU . 35.0 mmtp -77.11 118.2 19.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.489 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -26.42 66.56 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.232 1.013 . . . . 0.0 112.056 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 41.9 p-90 -88.66 5.97 40.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.056 -175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' B' ' 175' ' ' LYS . 96.7 mt -118.75 -20.46 8.25 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.874 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.77 140.01 21.24 Favored Pre-proline 0 C--N 1.317 -0.841 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.243 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.92 145.2 39.85 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.263 1.975 . . . . 0.0 111.944 175.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -99.67 -34.98 9.98 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 36.0 ttm180 -141.34 130.7 23.69 Favored 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.563 HG22 HG23 ' B' ' 192' ' ' ILE . 24.1 t -137.72 127.95 36.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 118.71 0.686 . . . . 0.0 109.685 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -160.48 145.55 14.61 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.243 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 3.8 p30 -109.77 161.43 15.44 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.691 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.657 ' HA ' ' O ' ' B' ' 162' ' ' ARG . 0.0 OUTLIER -138.28 110.8 7.52 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 174.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -54.32 1.33 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.611 -1.177 . . . . 0.0 115.266 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' B' ' 233' ' ' GLY . 9.7 tptm -160.43 -30.6 0.06 Allowed 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -171.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -92.28 132.36 36.75 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 18.5 m -102.83 123.48 46.57 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' B' ' 230' ' ' ILE . 50.8 m-85 -105.95 120.7 42.43 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.355 0.662 . . . . 0.0 109.408 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.563 HG23 HG22 ' B' ' 183' ' ' VAL . 9.0 mt -122.12 109.81 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -83.86 114.27 21.54 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.1 mtp -131.84 173.52 11.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.665 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 8.3 t0 -88.1 53.58 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.138 0.971 . . . . 0.0 109.271 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.533 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.5 mt -67.99 -12.83 61.51 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.268 -174.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 t -67.22 -10.05 46.59 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.175 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -89.11 -2.29 58.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.68 -0.637 . . . . 0.0 109.982 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.02 94.94 36.38 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.65 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -94.32 174.64 1.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.14 2.56 . . . . 0.0 111.886 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.9 m 64.42 22.01 12.62 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.557 1.17 . . . . 0.0 110.58 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.39 18.59 73.53 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.619 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -81.07 31.13 0.32 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.055 0.542 . . . . 0.0 111.369 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.51 145.77 97.01 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.043 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.73 168.7 17.76 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.859 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -104.36 115.41 30.34 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.177 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.01 134.31 44.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.507 0.67 . . . . 0.0 110.1 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.54 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 79.8 m-85 -122.36 168.79 11.64 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.968 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.21 156.38 32.54 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 123.46 0.704 . . . . 0.0 110.123 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -143.27 146.09 33.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.327 0.584 . . . . 0.0 111.225 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -88.45 -25.42 22.64 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.148 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -147.71 167.47 24.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.33 -31.9 70.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.178 0.99 . . . . 0.0 109.609 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -98.67 19.09 15.35 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.674 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.53 168.32 10.93 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.6 159.48 16.42 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.191 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' B' ' 208' ' ' PHE . 1.1 p30 -84.7 110.93 19.13 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.049 0.928 . . . . 0.0 111.96 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -90.79 128.4 36.69 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.942 -175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.473 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.2 pt? -58.22 -30.07 66.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 20.7 m 41.41 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.809 1.644 . . . . 0.0 114.652 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 13.8 m120 -109.85 134.06 52.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 50.3 m -141.81 137.8 31.76 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.766 -0.584 . . . . 0.0 111.719 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 56.0 m -111.26 147.41 35.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.27 116.57 52.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -118.17 99.85 7.14 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.938 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.58 -100.82 0.7 Allowed Glycine 0 N--CA 1.422 -2.287 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.451 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 194' ' ' MET . 35.1 p-10 -121.66 18.48 11.17 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.403 0.62 . . . . 0.0 109.478 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 3.0 m -120.44 124.88 46.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.306 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.533 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.6 mt -88.65 127.99 35.58 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' B' ' 191' ' ' TYR . 68.2 mt -110.04 99.64 9.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 61.4 t -87.14 119.14 34.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.635 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 19.7 m170 -77.84 101.16 6.63 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' B' ' 188' ' ' LYS . . . 131.81 121.92 2.31 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.06 125.96 35.6 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 123.264 0.626 . . . . 0.0 109.604 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -137.2 151.87 72.51 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.17 -23.41 60.13 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.453 2.102 . . . . 0.0 113.287 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.55 139.8 36.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.4 156.96 42.32 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.6 t -136.98 116.31 15.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.85 127.23 58.14 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -125.06 116.96 22.93 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.022 0.915 . . . . 0.0 109.33 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.47 ' HB2' HD22 ' B' ' 245' ' ' ASN . 14.0 m-70 -105.39 101.02 10.58 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.72 -101.95 0.58 Allowed Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -118.27 4.62 11.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.756 1.265 . . . . 0.0 109.285 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.9 t30 -104.57 154.3 20.1 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 29' ' ' ASP . 9.1 p -154.57 146.88 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 C-N-CA 119.086 -1.045 . . . . 0.0 112.423 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.86 141.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -112.81 143.59 17.76 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.221 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 95.8 mt -115.9 139.99 49.68 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 123.434 0.694 . . . . 0.0 110.428 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 59.6 ttp180 -118.38 117.66 29.66 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.55 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt-85 -77.46 125.1 28.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 24.6 m-80 -76.09 109.46 9.77 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -73.98 147.92 42.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.828 175.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -91.5 100.58 13.31 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.428 -1.55 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.419 -177.174 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.897 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -154.6 98.8 2.46 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.2 -174.66 2.07 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.16 1.907 . . . . 0.0 111.136 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' B' ' 172' ' ' ARG . . . -99.53 107.57 46.16 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.36 153.3 10.65 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.192 1.928 . . . . 0.0 110.692 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 63.63 -160.84 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.21 0.604 . . . . 0.0 110.456 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.07 143.5 30.54 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.62 -159.51 28.1 Favored Glycine 0 N--CA 1.424 -2.107 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.029 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.28 -61.4 4.24 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -136.07 95.99 3.31 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.774 0.797 . . . . 0.0 112.837 -179.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 64.4 m95 -78.78 111.81 15.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.397 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' B' ' 169' ' ' TYR . 61.6 tttp -130.29 155.63 45.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -71.0 139.6 50.58 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 118.351 0.523 . . . . 0.0 110.325 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 7.5 p -122.04 71.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 123.52 1.629 . . . . 0.0 111.323 177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' B' ' 165' ' ' TYR . 16.8 p30 -142.94 141.97 31.57 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.224 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB3' ' HD3' ' B' ' 182' ' ' ARG . 52.9 t-80 -118.36 105.45 11.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 172.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -87.29 76.71 9.11 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.8 0.81 . . . . 0.0 111.406 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -125.15 89.34 3.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 123.009 1.385 . . . . 0.0 110.146 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.23 -31.86 55.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.103 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.53 164.29 18.45 Favored Pre-proline 0 N--CA 1.426 -1.673 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.01 148.57 76.1 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 121.927 1.751 . . . . 0.0 110.737 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -73.53 93.4 2.0 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.322 0.582 . . . . 0.0 110.97 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.703 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.2 p -91.75 161.33 14.93 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 117.657 0.729 . . . . 0.0 109.52 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -89.91 -80.68 0.31 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -142.47 109.81 5.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.85 100.83 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 110.666 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -126.11 164.14 21.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.142 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -65.58 154.82 37.65 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 122.092 0.949 . . . . 0.0 111.273 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.68 133.79 34.36 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.554 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.709 HD23 ' H ' ' B' ' 158' ' ' LEU . 1.8 pt? -90.8 131.53 36.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -128.3 -177.67 4.25 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.612 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' B' ' 161' ' ' ARG . 20.7 t70 67.65 -156.14 0.21 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' B' ' 160' ' ' ASP . 4.3 mtp180 -74.1 -37.24 64.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.488 ' HA ' ' NE ' ' B' ' 162' ' ' ARG . 0.1 OUTLIER 67.97 110.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 112.76 -2.018 . . . . 0.0 113.663 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 86.2 m-85 -70.13 117.39 11.63 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 166' ' ' ASP . 20.3 t80 -95.66 112.91 24.53 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 58.9 m-85 -98.79 -6.8 28.62 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.697 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.434 ' HA ' HD22 ' A' ' 38' ' ' ASN . 10.9 m-20 -81.05 111.36 17.44 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.017 -1.473 . . . . 0.0 112.161 -175.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -148.74 145.51 27.66 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.537 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -117.33 155.46 29.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.674 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 14.5 p90 -131.46 146.22 52.15 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -135.75 134.39 38.99 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.409 ' OG1' HG22 ' B' ' 173' ' ' THR . 12.2 t -161.28 167.85 25.15 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 7.4 ptm180 -111.18 1.89 17.49 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.903 -178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.409 HG22 ' OG1' ' B' ' 171' ' ' THR . 15.0 t -102.56 157.74 16.72 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.009 0.433 . . . . 0.0 110.386 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -106.09 -5.85 19.09 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.604 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . 0.462 ' HD2' ' HE1' ' B' ' 177' ' ' TRP . 75.5 mmtt -73.41 116.74 14.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.131 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 23.7 m -72.35 -6.15 41.32 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.97 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 38.4 p-90 -98.8 5.82 47.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.813 0.816 . . . . 0.0 110.951 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' B' ' 242' ' ' HIS . 48.6 mt -116.88 -27.19 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.529 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.5 mt -94.67 134.24 25.5 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.23 153.26 78.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.448 2.098 . . . . 0.0 111.732 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 17.4 m -105.03 -27.41 11.66 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.465 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 39.5 ttp180 -147.29 131.83 17.74 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.459 HG22 HG23 ' B' ' 192' ' ' ILE . 38.7 t -135.7 125.92 42.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -160.81 151.05 17.81 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 8.7 p-10 -119.77 167.19 12.32 Favored 'General case' 0 CA--C 1.48 -1.722 0 CA-C-O 121.71 0.767 . . . . 0.0 111.612 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -141.91 111.71 6.72 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.409 -1.723 . . . . 0.0 107.32 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.61 -63.99 0.84 Allowed Glycine 0 CA--C 1.524 0.596 0 O-C-N 124.07 0.857 . . . . 0.0 113.624 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -144.13 -40.83 0.27 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 124.032 0.933 . . . . 0.0 109.129 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -78.65 117.59 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.675 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . . . . . . . . . 17.9 m -100.56 115.58 30.47 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.18 114.61 27.15 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.756 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.459 HG23 HG22 ' B' ' 183' ' ' VAL . 11.9 mt -112.67 104.05 16.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.736 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 21.8 m120 -82.4 116.76 22.02 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 62.8 mtp -132.78 179.34 6.22 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.906 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.652 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 3.3 t70 -95.14 49.48 1.22 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 74.2 mt -65.71 -12.44 53.71 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.719 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 8.9 p -67.41 -10.22 49.16 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 123.544 0.738 . . . . 0.0 112.28 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -87.28 -0.15 56.3 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.59 0.71 . . . . 0.0 109.677 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -116.86 93.45 41.55 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.749 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -93.5 175.46 1.51 Allowed 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.134 2.556 . . . . 0.0 111.483 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 68.05 17.29 9.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.87 17.89 79.39 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.862 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -83.78 41.94 0.82 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.216 1.008 . . . . 0.0 109.583 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -71.49 149.44 93.6 Favored Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.799 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.91 169.37 20.53 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.392 2.728 . . . . 0.0 112.872 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -106.2 130.61 54.04 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.22 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.06 136.99 51.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -123.55 163.36 21.12 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.829 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.81 145.72 44.35 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.192 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -129.79 144.15 51.16 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.137 0.494 . . . . 0.0 111.216 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.83 -22.4 46.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.402 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 15.9 ptpt -159.44 -179.3 7.81 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -65.1 -33.82 76.93 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.498 0.666 . . . . 0.0 110.74 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.489 ' H ' ' HG3' ' B' ' 212' ' ' LYS . 14.2 m-70 -108.16 23.68 14.13 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.933 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -82.97 170.2 15.17 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.71 159.7 20.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.33 114.19 20.63 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.931 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.37 124.63 37.49 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.6 pt? -60.25 -26.73 66.67 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 123.582 0.753 . . . . 0.0 112.577 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.263 16.4 m 40.38 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -103.5 114.87 29.48 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 81.8 m -135.35 135.96 41.13 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 25.1 m -110.7 149.46 30.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.91 107.65 23.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.37 96.91 6.39 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.02 -94.57 0.37 Allowed Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.545 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -121.12 11.07 10.84 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 111.096 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 8.4 m -119.21 130.47 55.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.78 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 95.4 mt -93.18 126.21 38.17 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 222' ' ' THR . 60.8 mt -109.47 101.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.46 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -86.61 121.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -81.41 100.83 9.48 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 121.59 136.34 4.98 Favored Glycine 0 C--N 1.276 -2.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.649 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 22.3 p -92.57 129.58 38.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.782 0.325 . . . . 0.0 110.27 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.64 150.53 76.0 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.0 -22.67 47.67 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.543 2.162 . . . . 0.0 112.726 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -141.75 138.96 32.7 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.56 151.72 50.72 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.95 120.19 39.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.91 136.51 35.09 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.674 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -126.45 118.85 25.8 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.097 0.475 . . . . 0.0 109.949 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.527 ' CB ' HD22 ' B' ' 178' ' ' LEU . 12.9 m-70 -127.03 100.63 6.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.135 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 57.88 -104.05 0.4 Allowed Glycine 0 C--N 1.305 -1.139 0 O-C-N 123.79 0.681 . . . . 0.0 114.458 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -90.55 -21.16 21.91 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.406 0.682 . . . . 0.0 110.58 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -117.58 164.9 14.24 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.59 149.88 22.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.471 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.54 125.75 69.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' B' ' 169' ' ' TYR . . . -101.24 129.69 9.98 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.13 128.89 55.71 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.892 0.477 . . . . 0.0 110.228 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.478 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 56.8 ttp180 -110.05 123.58 49.94 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.576 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.45 126.79 32.62 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -69.61 154.93 41.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.583 0.552 . . . . 0.0 112.384 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' B' ' 254' ' ' GLN . 13.2 tmtt? -66.62 143.96 56.69 Favored 'General case' 0 N--CA 1.416 -2.153 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.915 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . 0.473 ' N ' ' HD3' ' B' ' 253' ' ' LYS . 78.8 mt-30 -80.93 100.47 8.91 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.582 1.182 . . . . 0.0 111.148 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? . . . . . 0 C--N 1.29 -2.006 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.228 -178.853 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.553 1.071 0 CA-C-O 121.277 0.561 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -133.75 109.46 12.04 Favored Pre-proline 0 N--CA 1.434 -1.242 0 O-C-N 121.227 -0.92 . . . . 0.0 110.061 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -95.79 34.76 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.813 2.342 . . . . 0.0 110.097 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.1 146.89 95.35 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.887 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.86 105.27 0.15 Allowed 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 122.274 1.983 . . . . 0.0 112.915 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.504 ' H ' HG11 ' B' ' 246' ' ' VAL . 4.4 m-20 -67.74 84.87 0.2 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -121.25 135.22 55.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.91 166.32 13.93 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.356 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 -71.15 2.95 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 31.0 mmm180 -84.76 69.09 10.65 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.811 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 47.3 m95 -85.6 103.55 14.54 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HE3' ' OH ' ' B' ' 169' ' ' TYR . 26.4 ttpp -130.96 148.21 52.69 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -65.04 138.87 58.61 Favored 'General case' 0 C--O 1.254 1.301 0 O-C-N 124.03 0.831 . . . . 0.0 109.909 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.39 21.55 5.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 123.098 1.428 . . . . 0.0 109.363 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 31.4 t-20 -67.58 100.56 0.89 Allowed 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.952 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.401 ' HA ' ' HG3' ' B' ' 182' ' ' ARG . 30.5 t-80 70.52 -7.18 1.06 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.484 1.114 . . . . 0.0 112.911 173.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 181' ' ' SER . 70.0 t80 68.77 93.01 0.08 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -168.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.87 -31.56 14.28 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.628 -168.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 1.4 mp0 -60.74 106.96 0.63 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.149 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.56 117.4 57.08 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.285 -175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.03 -49.14 7.01 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.124 1.883 . . . . 0.0 110.648 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 1.2 p -119.06 94.44 4.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.329 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 45' ' ' THR . 14.6 mm-40 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.716 2.007 . . . . 0.0 107.759 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.965 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 26.1 t -88.26 82.9 6.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -94.16 104.82 16.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 56.6 ttp -108.63 118.9 37.97 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -76.84 97.3 4.51 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.531 0.681 . . . . 0.0 109.459 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.38 106.17 17.76 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.419 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -109.33 120.93 44.0 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.418 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.61 136.95 23.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.324 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.21 171.76 8.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.806 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -76.59 142.99 40.54 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.646 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -134.07 149.69 51.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -79.15 102.92 8.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -100.33 11.33 39.65 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.392 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 99.2 m-85 -69.14 116.98 10.21 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' B' ' 184' ' ' TYR . 24.0 t80 -94.95 115.65 27.71 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 70.3 m-85 -98.97 -8.93 24.71 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -172.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 17.2 m-20 -79.84 110.92 15.66 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 118.061 -1.455 . . . . 0.0 112.901 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -153.47 150.48 28.81 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.194 -1.821 . . . . 0.0 106.594 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -127.29 152.37 47.53 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.447 ' OH ' ' HE3' ' A' ' 35' ' ' LYS . 22.6 p90 -122.31 153.79 38.48 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.63 142.02 39.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 124.019 0.824 . . . . 0.0 109.023 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.455 HG21 HG12 ' B' ' 179' ' ' ILE . 10.0 t -164.83 175.92 9.19 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -111.54 -7.22 14.32 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.536 0.522 . . . . 0.0 109.895 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -87.28 167.32 14.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.982 0.42 . . . . 0.0 110.753 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -121.28 5.84 10.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.571 177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.71 122.78 30.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.839 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.5 m -76.58 -3.83 39.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.508 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 44.7 p-90 -101.28 5.6 42.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.288 1.042 . . . . 0.0 110.485 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.495 ' HB3' ' ND2' ' B' ' 245' ' ' ASN . 86.5 mt -121.78 -24.82 5.17 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.032 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . 0.455 HG12 HG21 ' B' ' 171' ' ' THR . 87.6 mt -94.85 132.77 27.69 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.184 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 11.7 Cg_endo -61.53 140.43 87.1 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.279 1.986 . . . . 0.0 111.713 174.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 11.0 t -95.44 -25.86 16.08 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.747 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 39' ' ' HIS . 37.9 ttm105 -152.86 135.73 15.44 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.576 HG22 HG23 ' B' ' 192' ' ' ILE . 26.0 t -134.49 129.46 52.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' B' ' 164' ' ' TYR . 35.3 p90 -159.98 141.07 12.38 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 123.286 0.366 . . . . 0.0 110.185 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -113.4 163.72 14.51 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-O 121.229 0.538 . . . . 0.0 111.424 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 11.5 t70 -138.85 111.07 7.37 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.79 -62.9 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 O-C-N 124.021 0.825 . . . . 0.0 113.947 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -149.03 -34.53 0.2 Allowed 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 124.761 1.224 . . . . 0.0 109.927 -173.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.38 120.4 25.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 20.9 m -101.69 116.52 32.92 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -95.64 117.65 30.86 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.663 0.785 . . . . 0.0 109.524 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.576 HG23 HG22 ' B' ' 183' ' ' VAL . 11.5 mt -114.22 107.02 21.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -82.9 111.55 18.88 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.437 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 44.7 mtm -133.23 177.33 7.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' B' ' 198' ' ' ARG . 13.6 t0 -90.95 69.45 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.498 1.142 . . . . 0.0 108.263 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 59.1 mt -76.11 -12.8 60.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.669 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.06 -13.24 62.05 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.332 176.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' B' ' 177' ' ' TRP . 13.0 mmt180 -85.38 -7.46 58.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.635 0.731 . . . . 0.0 109.631 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.85 82.49 35.45 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.246 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -84.8 174.14 7.74 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.289 1.993 . . . . 0.0 112.231 -175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.0 m 61.97 23.58 13.91 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.516 1.127 . . . . 0.0 111.136 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . 0.534 ' HA2' ' CE2' ' B' ' 204' ' ' PHE . . . 78.39 17.76 77.27 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.193 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -88.81 42.56 1.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.972 0.892 . . . . 0.0 109.858 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.534 ' CE2' ' HA2' ' B' ' 202' ' ' GLY . 70.3 m-85 -65.85 156.17 84.34 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.698 -175.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.0 169.24 16.86 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.374 2.716 . . . . 0.0 113.287 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -93.04 146.56 23.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.697 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.447 HG11 HG21 ' B' ' 222' ' ' THR . 11.3 p -136.79 143.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -139.56 167.63 21.65 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.25 151.84 40.65 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.516 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 51.3 mtt180 -135.03 147.56 49.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.171 0.51 . . . . 0.0 111.482 176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' B' ' 236' ' ' PRO . 33.3 mt-10 -74.4 -37.07 63.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 122.735 1.255 . . . . 0.0 107.74 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 34.8 mtmm -143.83 172.85 12.28 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.841 -172.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -26.37 61.53 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.291 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -106.97 19.93 19.77 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.109 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -94.64 175.92 6.48 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 11.7 pt-20 -87.66 166.98 14.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.693 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.37 123.13 33.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.219 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -98.48 132.11 44.18 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.468 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.4 pt? -66.12 -28.13 68.57 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.359 0.412 . . . . 0.0 111.956 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.266 18.1 m 41.94 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 127.182 2.193 . . . . 0.0 115.901 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' B' ' 232' ' ' HIS . 19.1 m120 -103.89 133.45 48.85 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.447 HG21 HG11 ' B' ' 207' ' ' VAL . 11.2 m -141.68 144.04 33.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.016 0.436 . . . . 0.0 110.802 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 63.3 m -122.68 146.87 47.09 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.01 114.76 47.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -121.55 95.27 4.61 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.757 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.92 -87.92 1.07 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.649 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.49 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.2 p30 -136.44 21.91 3.17 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.045 0.926 . . . . 0.0 109.133 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 12.5 m -123.03 127.16 48.39 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.522 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 72.7 mt -91.45 125.17 36.11 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.73 101.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 62.1 t -84.91 114.47 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' B' ' 221' ' ' ASN . 12.1 m170 -78.21 101.17 6.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 124.31 127.07 3.13 Favored Glycine 0 C--N 1.295 -1.746 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.261 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.4 p -89.28 124.36 34.33 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.924 0.393 . . . . 0.0 110.921 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.92 146.2 59.62 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' B' ' 211' ' ' GLU . 18.8 Cg_endo -64.21 -18.16 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.691 2.26 . . . . 0.0 113.845 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' B' ' 212' ' ' LYS . 92.5 m-85 -141.82 143.03 33.19 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -133.01 157.64 44.72 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.83 132.47 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 30.7 t -125.61 140.65 47.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -137.97 117.51 12.97 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.424 0.631 . . . . 0.0 110.218 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.569 ' HB2' HD22 ' B' ' 245' ' ' ASN . 12.4 m-70 -105.45 100.32 9.9 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.41 -95.63 0.12 Allowed Glycine 0 C--N 1.308 -0.993 0 O-C-N 123.603 0.565 . . . . 0.0 113.248 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -116.12 -0.05 12.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.875 1.321 . . . . 0.0 108.851 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.569 HD22 ' HB2' ' B' ' 242' ' ' HIS . 2.8 t30 -106.26 149.73 26.6 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 113.899 -1.501 . . . . 0.0 108.311 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.504 HG11 ' H ' ' A' ' 29' ' ' ASP . 10.8 p -146.0 147.21 18.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.244 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.14 138.82 50.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.56 136.49 13.6 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.15 135.78 53.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.967 0.413 . . . . 0.0 111.044 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -114.22 118.85 35.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.627 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.59 129.56 34.97 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 36.5 m-80 -85.99 138.26 32.11 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.21 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 154.44 30.1 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.135 173.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.27 101.73 0.14 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 124.312 1.008 . . . . 0.0 112.387 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 C--N 1.289 -2.043 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.796 174.546 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.437 -1.096 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -133.79 106.2 11.7 Favored Pre-proline 0 N--CA 1.428 -1.553 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.235 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -94.92 -172.01 0.24 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.152 1.902 . . . . 0.0 109.948 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.05 111.4 38.03 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -84.47 96.33 0.7 Allowed 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 122.111 1.874 . . . . 0.0 110.194 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -102.64 174.2 6.0 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.436 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 31.0 p90 -117.69 167.62 11.18 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.582 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.93 -169.06 28.74 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.124 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.63 -84.32 0.88 Allowed Glycine 0 N--CA 1.445 -0.701 0 O-C-N 124.112 0.536 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 33.1 tpt180 -78.62 74.41 5.16 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.173 0.989 . . . . 0.0 110.171 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 45.2 m95 -87.26 107.78 18.65 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.204 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.99 144.24 43.22 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.383 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -62.31 139.06 58.53 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.713 0.633 . . . . 0.0 110.088 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 p -119.73 25.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.72 1.248 . . . . 0.0 108.107 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 165' ' ' TYR . 47.1 t30 -58.29 104.02 0.18 Allowed 'General case' 0 C--O 1.251 1.14 0 CA-C-N 113.347 -1.751 . . . . 0.0 110.004 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.643 ' O ' ' HG3' ' B' ' 182' ' ' ARG . 36.4 m-70 77.94 -60.97 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 0.0 110.777 -176.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -155.53 177.18 11.66 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 125.248 1.419 . . . . 0.0 107.469 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -85.09 -54.39 4.66 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.43 98.78 0.02 OUTLIER 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.818 1.647 . . . . 0.0 113.891 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.59 93.44 0.05 OUTLIER Pre-proline 0 C--O 1.243 0.714 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.716 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.23 19.19 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.77 2.313 . . . . 0.0 111.958 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 m -66.81 -31.21 71.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.463 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 15.8 m -74.24 115.68 14.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.888 0.344 . . . . 0.0 111.359 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 36.6 m80 60.29 28.59 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.927 0.891 . . . . 0.0 112.918 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 25.5 ttt -74.85 -44.16 50.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.878 0.37 . . . . 0.0 110.5 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 m120 61.4 105.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.462 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.65 32.38 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.895 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -74.1 114.88 12.94 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 157' ' ' ILE . 3.1 mp -62.54 120.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.201 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.467 ' HB2' HH21 ' B' ' 162' ' ' ARG . 93.7 mt -98.89 126.8 44.65 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' B' ' 161' ' ' ARG . 33.2 mmtp -67.85 -171.88 0.24 Allowed 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.69 8.13 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 128.086 2.554 . . . . 0.0 113.474 -177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.473 ' H ' ' C ' ' B' ' 159' ' ' LYS . 98.4 mtt180 -88.59 -11.47 45.42 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.924 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.467 HH21 ' HB2' ' B' ' 158' ' ' LEU . 15.1 ptp180 -69.17 -46.03 68.52 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 122.391 1.091 . . . . 0.0 110.812 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 45.5 m-85 -164.05 151.12 11.87 Favored 'General case' 0 C--N 1.256 -3.466 0 C-N-CA 129.667 3.187 . . . . 0.0 103.376 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' B' ' 254' ' ' GLN . 9.2 t80 -96.48 112.25 24.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 117.859 -1.537 . . . . 0.0 108.91 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 95.1 m-85 -104.43 -12.36 16.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.562 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.86 110.15 14.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.605 -174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -153.14 151.83 30.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 249' ' ' LEU . 24.2 m-20 -124.93 146.78 49.18 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -112.38 148.6 33.95 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 33' ' ' ARG . . . -138.72 139.1 38.26 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.757 0.661 . . . . 0.0 110.222 175.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 12.6 t -167.81 165.92 13.8 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.836 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -110.55 12.72 22.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.752 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.6 t -99.92 155.79 17.49 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.155 0.502 . . . . 0.0 110.215 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.18 -10.73 16.33 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -70.11 113.35 7.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.505 0.669 . . . . 0.0 111.226 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 13.8 m -68.48 -15.7 63.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.726 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -89.69 1.05 56.54 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 242' ' ' HIS . 71.8 mt -107.08 -20.1 13.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 79.3 mt -94.6 136.34 23.23 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.486 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.22 142.04 59.3 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.648 2.232 . . . . 0.0 111.712 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 10.9 p -96.39 -23.77 16.46 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.462 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.643 ' HG3' ' O ' ' A' ' 39' ' ' HIS . 9.2 ttm180 -147.92 134.51 19.83 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.494 HG22 HG23 ' B' ' 192' ' ' ILE . 39.3 t -139.22 124.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -161.05 144.33 12.97 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 123.46 0.475 . . . . 0.0 110.503 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -122.69 168.08 12.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.909 0.861 . . . . 0.0 110.81 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 25.8 t70 -137.9 110.24 7.41 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 113.719 -1.582 . . . . 0.0 106.893 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 68.77 -66.01 0.45 Allowed Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.684 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -139.72 -44.12 0.44 Allowed 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.874 0.87 . . . . 0.0 110.526 -171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -76.48 116.67 17.38 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 12.3 m -103.07 122.7 45.21 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' B' ' 230' ' ' ILE . 83.0 m-85 -101.11 110.69 22.74 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 123.223 0.609 . . . . 0.0 109.428 -177.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.494 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.96 105.96 19.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.209 -177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -85.62 118.96 25.45 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 60.6 mtp -131.37 177.46 7.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.47 50.13 1.78 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.984 0.897 . . . . 0.0 108.986 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 52.4 mt -66.19 -10.99 46.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.557 -174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 5.5 t -60.95 -19.23 60.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 122.934 0.494 . . . . 0.0 111.408 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -78.39 -6.62 55.73 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.294 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' B' ' 203' ' ' ASN . 99.1 m-85 -114.45 92.38 27.98 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.76 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -89.13 175.15 3.51 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 19.7 m 69.53 5.29 5.09 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.371 1.068 . . . . 0.0 111.189 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.15 18.08 61.57 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' B' ' 199' ' ' PHE . 5.3 t30 -85.39 57.45 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.63 153.02 89.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.175 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.92 168.67 18.16 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 122.804 2.336 . . . . 0.0 112.445 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.01 116.54 33.1 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 222' ' ' THR . 6.9 p -104.82 137.26 34.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.307 0.575 . . . . 0.0 109.664 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' B' ' 217' ' ' ASP . 91.5 m-85 -130.12 165.4 22.37 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.907 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.35 150.66 39.79 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.804 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 87.9 mtt180 -132.93 143.85 49.76 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.044 0.449 . . . . 0.0 110.654 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -93.67 -8.94 39.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.33 0.586 . . . . 0.0 111.875 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 ptpt -151.41 171.09 18.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.47 -31.35 72.03 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.271 0.487 . . . . 0.0 111.583 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -111.33 24.6 12.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.459 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.637 ' HB2' ' HG2' ' B' ' 212' ' ' LYS . . . -70.98 172.84 8.33 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.94 154.02 34.04 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' B' ' 208' ' ' PHE . 21.7 m-20 -77.69 113.13 15.23 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -90.51 123.91 34.57 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.24 -27.18 68.26 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 124.165 0.915 . . . . 0.0 112.421 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 17.5 m 36.02 -166.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.951 0 C-N-CA 126.951 2.1 . . . . 0.0 116.008 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.72 126.59 54.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.484 HG21 HG11 ' B' ' 207' ' ' VAL . 29.4 m -140.91 136.5 32.34 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 9.4 m -110.68 142.15 42.98 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.3 102.53 13.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 120.923 0.392 . . . . 0.0 110.11 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -107.66 96.86 6.69 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.691 0.758 . . . . 0.0 110.436 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 74.33 -97.24 0.94 Allowed Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.783 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.44 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 34.3 p-10 -123.08 15.01 9.88 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 2.2 m -115.7 128.77 56.14 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' B' ' 196' ' ' LEU . 95.7 mt -96.83 112.68 24.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 190' ' ' THR . 56.2 mt -96.13 99.59 9.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 43.5 t -85.44 118.72 32.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.46 100.97 11.07 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.46 129.03 3.5 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.758 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 3.7 p -92.96 130.25 38.6 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.018 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.56 155.46 80.2 Favored Pre-proline 0 C--N 1.309 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -28.82 80.44 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.583 2.189 . . . . 0.0 112.712 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' B' ' 249' ' ' LEU . 95.4 m-85 -139.13 141.76 38.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.08 157.66 40.09 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.27 120.75 13.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.42 135.44 44.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -121.64 120.19 34.04 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 121.367 0.603 . . . . 0.0 109.829 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.461 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.9 m-70 -118.82 100.33 7.33 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.89 -109.76 3.07 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.959 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -106.78 -7.85 17.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.601 0.715 . . . . 0.0 109.634 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.12 142.72 33.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.04 149.74 32.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 50.3 t -124.48 127.85 73.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -105.8 140.64 15.2 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 168' ' ' ASP . 6.8 mp -118.37 132.11 56.28 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -109.98 125.61 53.07 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -86.3 124.25 32.45 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -76.04 167.04 22.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.525 0.515 . . . . 0.0 111.298 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 131.5 36.28 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.673 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' B' ' 164' ' ' TYR 0.274 3.8 pm0 -84.17 99.44 10.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -175.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt . . . . . 0 CA--C 1.491 -1.316 0 C-N-CA 128.331 2.653 . . . . 0.0 105.634 173.817 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -117.04 96.02 48.23 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 122.296 -0.253 . . . . 0.0 110.629 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -102.9 -150.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.371 0 C-N-CA 123.089 2.526 . . . . 0.0 107.995 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.28 122.2 4.09 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' B' ' 244' ' ' ASP . 31.2 Cg_exo -62.14 94.26 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.991 1.794 . . . . 0.0 108.338 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 153.0 31.84 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.398 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -82.63 125.54 31.3 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.52 -158.62 26.6 Favored Glycine 0 C--N 1.284 -2.352 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 -67.17 3.75 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.075 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -129.83 95.82 4.06 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -72.32 107.92 5.18 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.308 171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -124.9 156.69 37.53 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -83.81 135.96 34.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.36 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.559 ' HB ' ' CD1' ' B' ' 169' ' ' TYR . 14.5 p -116.64 17.53 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 123.197 1.475 . . . . 0.0 107.93 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -62.07 139.6 58.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.458 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' B' ' 165' ' ' TYR . 2.8 t60 -57.89 -19.35 28.87 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.528 1.131 . . . . 0.0 113.266 178.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -70.35 81.26 0.55 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.464 1.126 . . . . 0.0 111.681 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.49 93.39 4.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.92 -29.28 65.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.716 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 70.1 103.32 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.697 0 O-C-N 124.517 1.136 . . . . 0.0 110.658 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.56 99.58 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.063 1.842 . . . . 0.0 110.058 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.9 m -157.52 131.89 8.4 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--N 1.29 -1.988 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.646 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -150.55 -54.31 0.15 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.552 ' CD2' ' HG3' ' B' ' 153' ' ' MET . 42.2 t60 -110.5 126.47 54.4 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . 0.552 ' HG3' ' CD2' ' B' ' 152' ' ' HIS . 57.2 mtm 70.94 73.13 0.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 124.811 1.244 . . . . 0.0 112.531 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -106.57 16.5 24.51 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.29 1.519 . . . . 0.0 107.203 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.23 92.29 6.89 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 113.537 -1.665 . . . . 0.0 107.865 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.53 118.48 23.82 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.445 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 60.2 mt -75.08 136.73 24.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.77 162.11 13.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.037 0.446 . . . . 0.0 110.215 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -84.41 75.5 10.24 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.662 0.744 . . . . 0.0 111.291 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -96.86 116.71 29.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.59 141.85 58.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.587 0.555 . . . . 0.0 110.572 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -82.89 -7.26 59.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.059 0.933 . . . . 0.0 110.808 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 74.6 m-85 -83.6 120.06 25.5 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.163 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -97.86 115.64 28.48 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' HIS . 81.5 m-85 -102.06 -14.04 17.28 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -172.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.51 110.81 15.17 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.028 -176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -151.54 145.76 25.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.563 1.545 . . . . 0.0 107.721 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.405 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 21.7 m-20 -128.04 156.32 42.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 20.8 p90 -132.16 149.21 52.45 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.62 136.59 36.1 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 10.8 t -166.06 166.67 17.05 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -110.42 2.36 18.91 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.349 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 11.8 t -83.11 143.25 30.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.547 0.689 . . . . 0.0 109.204 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -106.98 11.56 29.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.119 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.68 117.88 31.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.937 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 39.2 m -70.19 -11.41 60.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -91.01 3.67 54.11 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.771 0.796 . . . . 0.0 111.311 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' CB ' ' B' ' 242' ' ' HIS . 80.1 mt -116.8 -19.98 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.746 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.9 mt -93.96 129.62 37.16 Favored Pre-proline 0 N--CA 1.42 -1.964 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.045 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' B' ' 194' ' ' MET . 12.3 Cg_endo -59.52 139.78 90.91 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.332 2.021 . . . . 0.0 111.62 176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 15.7 m -100.63 -18.82 16.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 34.1 ttm180 -155.15 132.9 11.35 Favored 'General case' 0 C--O 1.211 -0.961 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.663 HG22 HG23 ' B' ' 192' ' ' ILE . 38.9 t -139.86 128.69 27.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -160.36 150.71 18.3 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 123.448 0.468 . . . . 0.0 109.801 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.0 p30 -117.97 162.69 17.74 Favored 'General case' 0 CA--C 1.472 -2.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.32 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 29.5 t70 -138.05 110.64 7.54 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' B' ' 188' ' ' LYS . . . 74.01 -66.02 1.85 Allowed Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.725 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' B' ' 187' ' ' GLY . 2.6 mptm? -148.43 -33.78 0.23 Allowed 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 125.03 1.332 . . . . 0.0 110.055 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -84.76 120.37 26.35 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.515 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 30.1 m -99.35 120.32 39.38 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.427 ' CD1' HG12 ' B' ' 230' ' ' ILE . 76.0 m-85 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.05 0.94 . . . . 0.0 108.774 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.663 HG23 HG22 ' B' ' 183' ' ' VAL . 12.0 mt -114.68 108.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 20.4 m120 -86.27 113.1 21.99 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.451 ' HG2' ' HA ' ' B' ' 180' ' ' PRO . 47.0 mtm -133.03 177.6 7.53 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.459 ' CG ' ' HE ' ' B' ' 198' ' ' ARG . 5.2 t0 -90.55 65.7 6.1 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.666 1.222 . . . . 0.0 109.403 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' B' ' 227' ' ' ASN . 60.9 mt -72.93 -11.28 60.52 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.2 -176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.6 p -67.49 -8.06 30.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.459 ' HE ' ' CG ' ' B' ' 195' ' ' ASP . 8.4 mmt180 -83.43 -12.48 56.35 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.542 0.687 . . . . 0.0 109.357 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -112.65 97.42 40.78 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.348 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.18 174.76 2.51 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 122.966 2.444 . . . . 0.0 111.961 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 5.0 m 63.93 21.21 12.54 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.067 0.947 . . . . 0.0 111.235 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 74.52 15.59 80.4 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.18 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -85.81 49.02 1.69 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.473 0.654 . . . . 0.0 110.602 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -68.91 155.81 92.65 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.999 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.51 169.09 16.44 Favored 'Trans proline' 0 C--O 1.242 0.683 0 C-N-CA 122.898 2.399 . . . . 0.0 112.508 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.02 133.51 44.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.705 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.468 HG11 HG21 ' B' ' 222' ' ' THR . 9.4 p -116.75 143.82 26.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -131.73 157.75 42.97 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -117.8 150.55 38.96 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.392 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 86.2 mtt180 -133.55 143.96 49.04 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.74 -19.15 31.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.849 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 35.4 mtmm -151.2 166.3 31.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.415 ' HG2' ' CD2' ' B' ' 214' ' ' HIS . 0.3 OUTLIER -72.41 -27.71 62.52 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.543 0.687 . . . . 0.0 109.181 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' B' ' 213' ' ' GLU . 18.0 m170 -101.0 14.09 33.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.585 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.95 175.19 6.88 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 16.2 pt-20 -87.83 161.5 17.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.619 -1.233 . . . . 0.0 110.774 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.31 123.8 32.67 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.764 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -104.31 130.92 52.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.077 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.559 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.3 pt? -60.22 -25.61 65.77 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.203 1.001 . . . . 0.0 113.395 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.3 m 40.16 -170.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.2 122.41 45.87 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.967 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.468 HG21 HG11 ' B' ' 207' ' ' VAL . 87.5 m -141.61 134.37 28.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.123 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.8 m -110.87 143.74 41.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -111.85 119.94 61.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.713 0.768 . . . . 0.0 111.642 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -111.31 85.07 2.05 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.649 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.86 -92.52 0.2 Allowed Glycine 0 C--N 1.306 -1.108 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.914 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 31.6 p30 -111.14 10.29 21.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.144 0.497 . . . . 0.0 111.019 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 3.2 m -123.51 124.8 43.65 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.854 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . . . . . . . . . 79.3 mt -93.41 126.25 38.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' B' ' 190' ' ' THR . 61.4 mt -103.56 101.27 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -86.0 120.89 36.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.75 0.786 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -81.79 101.84 10.41 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.657 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 55.16 0.53 Allowed Glycine 0 C--N 1.303 -1.255 0 N-CA-C 116.927 1.531 . . . . 0.0 116.927 167.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 18.4 p 6.65 114.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 128.564 2.746 . . . . 0.0 116.976 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -119.11 147.86 43.67 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.38 -23.84 58.1 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.409 2.073 . . . . 0.0 112.815 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.72 141.55 33.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.43 150.96 52.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 80.9 t -133.1 126.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.31 144.95 19.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -130.4 117.25 19.42 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.441 0.639 . . . . 0.0 110.295 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.456 ' CB ' HD22 ' B' ' 178' ' ' LEU . 13.7 m-70 -116.85 100.69 7.95 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.49 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 63.04 -103.79 0.7 Allowed Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.503 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 8.5 m-20 -99.87 -10.6 21.56 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.047 0.451 . . . . 0.0 110.109 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 28' ' ' PRO . 14.4 m-80 -105.03 146.61 28.85 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.753 -168.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.37 146.72 33.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.25 133.65 68.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -106.49 123.49 7.41 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.7 139.82 47.99 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 29.4 ptt180 -123.23 139.2 54.29 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -94.1 129.17 40.75 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -72.29 134.03 45.33 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.134 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 164.76 25.45 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.406 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -66.14 99.97 0.56 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt . . . . . 0 C--O 1.259 1.599 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.842 -173.523 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -142.17 92.82 7.45 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.53 95.6 0.99 Allowed 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.906 1.737 . . . . 0.0 111.506 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 93.5 6.18 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.862 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.38 124.13 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.147 1.898 . . . . 0.0 111.549 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -147.99 173.92 12.42 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -62.93 153.68 32.74 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.189 0.518 . . . . 0.0 112.204 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.4 -157.63 33.87 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 120.006 -1.093 . . . . 0.0 112.177 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.67 58.11 0.71 Allowed Glycine 0 CA--C 1.476 -2.35 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.62 39.46 3.35 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.894 -1.153 . . . . 0.0 108.238 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 250' ' ' ARG . 78.7 m95 -49.68 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 124.545 1.153 . . . . 0.0 111.819 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' B' ' 169' ' ' TYR . 82.0 tttt -115.42 140.22 49.33 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.352 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -75.2 119.03 18.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 123.714 0.634 . . . . 0.0 111.105 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -115.63 95.92 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 121.975 0.893 . . . . 0.0 110.322 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -142.06 129.78 21.61 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' B' ' 157' ' ' ILE . 35.8 t-80 43.17 62.77 1.72 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.002 1.321 . . . . 0.0 111.327 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -86.27 92.01 8.65 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.36 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.02 -20.67 28.49 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.92 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -51.51 93.18 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.546 1.538 . . . . 0.0 112.391 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.05 113.56 62.46 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.19 87.65 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.138 1.892 . . . . 0.0 111.654 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 m -79.95 -30.93 39.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.855 1.262 . . . . 0.0 111.739 172.341 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 19.6 m 68.31 159.46 0.16 Allowed 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.345 1.058 . . . . 0.0 112.011 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 74.46 125.36 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.096 1.358 . . . . 0.0 111.602 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.54 118.52 14.46 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 73.68 81.95 0.12 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 124.637 1.175 . . . . 0.0 109.171 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.4 141.74 57.42 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.233 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -82.69 115.68 21.73 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 39' ' ' HIS . 77.7 mt -105.55 136.72 38.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.04 -178.16 4.97 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -124.02 173.08 8.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -143.56 143.46 31.53 Favored 'General case' 0 C--O 1.201 -1.452 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 43.99 -100.0 0.03 OUTLIER 'General case' 0 C--O 1.236 0.382 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -132.56 19.3 4.29 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 89.2 m-85 -74.76 116.86 15.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.925 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -95.35 112.71 24.38 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -105.09 -0.12 26.97 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -87.62 110.31 20.3 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.889 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' B' ' 250' ' ' ARG . 37.8 m-85 -152.84 161.58 42.38 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.722 0.809 . . . . 0.0 110.975 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -139.11 154.76 48.18 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.465 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 45.0 p90 -129.28 144.6 51.29 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.922 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.34 118.2 13.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.651 0.739 . . . . 0.0 112.202 177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.608 ' HB ' ' HB ' ' B' ' 247' ' ' VAL . 10.0 t -144.7 171.29 14.61 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -123.32 15.15 9.71 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.33 0.586 . . . . 0.0 111.444 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -89.16 158.01 18.07 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -107.92 -2.04 20.15 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.131 0.491 . . . . 0.0 109.747 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -81.37 115.75 20.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.831 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -70.52 -13.77 62.25 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.646 ' HA ' ' HB3' ' B' ' 195' ' ' ASP . 18.6 p-90 -86.22 5.96 31.74 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.641 0.734 . . . . 0.0 111.928 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' B' ' 242' ' ' HIS . 74.0 mt -121.46 -10.42 8.86 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.09 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.28 136.48 20.03 Favored Pre-proline 0 N--CA 1.434 -1.273 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.182 -177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.24 148.85 31.1 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.946 1.764 . . . . 0.0 111.225 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 23.5 m -106.79 -34.85 7.14 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 32.6 ttt180 -136.77 132.32 34.59 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.39 128.13 33.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.8 142.19 12.01 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 123.593 0.558 . . . . 0.0 109.954 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.5 p-10 -117.29 166.13 12.65 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 15.8 t70 -136.3 110.48 8.36 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.41 -65.51 0.57 Allowed Glycine 0 CA--C 1.537 1.406 0 O-C-N 124.126 0.891 . . . . 0.0 113.588 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -144.01 -38.25 0.31 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 124.167 0.987 . . . . 0.0 110.678 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -80.14 117.59 21.08 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.474 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' B' ' 231' ' ' VAL . 14.2 m -100.87 118.55 37.15 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -99.58 114.67 27.83 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.584 0.754 . . . . 0.0 109.627 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 228' ' ' THR . 11.6 mt -113.85 108.46 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.153 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 17.4 m120 -82.98 115.77 21.97 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' B' ' 227' ' ' ASN . 55.4 mtp -131.6 177.28 7.63 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' B' ' 177' ' ' TRP . 6.0 t70 -89.89 52.0 2.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' B' ' 229' ' ' LEU . 57.9 mt -68.94 -11.21 60.44 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.818 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.8 p -61.66 -13.49 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.491 1.116 . . . . 0.0 112.331 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -90.21 -4.38 57.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.321 0.581 . . . . 0.0 110.095 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -114.1 91.13 21.8 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.137 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -96.86 175.88 0.65 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.693 2.929 . . . . 0.0 111.193 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 10.7 m 68.06 15.5 9.45 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 111.392 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 88.35 12.58 64.96 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.386 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.82 32.32 0.37 Allowed 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.241 -0.564 . . . . 0.0 112.27 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -65.18 148.74 97.7 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.502 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.65 168.53 22.45 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.898 2.398 . . . . 0.0 112.87 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -102.55 135.63 43.83 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.64 140.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.536 ' CB ' ' HB2' ' B' ' 217' ' ' ASP . 76.4 m-85 -127.89 164.82 21.41 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.72 -177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.1 155.71 32.46 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 217' ' ' ASP . 85.6 mtt180 -139.24 144.29 38.37 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.92 -33.29 39.92 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.778 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 48.8 mtmt -140.27 163.25 33.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -60.16 -35.98 76.54 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.256 0.972 . . . . 0.0 109.633 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -103.65 17.51 23.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.167 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.88 175.49 7.79 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.29 156.48 21.92 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.696 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . 0.576 ' HB3' ' HE ' ' B' ' 210' ' ' ARG . 2.5 p-10 -91.58 122.8 34.48 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 122.008 0.908 . . . . 0.0 110.807 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -94.41 132.56 38.92 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.529 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.44 ' HA ' ' CD2' ' B' ' 208' ' ' PHE . 4.7 pp -61.06 -26.83 67.91 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m 39.79 -174.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 126.506 1.922 . . . . 0.0 116.091 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -106.17 141.5 37.41 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.9 m -141.23 151.58 43.87 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 120.85 0.357 . . . . 0.0 110.938 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 23.8 m -127.72 144.95 51.05 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.94 112.15 36.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' B' ' 225' ' ' GLU . 6.0 mm-40 -117.4 102.63 9.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 69.28 -92.82 0.33 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.384 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 9.4 p30 -128.03 16.67 6.75 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.351 0.596 . . . . 0.0 109.685 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 10.4 m -121.64 127.77 51.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.649 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.1 mt -90.01 124.5 34.81 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 55.4 mt -102.62 99.97 9.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' B' ' 190' ' ' THR . 56.4 t -85.01 119.13 33.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -79.15 101.45 7.94 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 119.26 125.81 3.42 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.309 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.5 p -91.85 128.24 37.61 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.165 0.507 . . . . 0.0 111.681 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -127.86 154.4 78.15 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.01 -26.26 73.9 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.208 1.939 . . . . 0.0 112.791 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -137.6 141.36 41.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.55 159.23 35.25 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.45 124.04 20.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 128.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -123.66 117.2 24.46 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.428 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.2 m-70 -111.64 100.33 8.88 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 60.13 -103.07 0.41 Allowed Glycine 0 C--N 1.306 -1.101 0 O-C-N 123.796 0.685 . . . . 0.0 112.557 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -114.12 7.7 16.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.128 0.489 . . . . 0.0 111.46 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.67 150.95 28.29 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.8 148.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.661 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 171' ' ' THR . 3.8 p -133.17 136.76 54.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 122.939 0.496 . . . . 0.0 110.374 177.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -101.33 138.97 14.17 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.37 137.07 52.45 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' B' ' 167' ' ' TYR . 58.8 ttp180 -113.18 122.11 46.51 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.971 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 -87.64 121.34 29.94 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -84.33 111.04 19.06 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -67.99 150.21 48.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.388 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -95.18 117.28 29.95 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.499 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.441 -0.901 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -154.05 93.85 2.92 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-O 120.785 0.326 . . . . 0.0 111.129 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -96.48 3.21 1.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.323 2.015 . . . . 0.0 110.994 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.83 136.13 34.76 Favored Pre-proline 0 C--O 1.244 0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.749 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.65 141.97 35.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.669 2.246 . . . . 0.0 112.662 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -137.08 -177.01 4.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -91.28 131.03 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.542 0.687 . . . . 0.0 110.669 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.4 -157.26 27.33 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.19 -68.89 3.44 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -128.58 95.53 4.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 122.319 0.247 . . . . 0.0 111.264 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 65.9 m95 -77.2 108.29 10.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -125.14 149.67 47.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -74.31 149.07 40.85 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.3 18.95 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.39 1.091 . . . . 0.0 110.296 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -76.35 93.39 3.45 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.216 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.4 t60 61.51 80.41 0.22 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 122.023 0.916 . . . . 0.0 112.539 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -132.79 24.4 4.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.93 1.348 . . . . 0.0 108.137 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.3 -40.49 17.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -91.91 -68.69 0.78 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.544 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 54.48 85.53 0.19 Allowed Pre-proline 0 C--N 1.342 0.264 0 O-C-N 124.492 1.12 . . . . 0.0 111.518 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.51 -65.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.6 2.2 . . . . 0.0 112.369 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -141.3 101.2 3.96 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.253 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.916 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.506 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 23.8 p -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.259 -0.554 . . . . 0.0 110.732 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.1 m80 71.36 13.52 6.58 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.535 1.134 . . . . 0.0 110.803 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 27.1 ttt -79.78 98.99 7.26 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.28 23.63 5.68 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 122.74 1.257 . . . . 0.0 111.177 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.44 170.15 10.26 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.053 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -93.63 172.65 8.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 50.6 mt -89.09 108.92 19.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.682 ' H ' HD23 ' B' ' 158' ' ' LEU . 2.1 pt? -94.49 132.92 38.65 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.745 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -97.79 179.0 4.96 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -68.98 139.23 55.01 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 123.456 0.702 . . . . 0.0 111.021 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 161' ' ' ARG . 23.9 mmt180 -130.6 178.36 6.68 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -97.35 4.68 50.68 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 109.645 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' B' ' 186' ' ' ASP . 71.5 m-85 -73.62 108.49 6.49 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 166' ' ' ASP . 37.4 t80 -92.25 113.0 25.15 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.4 -8.78 31.51 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.438 ' HB2' ' CE2' ' B' ' 164' ' ' TYR . 17.5 m-20 -80.04 110.55 15.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.328 -172.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -152.54 148.93 27.96 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 125.613 1.565 . . . . 0.0 106.929 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' B' ' 250' ' ' ARG . 7.1 m-20 -125.09 151.75 45.27 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -122.6 146.92 47.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.48 134.54 34.12 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . . . . . . . . . 8.8 t -168.5 160.34 10.95 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -97.38 1.06 48.89 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.719 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 6.4 t -93.95 157.81 15.93 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -125.53 14.7 8.2 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.92 114.28 16.63 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 15.7 p -67.2 -10.31 49.17 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 123.578 0.751 . . . . 0.0 112.313 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.447 ' HA ' ' CB ' ' B' ' 195' ' ' ASP . 22.3 p-90 -96.18 1.22 52.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.933 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.454 HD22 ' CB ' ' B' ' 242' ' ' HIS . 59.5 mt -115.38 -26.96 7.37 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 81.1 mt -94.02 129.72 36.7 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.386 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.07 150.33 79.54 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.058 2.505 . . . . 0.0 113.283 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 11.1 m -93.38 -37.14 12.15 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.437 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -151.17 130.4 12.75 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 192' ' ' ILE . 21.4 t -131.02 127.25 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.21 143.57 13.81 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.7 p-10 -113.85 167.07 10.95 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 121.446 0.641 . . . . 0.0 110.863 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.466 ' HB2' ' CD1' ' B' ' 163' ' ' TYR . 8.7 t70 -134.84 109.21 8.38 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 170.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.35 -63.04 0.59 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.023 0.827 . . . . 0.0 114.414 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -148.31 -34.14 0.23 Allowed 'General case' 0 C--O 1.202 -1.42 0 C-N-CA 125.478 1.511 . . . . 0.0 110.132 -172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -83.68 119.14 24.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 19.9 m -99.41 118.61 36.41 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.44 114.43 26.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 183' ' ' VAL . 10.1 mt -113.8 103.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -79.7 114.31 18.52 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 71.3 mtp -131.46 173.64 10.88 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . 0.447 ' CB ' ' HA ' ' B' ' 177' ' ' TRP . 0.2 OUTLIER -87.91 54.13 3.0 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.474 HD11 ' HG ' ' B' ' 229' ' ' LEU . 67.3 mt -71.46 -11.04 60.67 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.2 -175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 6.7 p -68.72 -8.67 44.94 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.551 1.141 . . . . 0.0 111.463 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.433 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.91 96.16 40.43 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.91 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -91.54 172.4 2.78 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 C-N-CA 122.918 2.412 . . . . 0.0 113.093 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' B' ' 203' ' ' ASN . 2.2 m 63.2 23.02 13.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.072 1.349 . . . . 0.0 111.35 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.25 79.64 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.636 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' B' ' 201' ' ' THR . 54.9 m-80 -87.06 47.85 1.56 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.229 0.538 . . . . 0.0 111.129 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.28 146.19 98.98 Favored Pre-proline 0 N--CA 1.434 -1.249 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.298 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' B' ' 242' ' ' HIS . 42.6 Cg_endo -65.54 164.64 25.5 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.787 2.325 . . . . 0.0 112.223 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.15 122.18 42.01 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.985 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.94 137.07 34.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.97 162.7 23.92 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.649 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 149.63 43.91 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.244 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 85.8 mtt180 -131.15 143.07 50.35 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.151 0.501 . . . . 0.0 109.94 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -90.45 -10.77 42.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.502 0.668 . . . . 0.0 110.98 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' B' ' 210' ' ' ARG . 17.8 ttmm -151.71 160.16 43.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 174.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.44 -29.7 68.41 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.288 0.566 . . . . 0.0 110.941 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -100.1 17.95 19.85 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.158 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -87.12 178.34 6.93 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 12.1 pt-20 -81.27 162.2 23.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -83.62 116.96 22.86 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -96.2 128.46 43.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.9 -18.34 63.39 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 123.572 0.545 . . . . 0.0 111.541 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' B' ' 221' ' ' ASN . 17.2 m 37.66 -163.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.515 1.926 . . . . 0.0 114.76 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' B' ' 220' ' ' VAL . 47.0 t30 -113.33 129.89 56.41 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 230' ' ' ILE . 89.2 m -141.92 136.02 30.02 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.78 -177.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 10.2 m -112.57 141.83 45.87 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.39 111.92 38.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.805 0.812 . . . . 0.0 111.476 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -107.17 95.52 5.77 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.768 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 68.32 -97.69 0.47 Allowed Glycine 0 C--N 1.291 -1.932 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.504 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -117.98 15.85 14.23 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.371 0.605 . . . . 0.0 109.694 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 192' ' ' ILE . 18.4 m -117.82 128.6 55.01 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.474 ' HG ' HD11 ' B' ' 196' ' ' LEU . 96.4 mt -94.36 120.1 34.09 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 222' ' ' THR . 66.8 mt -99.62 101.44 12.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.3 t -86.44 118.02 32.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.84 101.13 8.34 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 122.61 128.79 3.45 Favored Glycine 0 C--N 1.289 -2.037 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.433 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 5.8 p -93.51 121.22 34.7 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -120.29 151.82 53.96 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -27.45 76.93 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.18 1.92 . . . . 0.0 112.356 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -138.57 142.16 39.22 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -132.04 151.95 51.45 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 88.8 t -137.23 119.73 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.24 137.2 31.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -123.19 116.65 23.75 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.454 ' CB ' HD22 ' B' ' 178' ' ' LEU . 16.0 m-70 -118.84 101.64 8.22 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.553 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.36 -105.03 0.78 Allowed Glycine 0 C--N 1.301 -1.398 0 O-C-N 123.804 0.69 . . . . 0.0 111.95 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -113.84 3.87 15.65 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.957 0.408 . . . . 0.0 110.753 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -109.89 150.26 28.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.52 149.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.77 127.86 68.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -102.5 128.59 9.6 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.22 142.97 45.95 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' B' ' 168' ' ' ASP . 33.5 ptt180 -123.61 142.41 51.07 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.709 175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.43 129.98 39.4 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -73.1 133.72 44.25 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.491 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -70.15 159.38 34.04 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.609 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -90.3 99.59 12.58 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 C--N 1.285 -2.203 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.902 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -133.11 117.99 14.99 Favored Pre-proline 0 N--CA 1.426 -1.629 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.2 96.7 0.96 Allowed 'Trans proline' 0 N--CA 1.422 -2.718 0 C-N-CA 121.15 1.233 . . . . 0.0 111.423 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.43 146.13 80.51 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.01 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.35 151.48 54.05 Favored 'Trans proline' 0 C--O 1.256 1.405 0 C-N-CA 122.628 2.219 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 72.23 -70.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.602 1.161 . . . . 0.0 112.858 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' CG ' ' HA3' ' B' ' 248' ' ' GLY . 50.5 p90 -124.94 134.69 52.55 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.414 0.626 . . . . 0.0 110.926 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.15 -163.66 31.1 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 -57.97 4.83 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' B' ' 170' ' ' ALA . 24.1 mmm180 -124.88 92.99 3.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 122.376 0.27 . . . . 0.0 110.732 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.559 ' CD2' ' HB2' ' B' ' 170' ' ' ALA . 53.6 m95 -88.23 105.25 17.41 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.529 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -124.95 140.44 52.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.367 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -66.8 146.91 53.93 Favored 'General case' 0 C--O 1.257 1.462 0 CA-C-O 121.05 0.452 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' B' ' 169' ' ' TYR . 15.0 p -133.94 28.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.798 1.285 . . . . 0.0 108.308 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.428 HD22 ' C ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -65.04 89.22 0.08 Allowed 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.31 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 55.38 86.92 0.05 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.015 1.326 . . . . 0.0 111.452 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 87.24 129.23 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.753 1.621 . . . . 0.0 112.868 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -82.6 -28.22 30.99 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -91.28 21.19 4.57 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.53 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.86 103.86 12.85 Favored Pre-proline 0 N--CA 1.446 -0.647 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.26 121.45 6.49 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.491 2.128 . . . . 0.0 112.848 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.3 m -103.87 -30.72 10.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.359 0.6 . . . . 0.0 109.644 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.433 -1.288 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.755 177.512 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' SER . . . . . . . . . . . . . 24.7 p -116.16 -12.6 11.21 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.873 0.336 . . . . 0.0 111.065 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m170 66.36 18.35 10.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.024 0.93 . . . . 0.0 111.463 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.03 136.3 50.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -89.91 128.71 36.27 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.063 0.459 . . . . 0.0 109.969 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.62 104.92 15.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -87.27 122.88 31.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 53.0 mt -76.5 106.05 6.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 94.1 mt -71.63 130.26 40.76 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.068 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -114.52 104.12 11.7 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.893 -175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.7 136.27 52.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.701 0.762 . . . . 0.0 109.571 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' ARG . . . . . 0.645 ' HD3' ' OD2' ' B' ' 186' ' ' ASP . 76.7 mtt180 -88.53 172.66 9.16 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.21 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -96.43 84.63 3.75 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.427 0.632 . . . . 0.0 109.431 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' B' ' 185' ' ' ASP . 75.9 m-85 -74.7 129.89 38.53 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.548 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' B' ' 254' ' ' GLN . 14.4 t80 -96.62 112.93 24.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 85.2 m-85 -98.68 -11.38 22.06 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.987 -173.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' B' ' 252' ' ' ASN . 5.1 m-20 -73.86 110.47 8.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.339 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -154.36 148.7 26.08 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.522 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -132.06 154.15 49.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . 0.441 ' CD2' ' HB ' ' A' ' 37' ' ' VAL . 5.4 p90 -123.8 154.83 39.01 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 34' ' ' TRP . . . -138.33 143.2 39.81 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' THR . . . . . 0.551 ' OG1' HG22 ' B' ' 173' ' ' THR . 8.9 t -166.45 170.76 12.58 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -109.85 2.3 19.8 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.551 HG22 ' OG1' ' B' ' 171' ' ' THR . 13.1 t -94.66 158.21 15.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.676 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -122.26 12.25 10.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.36 112.27 24.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.979 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 49.3 m -72.11 2.03 6.48 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' TRP . . . . . 0.407 ' HB2' ' HG3' ' B' ' 198' ' ' ARG . 27.7 p-90 -101.28 5.29 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.035 0.922 . . . . 0.0 109.753 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' B' ' 242' ' ' HIS . 71.2 mt -120.87 -23.17 5.99 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.632 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 94.7 mt -94.1 141.0 23.06 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.38 149.0 85.01 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.418 2.079 . . . . 0.0 111.812 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 31.0 p -103.47 -22.53 13.63 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.005 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' B' ' 193' ' ' ASN . 8.8 ttm180 -153.29 131.78 12.15 Favored 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.424 HG22 HG23 ' B' ' 192' ' ' ILE . 14.7 t -136.82 129.9 45.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -160.82 139.68 10.24 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.655 0.597 . . . . 0.0 110.0 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 163' ' ' TYR . 4.1 p30 -111.86 166.57 11.08 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.427 0.632 . . . . 0.0 110.856 177.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.645 ' OD2' ' HD3' ' B' ' 161' ' ' ARG . 19.2 t70 -139.03 111.76 7.75 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.778 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.94 -62.64 0.2 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 124.322 1.014 . . . . 0.0 114.19 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.83 -41.28 0.28 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.291 1.436 . . . . 0.0 108.483 -174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -77.58 115.53 17.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.695 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 230' ' ' ILE . 18.8 m -99.18 115.26 28.66 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' B' ' 230' ' ' ILE . 94.6 m-85 -95.9 110.43 22.62 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.354 0.597 . . . . 0.0 110.184 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . 0.424 HG23 HG22 ' B' ' 183' ' ' VAL . 7.3 mt -112.89 105.19 18.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.831 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' B' ' 182' ' ' ARG . 18.4 m120 -81.92 115.84 21.29 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' HG11 ' B' ' 240' ' ' VAL . 63.2 mtp -129.31 178.79 6.19 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -90.72 58.48 3.89 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.462 1.125 . . . . 0.0 108.732 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' B' ' 229' ' ' LEU . 45.1 mt -73.69 -10.7 59.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.566 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -10.88 57.42 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 125.413 1.485 . . . . 0.0 112.057 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' B' ' 200' ' ' PRO . 21.5 mmt180 -85.63 -12.09 52.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.897 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -113.19 96.98 41.23 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.776 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' B' ' 198' ' ' ARG . 63.2 Cg_endo -93.7 175.3 1.47 Allowed 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 123.161 2.574 . . . . 0.0 111.313 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 3.1 m 67.29 17.72 10.24 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.69 15.76 81.31 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.576 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -80.84 40.89 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.177 0.591 . . . . 0.0 110.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -68.51 154.51 94.34 Favored Pre-proline 0 C--N 1.316 -0.877 0 C-N-CA 124.044 0.938 . . . . 0.0 112.582 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.86 169.29 22.72 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.37 2.714 . . . . 0.0 113.091 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' ALA . . . . . . . . . . . . . . . -95.94 145.93 25.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.478 HG11 HG21 ' B' ' 222' ' ' THR . 7.3 p -130.12 140.83 47.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' B' ' 218' ' ' PHE . 64.2 m-85 -130.96 161.9 30.9 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.855 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.34 31.43 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.308 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' B' ' 212' ' ' LYS . 83.4 mtt180 -134.55 144.12 47.79 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.257 0.551 . . . . 0.0 111.571 174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.45 6.45 48.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.596 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 215' ' ' ALA . 38.1 ttmt -167.59 167.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' B' ' 237' ' ' PHE . 2.6 mp0 -54.3 -48.43 71.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.162 0.982 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -112.05 26.99 10.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.506 -1.225 . . . . 0.0 112.469 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' B' ' 212' ' ' LYS . . . -76.37 -179.47 5.16 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 210' ' ' ARG . 13.7 pt-20 -71.66 150.81 44.23 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.2 114.87 26.6 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.622 0.725 . . . . 0.0 109.288 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' B' ' 208' ' ' PHE . 80.3 m-85 -91.07 142.46 27.74 Favored 'General case' 0 C--O 1.195 -1.789 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.683 -173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tp -66.2 -29.47 69.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.815 0.846 . . . . 0.0 111.562 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . 0.292 23.3 m 45.08 171.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.478 HG21 HG11 ' B' ' 207' ' ' VAL . 33.7 m -138.65 140.93 39.05 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' THR . . . . . . . . . . . . . 18.0 m -111.16 140.16 45.95 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.71 112.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -124.37 113.42 18.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 66.64 -91.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.704 0 O-C-N 124.24 0.962 . . . . 0.0 112.529 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 196' ' ' LEU . 32.7 p30 -135.01 14.64 3.57 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.388 0.613 . . . . 0.0 109.625 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 4.2 m -114.66 127.35 55.72 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.406 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.522 ' HG ' HD11 ' B' ' 196' ' ' LEU . 94.8 mt -92.59 114.27 26.77 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 222' ' ' THR . 52.7 mt -98.41 99.17 8.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.31 118.24 31.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -81.8 100.71 9.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' GLY . . . . . . . . . . . . . . . 128.67 135.43 3.99 Favored Glycine 0 C--N 1.293 -1.841 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.991 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.03 123.47 38.54 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.549 0.69 . . . . 0.0 111.504 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.15 150.5 59.95 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -66.16 -24.28 51.8 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 121.906 1.737 . . . . 0.0 112.253 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.548 ' CZ ' ' HG3' ' B' ' 213' ' ' GLU . 96.3 m-85 -141.08 143.46 34.36 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -129.01 157.55 41.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.7 118.35 11.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.455 HG11 ' SD ' ' B' ' 194' ' ' MET . 13.1 t -105.09 145.38 13.49 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -128.93 117.37 20.87 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' HIS . . . . . 0.456 ' HB3' HD22 ' B' ' 178' ' ' LEU . 11.1 m170 -112.47 100.36 8.69 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 62.45 -107.76 1.77 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.511 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.87 -18.81 20.06 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 123.289 0.636 . . . . 0.0 111.491 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.74 137.24 42.85 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.438 -172.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.54 149.69 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.94 129.42 72.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.465 ' HA3' ' CG ' ' A' ' 30' ' ' PHE . . . -104.01 125.95 8.59 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.16 129.09 55.19 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 123.08 0.552 . . . . 0.0 109.645 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.453 ' HB2' ' CH2' ' A' ' 34' ' ' TRP . 61.8 ttp180 -102.07 115.92 31.58 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.929 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -81.22 117.2 21.55 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' B' ' 166' ' ' ASP . 91.3 m-20 -67.61 148.26 51.63 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.678 -174.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.71 145.38 15.72 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.162 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' GLN . . . . . 0.477 ' HA ' ' OH ' ' B' ' 164' ' ' TYR . 25.1 mt-30 -79.42 98.78 6.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.92 0.866 . . . . 0.0 110.09 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' LYS . . . . . . . . . . . . . 19.9 pttp . . . . . 0 C--N 1.289 -2.048 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.339 -178.22 . . . . . . . . 0 0 . 1 stop_ save_